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5Abstract
The main objective of this thesis is to develop and analyze mathematical models of cel-
lular decisions. This work focuses on understanding the mechanisms involved in specific
cellular processes such as immune response in the vascular system, and those involved in
apoptosis, or programmed cellular death.
A series of simple ordinary differential equation (ODE) models are constructed de-
scribing the macrophage response to hemoglobin:haptoglobin (Hb:Hp) complexes that
may be present in vascular inflammation. The models proposed a positive feedback loop
between the CD163 macrophage receptor and anti-inflammatory cytokine interleukin-10
(IL-10) and bifurcation analysis predicted the existence of a cellular phenotypic switch
which was experimentally verified. Moreover, these models are extended to include the
intracellular mediator heme oxygenase-1 (HO-1). Analysis of the proposed models find a
positive feedback mechanism between IL-10 and HO-1. This model also predicts cellular
response of heme and IL-10 stimuli.
For the apoptotic (cell suicide) system, a modularized model is constructed encom-
passing the extrinsic and intrinsic signaling pathways. Model reduction is performed
by abstracting the dynamics of complexes (oligomers) at a steady-state. This simpli-
fied model is analyzed, revealing different kinetic properties between type I and type
II cells, and reduced models verify results. The second model of apoptosis proposes
a novel mechanism of apoptosis activation through receptor-ligand clustering, yielding
robust bistability and hysteresis. Using techniques from algebraic geometry, a model se-
lection criterion is provided between the proposed and existing model as experimental
data becomes available to verify the mechanism.
The models developed throughout this thesis reveal important and relevant mecha-
nisms specific to cellular response; specifically, interactions necessary for an organism
to maintain homeostasis are identified. This work enables a deeper understanding of the
biological interactions and dynamics of vascular inflammation and apoptosis. The results
of these models provide predictions which may motivate further experimental work and
theoretical study.
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Chapter 1
Introduction
This work presents a variety of mathematical approaches to model cellular decision-
making. Through the construction and analysis of mathematical models, the aim of
this research is to give quantitative and mechanistic insights to medically relevant ques-
tions in areas such as immune response in the vascular system and apoptosis, a type
of programmed-cell death. This research involves designing mathematical relationships
and methods to identify intra-cellular switches from a variety of available biological in-
formation and data. To achieve this, dynamical models are built, validated and analyzed;
moreover, model results provide insights to the general principles underlying the inter-
action and dynamical behavior of cellular biological switches. In this work, continuum
techniques are employed to depict the behavior of complex systems, and standard numer-
ical techniques are used to solve the models and compare model predictions to data.
In this thesis, two complex systems are studied: vascular inflammation and apopto-
sis. In these systems, the intra- and inter-cellular interactions may be difficult to explain
biologically or where intuition alone does not work. To gain a better insight of the com-
plicated interactions that occur among several agents requires a quantitative approach.
Therefore, mathematical models of cellular decision-making are developed and analyzed
to gain a better understanding of the underlying biology of these two topics. Inflamma-
tion in vascular plaques for this specific system have not previously been mathematically
modeled, and it is only recently that a better understanding of the network of compo-
nents has begun to emerge. While many models exist of the components of the apoptotic
signaling pathway, this work is one of the first simple full system models. In addition
to this work, a novel mechanism between the death receptor and ligand is hypothesized.
For both systems, the incorporation of biological knowledge and data of cellular mech-
anisms motivated the construction of models with results that may provide hypotheses
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and predictions. Overall, this work may have implications for future models of cellular
switching and provide mechanistic insights to the systems of interest.
The first set of models presented focus on immune response specific to an inflam-
matory disease called atherosclerosis. Atherosclerosis is a precursor to many acute car-
diovascular diseases that is characterized by the formation of plaque in the arterial wall.
When immune cells located in ruptured plaque are introduced to certain stimuli, these
cells may participate in a switch like transition in cellular phenotype. This switch is char-
acterized by the release of anti-inflammatory mediators, important for immune response.
In collaboration with Dr. Joseph J. Boyle and co-workers from the Imperial College Lon-
don Faculty of Medicine, a simplified model is developed based on these findings using a
pharmacological/systems biology approach. This effort resulted in a published paper in a
peer-reviewed journal with experimental and modeling results (Boyle et al., 2009) and is
presented in Chapter 4. Furthermore, this model is extended in Chapter 5 to describe the
intra-cellular mechanisms governing the anti-inflammatory response using experimental
data. These results are currently in preparation for submission.
The second focus of this thesis reproduces, extends and develops models of apoptosis,
or programmed-cell death, a regulatory process employed by the cell that is necessary for
homeostasis, or internal maintenance, of an organism. Apoptosis is characterized by a
series of molecular interactions which must behave appropriately to ensure homeostasis.
When dysregulation of apoptosis occurs, these interactions fail to respond properly and
this may result in cancer or neurodegenerative diseases. A modularized model is con-
structed and analyzed of the activation and signaling pathways involved in the apoptosis
process to highlight the key apoptotic mechanisms involved in different cell types and
lineages. This research was conducted in collaboration with participants from the 2007
Mathematical Biosciences Institute Summer School at Ohio State University, Colum-
bus, OH, USA, resulting in a first author published paper in a peer-reviewed journal
(Harrington et al., 2008) and is presented in Chapter 6. Subsequently, in collaboration
with co-author Kenneth L. Ho from Courant Institute of Mathematical Sciences at New
York University, New York, NY, USA, a novel mathematical model was developed of
receptor-ligand trimerization mechanisms in apoptosis, as presented in Chapter 7 and has
been accepted by PLoS Comput Biol for publication.
The thesis is organized as follows: relevant biology is introduced in Chapter 2 fol-
lowed by an introduction of the necessary mathematical modeling techniques in Chap-
ter 3. The results chapters of this thesis (Chapters 4 - 7) are split into two themes: the
first theme, models of immune cell response in vascular plaque, is presented in Chap-
ters 4 and 5. Simple models of vascular inflammation are presented in Chapter 4. These
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models are extended in Chapter 5 to investigate intracellular mechanisms, various signals,
and parameter fitting. The second theme (contained in Chapters 6 and 7) encompasses
models of apoptosis. A modularized model of apoptosis is developed and analyzed in
Chapter 6, and Chapter 7 presents a novel model of death ligand-receptor interaction.
Chapter 8 provides general conclusions and suggests further work.
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Chapter 2
Biological background
2.1 Introduction
How a cell comes to a coordinated decision is a complicated process; the internal envi-
ronment in the cell must decide how to appropriately respond to its external environment.
A pioneer in the field of cellular response, Earl W. Sutherland, revealed the complexity
and rich structure of signaling (Sutherland, 1972). Sutherland and colleagues found that
a cell’s surface is important for a stimulus, such as epinephrine, to trigger signal transmis-
sion; following this, Sutherland and co-workers discovered that when liver and skeletal
muscle cells are stimulated by epinephrine, intermediate steps are required for glyco-
gen breakdown. Since this work, the study of the cellular decision processes remains an
active area of research (Campbell and Reece, 2002).
Many signals in the body are mediated by one of two ways: direct cell-cell contact or
by small signaling proteins such as cytokines and hormones which convey information
from one cell to another. When a cytokine binds to the receptor of its target cell, as
shown in Fig. 2.1, it triggers an intra-cellular signaling cascade, which may result in gene
expression or other responses (Campbell and Reece, 2002). Such interactions allow a
collection of cells to come to a coordinated decision and change of physiological state
(Alberts et al., 2002).
Signal reception is the process by which cells sense the extracellular environment.
This may be initiated by cell-cell contact or through small signaling molecules (Perkins
and Swain, 2009; Saez-Rodrı´guez et al., 2004). Cell-cell interaction may occur through
structures such as gap junctions, enabling chemical communication between cells, or
a cell may present a protein, which binds to a receptor, usually a transmembrane pro-
tein, of its target cell. Receptors, often large molecules that are highly specific, bind to
ligands which are small signaling molecules, such as hormones, cytokines, or growth
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Figure 2.1: Cellular signaling. Consider a cell in the presence an environment of signaling molecules such
as cytokines. Specific receptors on the cellular plasma membrane may detect a specific ligand and bind to
it. If the receptor-ligand binding has high affinity in the concentration range of this ligand then an intra-
cellular response is communicated via a complex signal pathway. A signal transduction pathway consists
of many proteins which may interact through different mechanisms, mediating the expression of genes and
synthesis of proteins. This schematic was inspired by Saez-Rodrı´guez et al., 2004.
factors. Following receptor-ligand binding, the ligand may remain in the extracellular
environment or enter the cell by a process called endocytosis, and the receptor under-
goes a change in its conformational shape. This enables the receptor to interact with an
intracellular molecule and initiate a signaling cascade within the cell.
The initial signal is converted into a cellular response by signal transduction path-
ways, a multistep sequence of intracellular signaling and communication between molecules.
Most of these molecules are proteins, such as enzymes that catalyze a reaction, and per-
form a crucial role in relaying information. Special enzymes called kinases bind and add
a phosphate group, resulting in activation or inactivation of a protein. If the protein is ac-
tivated, it transfers information downstream and may engage multiple signaling cascades
by chemical reactions. Sometimes these chemical interactions occur in a linear fashion,
that is, the input of the interaction is proportional to the output (Stark and Hardy, 2003);
however, many interactions are not linear, or nonlinear, and amplification of the signal
may occur via positive feedback loops, or inhibition may exist via negative feedback.
Specifically, the repertoire of upstream dynamics, such as interactions between signal-
ing molecules and signaling pathways, may control enzymatic activity, and/or activate or
inhibit regulatory proteins called transcription factors.
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Transcription factors regulate gene expression: to turn a gene on, an activated tran-
scription factor translocates from the cytoplasm into the nucleus, binds to the enhancer or
promoter region of DNA, and RNA polymerase transcribes the DNA template to synthe-
size RNA. Then a type of RNA, messenger RNA (mRNA), leaves the nucleus and enters
the cytoplasm where ribosomes translate mRNA into a protein (Alberts et al., 2002).
Conversely, transcription factors may also turn a gene off by repressing the recruitment
of RNA polymerase. These two possible responses regulate proteins synthesis, whereby
proteins may be released out of the cell, modify the cellular environment, and act as
signaling molecules which restart the cellular sensing and signaling process.
2.2 Vascular inflammation
Immune response is highly dependent on how immune cells, such as mononuclear phago-
cytes, respond to their external environment (Gordon, 2003; Gordon and Taylor, 2005;
Mosser, 2003; Mosser and Edwards, 2008). This is particularly the case in atherosclero-
sis, an inflammatory disease of the arteries, which is the formation of plaque along the
arterial wall and is a precursor to many cardiovascular diseases (CVDs). CVD risk factors
increase oxidative stress via highly reactive oxygen species, leading to the modification
of the inner lining of the blood vessel wall (endothelium), cholesterol in blood plasma
and erythrocytes (Kolodgie et al., 2003; Virmani et al., 2005). Subsequently, atherogenic
substances composed of mononuclear phagocytes (i.e., blood monocytes that may differ-
entiate into different subsets of macrophages after entering the subendothelium (Gordon
and Taylor, 2005; Hansson and Libby, 2006; Weber et al., 2008)), endothelial cells, and
smooth muscle cells may ingest low-density lipoproteins (LDL), which may transform
into foam cells, accumulate and calcify in the endothelium; thus, narrowing the arterial
passage ways and triggering an inflammatory response (Glass and Witztum, 2001; Hans-
son et al., 2002; Heinecke, 2006; Lee et al., 2004; Morita, 2005). Vascular inflammation,
metabolic factors and neovessels invading the arterial plaque may cause exceptionally de-
veloped plaques to rupture, known as intraplaque hemorrhage; this event accelerates the
progression of atherosclerosis, and may implicate highly fatal conditions such as throm-
bosis, stroke and coronary heart disease (Davies and Thomas, 1985; Kolodgie et al.,
2003; Levy and Moreno, 2006; Takaya et al., 2006; Virmani et al., 2005). Recent work
has revealed an anti-inflammatory response within plaque macrophages (Boyle et al.,
2009; Lee and Chau, 2002; Moestrup and Moller, 2004; Otterbein and Zuckerbraun,
2005; Ugocsai et al., 2006; Van den Heuvel et al., 1999); hence, it is important to under-
stand how blood monocytes differentiate into different subsets of macrophages. Much
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effort is still needed to unveil the cellular players, signaling pathways and mechanisms
involved in this disease; specifically, the interactions governing an anti-inflammatory
macrophage response remain unresolved.
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Figure 2.2: Vascular inflammation signaling pathway. The cluster of differentiation 163 (CD163) receptor,
binds with the hemoglobin-haptoglobin (Hb:Hp) complex which undergoes endocytosis, recycles CD163
back to the cell surface and acts as a heme transporter. Alternatively, extracellular heme may be trans-
ported via heme carrier protein (HCP)-1 or diffuse passively into the cell. Intracellular heme is negatively
regulated by Bach1. Heme serves as a signaling molecule, by synthesizing its enzyme, heme oxygenase-1
(HO-1), which thereby degrades heme into its metabolites. Following heme degradation, the metabolites
activate a signaling cascade resulting in an anti-inflammatory response. Original schematic courtesy of
Dr. Boyle and extended using pathway information from BioCarta, 2010; Latunde-Dada et al., 2006; Ot-
terbein and Zuckerbraun, 2005; Philippidis et al., 2004; Sabosciences, 2010; Sulahian et al., 2000.
Key players in vascular inflammation are mononuclear phagocytes, specific types of
cells of the innate immune system. As the name would suggest, mononuclear phago-
cytes are single nucleus “eating” cells, such as monocytes and macrophages. As shown
in Fig. 2.2, a large number of molecular components within monocytes/macrophages are
involved in complicated interactions which may result in an anti-inflammatory response.
The cluster of differentiation 163 (CD163) receptor on macrophages, known to be in-
volved in the regulation of inflammatory processes, mediates endocytosis of hemoglobin-
haptoglobin (Hb:Hp), a molecular complex found in the blood; subsequently, the com-
plex undergoes lysosomal catabolism reducing to heme (Takami, 1993; Van den Heuvel
et al., 1999). Heme may also enter the cell by other means; however, intracellular heme
is regulated by many mediators (Ogawa et al., 2002; Tsiftsoglou et al., 2006). Intra-
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cellular heme activates signal transduction by contributing to the synthesis of its rate
limiting enzyme heme oxygenase-1 (HO-1) (Hoekstra et al., 2004; Siow et al., 1999),
which degrades heme into its metabolites (Morita, 2005; Otterbein et al., 2003). This
signaling cascade induces interleukin-10 (IL-10), an anti-inflammatory cytokine (Boyle
et al., 2009; Lee and Chau, 2002; Moestrup and Moller, 2004; Otterbein and Zucker-
braun, 2005; Ugocsai et al., 2006), which contributes to the synthesis of HO-1 (Abraham
and Drummond, 2006; Lee and Chau, 2002) and induces a high expression of CD163
(Sulahian et al., 2000). Therefore, Hb:Hp is responsible for activating signal transduc-
tion resulting in an anti-inflammatory and atheroprotective cell response.
Heme, the molecule found in hemoglobin (Hb), is responsible for oxygen binding,
electron transport, and chemical catalysis (Gunsalus et al., 1977; Mense and Zhang,
2006). When erythrocytes undergo hemolysis such as in intraplaque hemorrhage, the po-
tentially harmful free extracellular Hb quickly binds with a molecule common in blood
plasma, haptoglobin (Hp) forming a hemoglobin-haptoglobin (Hb:Hp) complex (Ascenzi
et al., 2005; Levy and Moreno, 2006; Nielsen and Moestrup, 2009). This complex,
while less harmful, may still catalyze LDL oxidation; therefore, immune cells such as
monocytes or macrophages are recruited to the atherosclerotic lesion where the free pro-
oxidative Hb:Hp are endocytosed by the CD163 scavenger receptor (Kristiansen et al.,
2001). CD163, a transmembrane glycoprotein, is exclusively expressed on monocyte
cells and acts as a heme transporter (Buechler et al., 2000; Philippidis et al., 2004). En-
docytosed Hb:Hp then undergoes lysosomal catabolysis, and intracellular heme may then
be degraded; conversely, if free heme, not Hb:Hp, is present extracellularly, heme may be
transported into the macrophage by heme carrier protein (HCP)-1 (Latunde-Dada et al.,
2006; Schaer et al., 2008) and/or may enter the cell via passive diffusion (Schaer et al.,
2008; Tsiftsoglou et al., 2006). In order for the cell to regulate heme import, Hb:Hp-
CD163 mediated scavenging saturates (Nielsen and Moestrup, 2009); and heme and Hb
somewhat suppress HCP-1 (Schaer et al., 2008).
To protect macrophages expressing CD163 from heme’s critically pro-oxidative and
cytotoxic effects, intracellular levels of heme are regulated by synthesis and degradation
rates. Another two mediators of intracellular heme levels are HO-1 (Immenschuh and Ra-
madori, 2000; Otterbein and Zuckerbraun, 2005; Pae et al., 2008) and basic leucine zip-
per transcription factor 1 (Bach1) (Kitamuro et al., 2003; Ogawa et al., 2002; Sun et al.,
2002, 2004). Unlike erythrocytes that rely on reactive oxygen species for non-enzymatic
heme degradation (Nagababu and Rifkind, 2004), non-erythroid cells such as monocytes
and macrophages degrade heme via the inducible form of the rate limiting enzyme, heme
oxygenase (HO-1) (Schaer et al., 2006). HO-1 is upregulated by many factors such as
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CVD risk factors, cytokines (i.e., IL-10), endotoxin, growth factors, highly reactive oxy-
gen species and transcriptionally by pro-inflammatory mediators, such as transcription
factor nuclear factor κ B (NF-κB), activator protein 1 (AP-1) and interleukin-6 (IL-6),
as well as heme (Idriss et al., 2008; Morita, 2005; Philippidis et al., 2004; Schaer et al.,
2006; Takaya et al., 2005). Subsequently, HO-1 plays an important role in modulating
intracellular heme levels by catabolyzing heme into equimolar amounts of its putative
anti-oxidative and vasoprotective metabolites bilirubin, ferrous iron (Fe2+) and carbon
monoxide (CO) (Morita, 2005; Otterbein et al., 2003; Ryter et al., 2002; Takami, 1993).
In addition to degrading heme, HO-1 is cytoprotective and mediates anti-inflammatory,
anti-proliferatory, and anti-apoptotic functions (Cheng et al., 2009; Otterbein et al., 2003;
Pae et al., 2008). When HO-1 levels decrease, intraceullar heme levels may bind to hemo-
protein Bach1, a negative regulator of HO-1 transcription and promote HO-1 expression
(Otterbein and Zuckerbraun, 2005; Sun et al., 2002, 2004). Hence, heme modulates the
level of its intracellular heme by feedback mediated by transport (HCP-1), enzymatic
degradation (HO-1), and repression of its degradation enzyme (Bach1).
Mononuclear phagocytes stimulated with heme molecules play a significant role in
the anti-inflammatory response (Boyle et al., 2009; Lee and Chau, 2002; Moestrup and
Moller, 2004; Otterbein and Zuckerbraun, 2005; Ugocsai et al., 2006). The products of
heme degradation by HO-1, that is, CO may upregulate the expression of HO-1 (Sawle
et al., 2005) as well as IL-10, via mitogen-activated protein kinase (MAPK) family mem-
bers:1 p38 MAPK, MAPK 3/6 and extracellular signal regulated kinase (ERK) (Morita,
2005; Pae et al., 2008). Experimental agreement shows IL-10 induces HO-1 (Abra-
ham and Drummond, 2006; Lee and Chau, 2002; Ricchetti et al., 2004; Schaer et al.,
2006); however, there is disagreement between the responsible signaling pathway. Lee
and Chau, 2002 find HO-1 upregulation by IL-10 requires p38 MAPK; whereas, Ric-
chetti et al., 2004 observe HO-1 expression is induced by IL-10 via signal transducer and
activator of transcription (STAT)-3 and phosphatidylinositol-3 kinase (PI-3K), not p38
MAPK. This conflict extends to the existence of an anti-inflammatory feedback loop be-
tween IL-10 and HO-1. Moreover, previous findings show that CD163 ligation by Hb:Hp
is linked to secretion of IL-10 (Philippidis et al., 2004; Sulahian et al., 2000), resulting in
1The mitogen-activated protein kinases are a large family of kinases involved in a regulator of cellular
activities such as proliferation, differentiation and apoptosis. TheMAPKs are characterized by the presence
of a Thr-Xxx-Tyr activation motif and often these kinases require the phosphorylation of both threonine
and tyrosine in this motif. There are three main sub-families: the extracellular signal regulated kinases
(ERKs, encoded by two genes where the amino acid Xxx is glutamic acid), cJun N-terminal kinases (JNKs,
encoded by three genes where Xxx is proline), and the p38 MPAKs (encoded by four genes where Xxx is
glycine).
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the upregulation of CD163 (Sulahian et al., 2000; Williams et al., 2002) and facilitating
atheroprotective function against plaque hemorrhage (Mallat et al., 1999; Potteaux et al.,
2004).
The roles of cellular mediators in vascular inflammation are only now becoming bet-
ter characterized; therefore, a better understanding of the mechanisms and interactions
leading to an anti-inflammatory response may provide future treatments to the classically
observed pro-inflammatory response in atherosclerosis.
Data
In the past ten years, significant advances have revealed the cellular components and
their functions that govern the monocyte/macrophage response to Hb:Hp, Hb and heme.
Published time-course data and dose-response curves of inflammatory markers in re-
sponse to human peripheral blood mononuclear cell (PBMC) stimulated with Hb:Hp are
given in Fig. 2.3 and Fig. 2.4; these are normalized to represent fold change according
to the baseline level of initial marker obtained from Schaer et al., 2006 and Philippidis
et al., 2004, respectively. This work shows induction of HO-1 and IL-10, respectively,
by macrophages in response to Hb:Hp; furthermore, both indicate at approximately 10
µg/mL Hb:Hp, there is a four-fold increase in expression. As previously discussed (not
shown), Sulahian et al., 2000 observed that monocytes incubated with increasing con-
centration levels of IL-10 result in increased expression of CD163.
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Figure 2.3: HO-1 mRNA expression by Hb:Hp complexes (Schaer et al., 2006). HO-1 mRNA expres-
sion of CD163 positive-HEK macrophages stimulated with Hb:Hp complex. Assays were determined by
LightCycler-polymerase chain reaction (PCR), an experimental technique which provides a quantitative
measure of mRNA, where each data point is the estimated mean (± standard deviation) fold change from
n= 3 experiments. Time course of CD163-mediated IL-10 protein induction by macrophages stimulated
with Hb:Hp complexes (100 µg/mL). Dose response of HO-1 mRNA expression after 8 hours incubation
of Hb:Hp complex (increasing concentration).
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Figure 2.4: IL-10 induction by Hb:Hp complexes (Philippidis et al., 2004). IL-10 protein expression of
CD163 positive in vitro differentiated human macrophages (day 7) stimulated with Hb:Hp complex. As-
says were carried out in duplicate and determined by enzyme-linked immunosorbent assay (ELISA) PCR,
an experimental technique which provides a quantitative measure of protein, such as IL-10 expression,
where each data point is the estimated mean (± standard deviation) fold change from n= 3 experiments.
Time course of CD163-mediated IL-10 protein induction of macrophages incubatedwith Hb:Hp complexes
(1mg/mL). Dose response of IL-10 protein after 24 hours of incubation of Hb:Hp complex (increasing con-
centration).
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2.3 Apoptosis
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Figure 2.5: Apoptosis signaling pathways. Apoptosis is triggered by the activation of caspases in response
to both extracellular (extrinsic) and intracellular (intrinsic) signals. The extrinsic and intrinsic pathways
are characterized by the formation of the death-inducing signaling complex (DISC) and the apoptosome,
respectively; both the DISC and the apoptosome are oligomers with complex formation dynamics. Once
the oligomers are formed, procaspases may be cleaved (illustrated as scissors) to activate corresponding
caspases of both pathways. Additionally, the extrinsic and intrinsic pathways are coupled through the
mitochondrial apoptosis-induced channel (MAC) via the Bcl-2 family of proteins. Schematic inspired by
Zheng and Flavell, 2000.
Apoptosis, or programmed cell death, is a highly regulated cell death mechanism
involved in many physiological processes. Normal function of apoptosis is critical for
development, tissue homeostasis, cell termination, and immune response (Hengartner,
2000; Hutchins and Barger, 1998; Jacobson et al., 1997; Leist and Ja¨a¨ttela¨, 2001; Lock-
shin and Zakeri, 2001; Meier et al., 2000; Oppenheim, 1991; Raff, 1998; Zuzarte-Luis
and Hurle, 2002). Dysregulation of apoptosis is associated with pathological conditions
such as developmental defects, neurodegenerative disorders, autoimmune disorders, and
tumorigenesis (Chang and Yang, 2000; Fadeel et al., 1999; Haass, 1999; Johnstone et al.,
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2002; Pritchard and Hickman, 1994; Thompson, 1995; Thornberry and Lazebnik, 1998).
As shown in Fig. 2.5, the apoptotic pathway is characterized by complex interactions of
a large number of molecular components which are involved in the induction and execu-
tion of apoptosis. Due to its fundamental importance, apoptosis is the subject of intense
active research, and key characteristics have been identified which motivate further study
of this cellular process.
Apoptosis is a cell suicide mechanism in which cell death is mediated by apoptotic
complexes along one of two pathways: the extrinsic pathway (receptor mediated) via
the death inducing signaling complex (DISC), or the intrinsic pathway (mitochondrial)
via the apoptosome (Ashkenazi and Dixit, 1998; Budihardjo et al., 1999; Cain et al.,
1999, 2000, 2002; Fumarola and Guidotti, 2004; Hengartner, 2000; Jiang and Wang,
2004). The extrinsic initiator caspase (caspase-8) couples the two pathways by initiating
the mitochondrial apoptosis-induced channel (MAC), leading to activation of the intrin-
sic pathway (Li et al., 1998). The subsequent cell death for either pathway is executed
through a cascade activation of effector caspases (e.g., caspase-3) by initiator caspases
(e.g., caspase-8 and -9) and the amplification of death signals implemented by several
positive feedback loops and inhibitors in the network (Arends and Wyllie, 1991; Budi-
hardjo et al., 1999; Nunez et al., 1998; Oppenheim, 1991; Takahashi and Earnshaw, 1996;
Thornberry and Lazebnik, 1998; Zimmermann et al., 2001). While apoptosis can be ac-
tivated by either pathway, some cell lines are pathway specific. Cells requiring death re-
ceptors (and caspase-8) but not needing help from mitochondria organelles for apoptosis
are classified as type I, such as T cells and thymocytes (Barnhart et al., 2003); conversely
type II cells, for example, hepatocytes of Bcl-2 transgenic mice (Barnhart et al., 2003),
have a reduced DISC formation and predominantly depend on the mitochondria pathway
(formation of apoptosome and caspase-9) to undergo cell death (Barnhart et al., 2003;
Fulda et al., 2001; Scaffidi et al., 1998; Schmitz et al., 2000).
The extrinsic pathway is initiated by the assembly of the DISC, which is formed by
the ligation of transmembrane death receptors with extracellular death ligands (Ashke-
nazi and Dixit, 1998). One of the most easily characterized death receptors is Fas, a
member of Tumor necrosis factor receptor family TNFR1 also called CD95 or Apo1,
(Marsden and Strasser, 2003; Strasser et al., 1995) with corresponding ligand FasL. FasL
is a homotrimer, a molecule with three identical polypeptides, that serves as an extracel-
lular signal of apoptosis and induces the trimerization of Fas (Gruss and Dower, 1995;
Nagata, 1997; Smith et al., 1994). This binding clusters the intracellular death domains
of each Fas (Ashkenazi and Dixit, 1998; Nagata, 1997; Tartaglia et al., 1993), allow-
ing adaptor proteins called FADD (Fas-associating proteins with death domain) to attach
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(Boldin et al., 1995; Chinnaiyan et al., 1995). Recent structural data by Scott et al., 2009
found Fas to exist in both closed and open forms, only the latter of which allows FADD
binding and hence transduction of the apoptotic signal. Moreover, open Fas were shown
to be capable of self-stabilization through stem helix and globular interactions, suggest-
ing that perhaps FasL is not necessary for Fas clustering. The full complex then recruits
initiator caspase zymogens, such as, procaspase-8, through death effector domain inter-
actions, and catalyzes their activation to, its corresponding, caspase-8. Initiator caspases
then activate effector caspases, e.g., procaspase-3/caspase-3, which ultimately execute
cell death by direct cleavage of cellular targets (Nicholson, 1999; Nicholson and Thorn-
berry, 1997; Nunez et al., 1998; Thornberry and Lazebnik, 1998).
The intrinsic pathway is activated by stimuli (such as cellular stress or extrinsic path-
way signals) inducing mitochondrial membrane permeabilization, followed by the for-
mation of the apoptosome (Eskes et al., 2000; Green, 2000). The apoptosome is a large
caspase-activating complex (Cain et al., 1999, 2000, 2002) that assembles in response to
cytochrome c released from mitochondria due to physical or chemical stress (Fumarola
and Guidotti, 2004; Jiang and Wang, 2004). Cytosolic cytochrome c activates the protein
Apoptotic protease activation factor-1 (Apaf-1) by inducing a conformational change that
allows the binding of deoxyadenosine triphosphated/adenosine triphosphate (dATP/ATP)
(Jiang and Wang, 2000; Kim et al., 2005). Activated Apaf-1 then oligomerize to form
the apoptosome, a wheel-like heptamer with angular symmetry (Acehan et al., 2002;
Cain et al., 2000), which recruits and activates procaspase-9 through proteolytic cleav-
age (Cain et al., 2002). Caspase-9 then induces the apoptotic cascade through catalytic
activation of procaspase-3 (Li et al., 1997; Rodriguez and Lazebnik, 1999).
These apoptotic pathways also include essential positive and negative regulators.
Negative regulators such as bifunctional apoptosis inhibitor (BAR), cellular FADD-like
IL-1b-converting enzyme inhibitory protein (c-FLIP) or X-linked inhibitor of apoptosis
(XIAP) prevent caspase activation. Conversely, Smac/DIABLO (Second mitochondria-
derived activator of caspases/Direct IAP binding protein with low PI), which is a protein
released with cytochrome c from the mitochondria, interacts with inhibitors of apopto-
sis to promote caspase activation (Du et al., 2000; Li et al., 2004; Madesh et al., 2002;
Srinivasula et al., 2000).
Both the extrinsic and intrinsic pathways may converge at the destruction of the mito-
chondrial membrane. The extrinsic pathway may activate the intrinsic pathway through
a mitochondrial apoptosis-induced channel (MAC) of intracellular signals involving the
Bcl-2 protein family, which includes both pro-apoptotic members such as Bid, tBid, Bax,
Bad, Bcl-xs, and anti-apoptotic members, including Bcl-2, Bcl-xL (Adams and Cory,
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1998; Danial and Korsmeyer, 2004). Specifically, mitochondrial release of cytochrome c
is enhanced by truncated Bid (Sprick and Walczak, 2004; Werner et al., 2002a,b); upon
cleavage by caspase-8, Bid translocates to the outer mitochondrial membrane. The MAC
formation requires truncated Bid interaction with Bax, leading to membrane pore for-
mation by Bax oligomerization (Antonsson et al., 2000; Bagci et al., 2006; Danial and
Korsmeyer, 2004; Li et al., 1998; Schlesinger and Saito, 2006; Suzuki et al., 2000). The
sequence of activated pro and anti-apoptotic signaling may result in cytochrome c release
and caspase activation; therefore, the particular cell undergoes apoptosis.
Corresponding to the two apoptotic signaling pathways are two principal classes of
cells: type I and type II (Barnhart et al., 2003; Schmitz et al., 2000). In response to death
ligand, cells that require the mitochondrial release of apoptogenic factors for apoptosis
are type II (e.g., hepatocytes of Bcl-2 transgenic mice), whereas cells that do not are type
I (e.g., T cells and thymocytes). Thus, type I and II cells rely primarily on the extrinsic
and intrinsic pathways, respectively (Barnhart et al., 2003; Fulda et al., 2001; Scaffidi
et al., 1998; Schmitz et al., 2000).
2.4 Conclusion
The biology of decision making can be divided into three phases. The cellular sensing
phase, in this context, is the receptor-ligand interaction, i.e., CD163-Hb:Hp or Fas-FasL.
In both of the biological systems of interest, vascular inflammation and apoptosis, the sig-
nal transduction phase, or communication within the cell plays a determinant role in the
outcome. While many of the intracellular signaling molecules and pathways are known,
the interactions and mechanisms by which positive and negative feedbacks occur remains
elusive. The response phase occurs as a result of the upstream dynamics, and often, the
outcome is the only experimentally testable information, in this context, protein expres-
sion of caspase-3, CD163, and IL-10. Despite scientific advances in the aforementioned
biological systems, further theoretical and quantitative study is required to understand
the mechanisms responsible for a particular cellular response.
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Chapter 3
Mathematical modeling background
3.1 Introduction
A given behavior in a biological system is often governed by many cellular interactions,
which in aggregate, ultimately translate into a full system decision or outcome (Bhalla
and Iyengar, 1999; Weng et al., 1999). In the last few decades, scientific and medical
technology has provided significantly more information and data about biological sys-
tems and their behavior, for example consider the genomic/proteomic technologies which
have enhanced the knowledge of gene/protein function and network structure. However,
these governing dynamics and mechanisms may be difficult to interpret and understand
qualitatively (Hashimoto et al., 1999; Hooper et al., 2001; Stark et al., 2003b), thus,
mathematical models may be developed to explain observations that arise from seem-
ingly simple biological components and that may be difficult to reconcile biologically,
such as intra/inter-cellular interactions (Stark et al., 2003b).
Mathematical models are often constructed in a conceptual, theoretical, and quan-
titative framework using known information to describe a system. These models may
provide hypotheses and/or an explanation of the inner workings of a system; however,
the model findings must also be validated by experimental results. Models may be nu-
merically simulated as computational experiments, which are often less expensive in re-
sources than biological experiments, and may enable a deeper insight to the biology, such
as predicting how physiology and phenotype emerge via cellular decisions and switches
(Alon, 2007; Lodhi and Muggleton, 2009). Another benefit of creating models is the
ability to motivate new experiments and then test the real biological system which can
either validate a model or identify an incorrect one. While many experimentalists take
into account the numerous variables and complexity within a biological system, theo-
reticians attempt to create a simplified representation of the system, whilst including key
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components and attempting to capture the behavior of the system. For example, consider
some of the first mathematical representations of a biological system, such as Alan Tur-
ing’s work on morphogenesis, the process of different chemicals reacting and diffusing
throughout a tissue (Turing, 1952), or Hodgkin and Huxley’s mathematical model, that
explained the ionic mechanisms in the giant axon of a squid responsible for initiation
and propagation of an action potential along a nerve (Hodgkin and Huxley, 1952). These
scientists started a trend of modeling using mathematical approaches to predict biolog-
ical mechanisms. Since then, the science of modeling has evolved and presented new
challenges; often, these include investigating the importance of model components such
as interactions and rates of these interactions, and parameters using existing data and
optimization routines.
This chapter overviews the theoretical framework and methods of analysis used for
modeling biological processes specific to this thesis. Other texts are more comprehen-
sive, see: Britton, 2003; de Vries et al., 2006; Edelstein-Keshet, 2004; Keener and Sneyd,
1998; Murray, 2002; Rubinow, 1975; Segel, 1980, and the following publications: Al-
beck et al., 2006; Aldridge et al., 2006; Alon, 2007; Angeli et al., 2004; Callard et al.,
1999; Ferrell, 1996; Higham, 2008; Janes and Yaffe, 2006; Kholodenko, 2006; Lodhi and
Muggleton, 2009; Stark et al., 2003a; Tyson et al., 2003.
3.2 Approach
3.2.1 Type of model
Systems encompassing complicated interactions, for example, signaling pathways and
biochemical reactions, can be translated into different types of quantitative representa-
tions (Murray, 2002). Dynamical approaches, such as ordinary differential equations
(ODEs) and partial differential equations (PDEs), may be employed for most reactions in
signal transduction since these consider the temporal deterministic evolution of the sys-
tem, and may provide mechanistic information about pathways, components and kinetics.
Conversely, non-dynamic approaches i.e., statistical/clustering, may be appropriate for
systems with an overwhelming amount of data and relatively little prior knowledge. In
a system exhibiting homogeneous mixing, the reactions or interactions between species
can be written into a system of ODEs; whereas, in systems that have spacial constraints,
for example diffusion, PDEs may be more appropriate. Molecular biological systems
that exhibit intrinsic noise and cell variability may be modeled by using a stochastic
approach, such as stochastic simulation algorithms or stochastic differential equations;
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however, these techniques are often used for populations of species with a small num-
ber of molecules. For the systems of interest, the mathematics of nonlinear ODEs are
well developed and enable suitable analysis of a model to be performed; therefore, this is
the chosen approach (Callard et al., 1999; Howison, 2005; Stark and Hardy, 2003; Stark
et al., 2003a, 2007; Yates et al., 2001).
3.2.2 Level of model
While there is not a unique way to formulate a mathematical model, certain factors, such
as the level of the model, must be considered. Previous models have almost exclusively
focused on decision making by a single cell. There is now considerable biological in-
formation on the transcription factors, such as T-bet and GATA-3, which determine the
decision made by a single cell in the immune system. The intra-cellular behavior of these
has been modeled using systems of ordinary differential equations (Ho¨fer et al., 2002;
Yates et al., 2004), revealing switch-like behavior in each transcription factor, with the
whole system acting as a pair of coupled switches (Yates et al., 2004). Models have also
previously been constructed at the cell-population level, for example Yates et al., 2000;
in practice, however, the behavior of switches within individual cells is modulated by a
rich repertoire of cell-cell signals. A preliminary multi-level model, combining the intra-
cellular switches with cell-cell signaling via cytokines was constructed in Yates et al.,
2004, using a state-structured framework. Since signaling occurs within an individual
cell as well as coupled cells, the development, solution and analysis of such models is a
major challenge, for example consider the work of Diekmann et al., 2003, where even
basic questions regarding existence and stability of solutions require sophisticated math-
ematical techniques. This is in marked contrast to the rich variety of standard mathemat-
ical tools that exist to analyze the behavior of ODE models at either the intra-cellular, or
cell population levels. Formulating multi-scale models that range from the cellular to the
population level is currently an active area of research since it provides the potential to
develop new mathematical techniques as well as model complicated biological problems
whose outcome may depend on decisions made at both the cellular and system level.
3.2.3 Level of complexity
Models of biological systems have been developed at differing levels, ranging from mod-
els with minimal interactions, which have few components and parameters, to compre-
hensive models that include the entire network of interactions, for example, consider
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models of mitogen activated kinase pathway (MAPK) (Aksan and Kurnaz, 2003; An-
geli et al., 2004; Brightman and Fell, 2000; Ferrell and Machleder, 1998; Ferrell and
Xiong, 2001; Hatakeyama et al., 2003; Huang and Ferrell, 1996; Kholodenko et al.,
1999; Markevich et al., 2004; Schoeberl et al., 2002; Yamada et al., 2004) or cell cy-
cle oscillator (see Figure 1 of Ingolia and Murray, 2004). The level of complexity of
models may be constrained by the known network of interactions, and often, a model
does not require the inclusion of the entire network in order to analyze a specific fea-
ture or behavior of the system, as reviewed in Schlitt and Brazma, 2005 and Sauro and
Kholodenko, 2004. In some cases, models may be developed and analyzed in a modular-
ized fashion (Saez-Rodrı´guez et al., 2004), whereby the network is divided into disjoint
sub-networks or modules with each module defined by an independent function or pro-
cess, for example consider the integrative model of yeast’s response to osmotic shock by
Klipp et al., 2005. This approach may create connectedness within a large system and
determine dependencies between functions.
Therefore, the scale and complexity of the system must be considered when develop-
ing a model.
3.3 Theoretical framework
3.3.1 Reaction kinetic models
Chemical reactions are necessary to drive changes in any organism. For reactions in the
context of this thesis, consider a protein molecule binding to another molecule called a
ligand. This binding forms weak chemical bonds which often require a good physical
fit, such as a lock and key between the two molecules. These two molecules or reactants
may be represented by A and B and their interaction produces a product C at a speed or
rate of k, which can be described by the following forward reaction:
A +B
k−→ C. (3.1)
Valuable information may be obtained from describing reactions in an ODE frame-
work, such as exact or approximate solutions, quantitative or qualitative behavior, from
the powerful theories of dynamical systems (Stark et al., 2003b). Consider a simple
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ordinary differential equation for n variables
dx
dt
= f(x, t,α), (3.2)
where x ∈ Rn is an n length vector of state variables (such as species, concentrations,
or reactants), α ∈ Rm is a set of m parameters (relationship of interactions between
variables such as binding or reaction rates), t is time, and f : Rn → Rn is the rate
function that describes the balance between production and consumption of each xi for
i = 1, . . . , n. When a system of ODEs, dxdt , and an initial condition of the system, x(0),
is given, then the behavior of the system can be fully determined. Note, for convenience,
bold face notation is used throughout this thesis to denote both vectors and sets inter-
changeably as appropriate.
Mass action
Define [A] = a, [B] = b, and [C] = c, where [−] denotes concentration and x = [a, b, c]T .
Then this forward reaction (Eq. 3.1), can be written as an ODE, where we solve for the
product (dcdt) and conservation is maintained, that is, a+ b+ c = constant. Conceptually,
this means the change of product over time is equal to the number of times A and B
collide times the probability that enough collisions occur for kinetic energy to initiate a
reaction. Thus, the equation
dc
dt
= kab,
where k is the same rate as in Eq. 3.1 is called law of mass action. This is the simplest
reaction model, and in this case, only describes the forward direction. The reversible
reaction,
A+B
kf−⇀↽−
kr
C, (3.3)
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where kf and kr are the forward and reverse reaction rates, respectively, and α =
[kf , kr]T . The bidirectional reaction can be written as:
da
dt
= krc− kfab, (3.4)
db
dt
= krc− kfab, (3.5)
dc
dt
= kfab− krc, (3.6)
where a, b, and c are modified by both directions of the reaction. By formulating math-
ematical equations from these reactions, the behavior of the dynamical system may be
analyzed.
A useful method for understanding and analyzing molecular dynamical systems is
investigating the long-term or steady-state behavior of the system. From Eq. 3.2, the
long-term or asymptotic behavior of the solutions of the vector field f are considered. As
t→∞, there are a number of possibilities: f goes to plus or minus infinity, f converges
to a steady-state (or equilibrium point) of the system x∗, such that f(x∗, t,α) = 0, or
there is no convergence. If there is convergence, as in the second case, then the solution
may give points x∗, which provide information about the stability of the system. Con-
versely, as in the latter case, the solution may not converge; consider f(x, t) = sin t,
which yields an oscillating solution. Many systems of equations given a starting point
or initial condition, f(0,α) = f0(x,α) converge to a steady-state, an attractor (a point,
curve or manifold) and have a basin of attraction, such that solution of the system for
certain initial conditions follow a path to the attractor. If small perturbations are made to
a state near a stable attractor, then it remains in the neighborhood of the basin of attrac-
tion. Other attractors may be, for example, a periodic orbit, such as circadian rhythms or
clocks, or even more complex attractors, exhibiting behavior difficult to predict, known
as chaos. In most cases, applying mathematical techniques such as linearization and
eigenvalue calculations of the Jacobian matrix may determine connectivity and stabil-
ity at steady-state. In this case, the system of kinetic equations (Eqs. 3.4-3.6) may be
solved to determine the steady-state concentrations, that is, dxdt = 0. From Eq. 3.4, then
ceq =
kf
kr
aeqbeq (see Fig. 3.1). If there are no other reactions, then it is clear for initial a,
denoted a0, and assuming a+ c = a0, then
ceq =
a0b
Keq + b
,
where Keq = kr/kf is the equilibrium constant and indicates the affinity between a and
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b. Note that for B = Keq, then exactly half of A is in the bound state.
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Figure 3.1: Time course of simplest reaction model. The simplest reaction model given in Eq. 3.1 may
be written as a system of ODEs (Eqs. 3.4-3.6) and solved given initial conditions and reaction rates (in
arbitrary units). These steady-states are solved for a(0) = b(0) = 1, kf = 0.1 and kr = 0.2.
Michaelis-Menten
When an enzyme, such as a protein, binds to a substrate, such as a ligand, the enzyme
may catalyze the reaction; however, there may not be an equal or abundant number of re-
actants as assumed in the conventional chemical mass-action kinetics (Keener and Sneyd,
1998; Segel and Slemrod, 1989). In 1913, Michaelis and Menten derived the standard
enzymatic reaction scheme to describe the process where an enzyme is saturated by the
substrate (Edelstein-Keshet, 2004;Murray, 2002), causing the substrate to be a bottleneck
(rate-limiting) for the entire reaction (Keener and Sneyd, 1998). In this reaction, there
are four variables: enzyme (E), substrate (S), enzyme-substrate complex (C) and prod-
uct (P ). Here, the enzyme catalyzes the reaction such that an intermediate step occurs
and the product is created in a two-step process: one describing the reversible substrate
binding, followed by an irreversible catalytic step.
E + S
kf−⇀↽−
kr
C
kcat−−→ P + E. (3.7)
Define s = [S], e = [E], c = [C] and p = [P ], then it follows that the ODEs are
ds
dt
= krc− kfse,
de
dt
= (kr + kcat)c− kfse,
dc
dt
= kfse− (kcat + kr)c,
dp
dt
= kcatc.
At steady-state, as shown in Fig. 3.2, these equations can be analyzed as before. Given
that p can be found by integration and dedt + dcdt = 0, then by conservation e + c = e0,
3.3 Theoretical framework 40
0 50 100
0
0.5
1
time
su
bs
tra
te
0 50 100
0
0.5
1
time
en
zy
m
e
0 50 100
0
0.1
0.2
time
co
m
ple
x
0 50 100
0
0.5
1
time
pr
od
uc
t
Figure 3.2: Time course of standard enzymatic reaction system. The standard enzymatic reaction given
in Eq. 3.7 may be written as a system of ordinary differential equations (ODEs) and solved given initial
conditions and reaction rates (in arbitrary units). These steady-states are solved for s(0) = e(0) = 1 and
kf = 0.1, kr = 0.2, and kcat = 0.3.
where e0 is total available enzyme. One method to derive the Michaelis-Menten reaction
rate expression requires the assumption that the substrate and complex are in equilibrium
because one assumes that some reactions are fast, this yields
kfse = krc.
Given that e+ c = e0, substituting e0 − c for the enzyme, then,
c =
e0s
Ks + s
, (3.8)
where Ks = kr/kf . It then follows that the rate, or velocity, V , at which the product is
formed, is
V =
dp
dt
= kcatc =
kcate0s
Ks + s
=
Vmaxs
Ks + s
,
where Vmax = kcate0 is the maximum velocity; and the dissociation rate constant, kcat,
is the limiting rate in this reaction. For s = Ks, the reaction rate is half the maximum
reaction rate.
An alternative way to analyze the enzymatic reaction is possible by quasi-steady-state
assumption (QSSA) (Fowler, 1997; Segel, 1993), which assumes the concentration of the
substrate-bound enzyme changes slower than that of the substrate or product and allows
the dynamics of speciesC to be neglected, dcdt = 0. It follows that the forward and reverse
Chapter 3. Mathematical modeling background 41
0 5 10 15 20
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
substrate
ve
loc
ity
 
 
V = Vmax∗sKs+s
(Ks,
Vmax
2 )
Vmax
(a) Michaelis-Menten plot (equilibrium assumption)
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Figure 3.3: Saturation curves of standard enzymatic reaction system. The blue curve describes the rela-
tionship between the substrate concentration and the reaction rate at which the product is formed using
e(0) = 1 and kf = 0.1, kr = 0.2, and kcat = 0.3; whereas, the maximum velocity, Vmax, is the red
horizontal asymptote. Although clear from the derivation, the blue curve here is precisely that shown in
Fig. 3.2d. (a) The blue marker represents the point at which s = Ks = kr/kf or the reaction rate is half
of its maximum. (b) The Km, as used in the quasi-steady-state assumption (QSSA), also indicates the
half maximal velocity; however, this relationship also includes the catalytic rate kcat. As a result, the blue
marker maintains the same vertical coordinate as (a); whereas, the horizontal coordinate changes due to
the different properties of the kinetic rate constantKm = kr+kcatkf .
reaction rates are equal, and the velocity may be determined
V =
dp
dt
= −ds
dt
=
kcate0s
Km + s
=
Vmaxs
Km + s
,
whereKm = kr+kcatkf , and the concentration of the complex is
c =
e0s
s+Km
. (3.9)
Note the similarity between Eqs. 3.8 and 3.9. These reaction equations are slightly dif-
ferent due to the kinetic rate constants; however, the derivation of the Michaelis-Menten
reaction rate equation using the equilibrium or the QSSA assumption gives the same
form. Based on the equilibrium or QSSA assumption, the Michaelis-Menten constant
KM is essentially three parameters; however, only one must be determined which al-
lows a reduction of parameters and variables. There are, however, certain conditions that
must be satisfied in order to assume QSSA, such as separation of time-scales and the
assumption that inermediate reactions are short lived in relation to other reactants (Segel
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and Slemrod, 1989). Conversely, for larger kinetic models, analytical investigation may
be more difficult using Michaelis-Menten than mass action, despite the reduction in pa-
rameters. For more details on kinetic models, see Keener and Sneyd, 1998 and Segel,
1993.
Cooperativity
The Michaelis-Menten equation does not reflect reactants that exhibit cooperative kinet-
ics such as when a ligand may have a higher affinity to bind to a molecule if there are
already other ligands bound to that molecule or it has multiple binding sites, both of
which are circumstances that relate the nature of cooperative binding. Originally, the
reaction velocity of cooperative binding was discovered by Hill, 1910 to understand the
dissociation curve of the enzyme, hemoglobin to its substrate, oxygen, which can be
described by the general Hill equation,
V =
Vmaxsn
Knm + s
n
, (3.10)
where n, a Hill coefficient, also known as an “interaction” coefficient, denotes coop-
erative binding and provides a global measure of the response, such as ultrasensitivity
(Hill, 1910; Huang and Ferrell, 1996; Weiss, 1997). The Michaelis-Menten formulation,
a subcase of the Hill equation, reflects independent binding, that is, n = 1 (see Murray,
2002 for derivation). Positive cooperative binding is reflected in Eq. 3.10 where n > 1;
conversely, n < 1 suggests negative cooperativity. Hill equations may provide many ben-
efits such as superseding more complicated rate equations when exact mechanisms are
unknown and data is insufficient (Westermark et al., 2004). Often Hill coefficients n > 1
may increase ultrasensitivity or amplify the response to a stimulus, resulting in a sharp
switch transition between states. In fact, if a Hill coefficient is equivalent to n at one
level of a signaling cascade and m at another level, then the response is multiplicative,
that is n ·m, and the response becomes more switch-like (Ferrell, 1997). Since equations
including Hill functions are nonlinear in nature, solutions may not be determined analyt-
ically as explained in detail by Polynikis et al., 2009. Cooperativity alone, giving rise to
ultrasensitivity, while significant to capturing biological behavior, is not the only feature
of complicated system interactions.
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3.3.2 Feedback mechanisms
The universal motifs of cell-signaling networks often include feedback loops, where a cell
will regulate biological products via activation or inhibition, corresponding to positive or
negative feedback loops, respectively (Kholodenko, 2006; Sauro and Kholodenko, 2004;
Tyson et al., 2003). If X and Y denote two species interacting, where species may
be cells or molecules. As shown in Fig. 3.4, there are three nondegenerate feedback
+
XY
+
(a) Mutual activation
+
XY
−
(b) Activation/inhibition
XY
−
−
(c) Mutual inhibition
Figure 3.4: Schematic of feedback interactions. Feedback loops corresponding to biological behavior in
speciesX and Y (a) Both species contribute to the production of the other resulting in a positive feedback
loop (b) SpeciesX activates the production of Y which inhibits the production ofX resulting in a negative
feedback loop (c) Species X and Y mutually inhibit one another and create a double negative feedback
loop.
scenarios:
1. mutual activation giving rise to a positive feedback loop
(X activates Y and Y activatesX);
2. mutual inhibition resulting in a negative feedback loop
(X activates Y and Y inhibitsX , or X inhibits Y and Y activatesX) ;
3. mutual inhibition creating a double negative feedback loop
(X inhibits Y and Y inhibitsX).
Interestingly, the behavior of double feedbacks is of particular interest to cells switching
between two courses of action, such as a phenotypic switch or cell fate (Angeli et al.,
2004; Balaban et al., 2004; Kussell and Leibler, 2005; Laurent and Kellershohn, 1999;
Pomerening et al., 2003; Xiong and Ferrell, 2003). Negative feedback may provide ro-
bustness to noise, increase resistance to disturbances inside a feedback loop, and create
oscillatory behavior (Ma et al., 2009). Examples of models displaying oscillatory behav-
ior in the immune system, as reviewed by Stark et al., 2007, have focused on transcription
factor nuclear factor κ B (NF-κB) (Hayot and Jayaprakash, 2006; Hoffmann et al., 2002;
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Krishna et al., 2006; Monk, 2003; Nelson et al., 2004), and transcription factor Hes1 (Hi-
rata et al., 2002; Momiji and Monk, 2008; Monk, 2003). Conversely, positive feedback
may increase sensitivity of the target to the signal and lead to multiple possible outcomes
(Bagowski and Ferrell, 2001; Kholodenko, 2006; Pomerening et al., 2003). If feedback
loops are interlinked and signal at different speeds, then this may result in switches (such
as turning a gene on or off) that regulate vital cellular decisions (Brandman et al., 2005).
There are many well-known examples where theoretical models and their predicted be-
havior have improved the knowledge of complicated biological systems; for example,
consider multistability of the mitogen-activated protein kinase (MAPK) cascade (An-
geli et al., 2004; Ferrell and Machleder, 1998; Ferrell and Xiong, 2001; Hornberg et al.,
2005; Markevich et al., 2004) or switches in the cell-cycle (Angeli et al., 2004; Ingolia
and Murray, 2004; Kholodenko, 2006; Tyson et al., 2003).
Reaction kinetic models that were previously discussed only described specific chem-
ical reactants; however, these concepts may be extended to describe general molecules
interacting in cell signaling. These interactions can be translated into mathematical mod-
els which describe temporal dynamics of signaling cascades, such as cellular and intra-
cellular communication between cells. Consider, for example, a simple two-variable
system demonstrating switching in the G2/M component (entry into mitosis) of the cell
cycle from Angeli et al. (2004) and Tyson et al. (2003). This model describes the mu-
tual inhibition between Cdc2-cyclin B complex (which was previously called M-phase
promoting factor) and Wee1 protein (the activated kinase that favors the G2 or interphase
state). The relationship between these two variables is a double-negative feedback mech-
anism which my be represented by substituting the complex and protein into the X and
Y of Fig. 3.4(c). Furthermore, the Cdc2-cyclin B complex and Wee1 kinase may be in
either the active (on) form x1 and y1, or inactive (off) form x2 and y2, respectively. Thus,
the interactions of the active and inactive forms of the species can be written as equations:
dx1
dt
= α1x2 − β1x1 · (ω · y1)
γ1
K1 + (ω · y1)γ1 ,
dx2
dt
= −α1x2 + β1x1 · (ω · y1)
γ1
K1 + (ω · y)γ1 ,
dy1
dt
= α2y2 − β2y1 · x
γ2
1
K2 + x
γ2
1
,
dy2
dt
= −α2y2 + β2y1 · x
γ2
1
K2 + x
γ2
1
,
where αs and βs are rate constants, Ks are Michaelis (saturation) constants, γs are Hill
coefficients and ω is the coefficient reflecting the strength that Wee1 influences Cdc2-
cyclin B. If conservation is assumed (total concentrations of Wee1 and Cdc2-cyclin B
are unchanging), then it follows x2 = 1 − x1 and y2 = 1 − y1. For convenience, the
active forms x1 and y1 are denoted as x and y, which yields a simpler system of coupled
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differential equations:
dx
dt
= α1(1− x)− β1x · (ω · y)
γ1
K1 + (ω · y)γ1 , (3.11)
dy
dt
= α2(1− y)− β2y · x
γ2
K2 + xγ2
, (3.12)
where x = [x, y]T represent active Cdc2-cyclin B and Wee1, respectively; and
α = [α1,α2, β1, β2, γ1, γ2, K1, K2] are parameter values from Angeli et al. (2004). For
the remainder of the chapter as mathematical techniques are introduced, we will refer to
this cell cycle example.
The cell cycle system (Eqs. 3.11 and 3.12) includes Hill coefficients (γ1, γ2) to de-
scribe the interactions between Cdc2-cyclin B complex and Wee1 protein, which makes
the analytical solution not easily understood; therefore, numerics are used to calculate the
steady-state. As shown in the Fig. 3.5, a time course of the system may be numerically
solved and simulated given initial conditions and parameter values. When analyzing this
Figure 3.5: Time course for Cdc2-cyclin B complex/Wee1 system. The steady-state of the switch example
system from Eqs. 3.11 and 3.12 for parameter values α1 = α2 = 1, β1 = 200, β2 = 10, γ1 = γ2 = 4,
K1 = 30, K2 = 1, and ω = 1 (Angeli et al., 2004) show Wee1 (yellow) approaches a low steady-state
whereas Cdc2-cyclin B complex (black) approaches a high steady-state. The Wee1lowCdc2-cyclin Bhigh ∼
Wee1offCdc2-cyclin Bon state, suggesting that for the given parameters and initial conditions, the cell favors
the M phase of the cell cycle.
two-dimensional system, nullclines, curves that are horizontal or vertical in the vector
field, may be determined by setting either dxdt = 0 or dydt = 0 and can provide a graphical
representation of the dynamical system that is especially helpful when the analytical so-
lution is not available. The nullclines can be graphically shown in the state space (space
of variables) or phase plane and these curves divide the dxdt and dydt into regions where
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the sign changes and the intersection of nullclines, that is, dxdt = dydt = 0, is an equilib-
rium point. This system is monostable at low or high levels of Wee1, dependent on the
parameter value of the input signal ω, as shown in Fig. 3.6(a) and Fig. 3.6(b).
(a) ω = 0.75 (b) ω = 1.9 (c) ω = 1
Figure 3.6: Nullclines of Cdc2-cyclin B complex/Wee1 system. Nullclines in phase plane of the Cdc2-
cyclin B complex (x) and Wee1 (y) system from Eqs. 3.11 and 3.12. The vector fields represent the state
space where red arrows denote the basin of attraction for each system, and nullclines (y and x nullclines
are green and blue, respectively) indicate fixed points at intersections.
Biological systems may have many attractors for a given set of initial conditions
and parameter values giving rise to multiple states, called multistability. Many dynamic
cellular systems are bistable, that is, the system has three attractors, where two are stable
states and one unstable. This is easily observed in the nullcline intersections of the cell
cycle example (Eqs. 3.11 and 3.12) where Fig. 3.6(c) graphically displays the three fixed
points for a value of ω that yields the two possible stable states or outcomes. The unstable
state, as shown where the nullclines intersect in Fig. 3.6(c), is not observed in a biological
system since even a small perturbation or noise to this initial value will destabilize it
and the other two states dictate the two outcomes, such as an on or off switch. Recall
positive feedbacks may lead to this switching, often bistability, and a hysteresis loop can
occur representing the switches between states. A hysteresis loop occurs in a bistable
system where the switching between states depends on the initial state (or condition) of
the system, meaning that the system has memory and may be reversible; however, for
systems with strong feedback and exhibiting irreversible bistability, the system cannot
switch between states even after the parameter is changed (stimulus turned off) (Ferrell,
2002; Ferrell and Xiong, 2001; Pomerening et al., 2003). The bistable properties of the
cell cycle example exhibit a switch between two states as demonstrated in Fig. 3.6. The
concept of stability is vital in modeling biological systems, since stable states are robust
to noise. When considering the asymptotic behavior of systems, a change in parameters
can:
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1. slightly alter the steady-states of a system;
2. create or destroy a fixed point; or
3. change the state dramatically.
In the context of the biological systems in this thesis, a change in parameters, such as the
strength of an activation or inhibition signal, initial concentration or rate of a reaction,
can all change the state of the system, often rendering a different cellular phenotype. To
study this behavior, we use bifurcation analysis techniques. A bifurcation occurs when
a change in parameter causes significant qualitative changes in system output (Strogatz,
1994). The parameter responsible for the change in system behavior is called a bifur-
cation parameter and the point at which a system changes is called a bifurcation point.
When drastic changes occur to the behavior of a system based on a variation in param-
eter, then bifurcation analysis may lead to classifying the system and the properties it
holds. A bifurcation can be shown visually in a bifurcation diagram, also known as a
dose-response curve in biology (see the corresponding cell cycle bifurcation diagram in
Fig. 3.7). For full ODE and dynamical systems treatment, see texts such as Bender and
Figure 3.7: Bifurcation diagram of Cdc2-cyclin B complex/Wee1 system. The switch in the cell cycle
example (see Eqs. 3.11 and 3.12) occurs as ω is varied. The cellular decision or behavior of the system
under bistable conditions, that is for ω = 1, is dependent on the initial condition (x = y = 0).
Orszag, 1999; Ellner and Guckenheimer, 2006; Glendinning, 1995; Heinrich and Schus-
ter, 1996; Keener and Sneyd, 1998; Lodhi and Muggleton, 2009; Murray, 2002; Strogatz,
1994; Tenenbaum and Pollard, 1963.
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3.3.3 Parameter analyses
The selection of parameters, such as their meaning and value in a model, is especially
important; therefore, parameter analysis examines the response of the system to changes
in parameters. Many methods for estimating parameters depend on time series, known
in experimental biology, as time course data. These data generally give a quantitative
measure of the variable level, such as mRNA or protein concentration level, at different
time points. Testing a model against experimental data is a good way to identify an incor-
rect model; however, experimental data is often too expensive to determine all parameter
values and overfitting (describing noise instead of the relationship) is a risk. Parame-
ter estimation and model identifiability is so crucial in this field that once estimates of
parameter values are calculated the next challenge is to determine which mechanisms
and interactions are most significant. A good way to test the model is by exploring the
sensitivity of model parameters, which is the evaluation of a qualitative or quantitative
relationship between parameters and their effect on the system outcome (Saltelli et al.,
2005).
Parameter estimation
The output and prediction of mechanistic models is often verified by inferring interactions
and parameters from experimental data, which may be unknown (Brewer et al., 2008;
Crampin et al., 2004). To estimate parameters, as explained in Brewer et al. (2008), the
model is compared to the data and the difference between the two values for a given
set of parameters at different points in time is calculated. This difference is the error
as a function of parameters, ED(α), and the goal is to minimize ED(α) which may be
performed in an iterative fashion (Brewer et al., 2008; Gershenfeld, 1999).
To implement any of these iterative minimization techniques, an approximate numer-
ical solution u(t) ≈ x(t) from Eq. 3.2 must be found by solving
du
dt
= f(u, t,α), (3.13)
with parameters αi, using Runge-Kutta (Atkinson, 1988) or a similar numerical method
whenever an analytical solution is not available; otherwise, regression analysis or non-
linear fitting is implemented. The values of u(ti) should be close to the data points of
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xˆ(ti) which motivates quantifying the error function ED(α) using sum of squared errors
ED(α) =
n∑
i=1
||u(ti)− xˆ(ti)||2. (3.14)
As described in Eq. 3.14, the sum of squared errors, a common regression technique,
is the same as the maximum likelihood where the error is minimized through an opti-
mization routine (Jaqaman and Danuser, 2006). Here, direct search algorithms instead
of other faster techniques are used when the analytical form of the function is not avail-
able. Common iterative methods include Nelder-Mead Simplex, Levenberg-Marquart,
simulated annealing and Markov Chain Monte Carlo, as described by Brewer et al., 2008
and Ray et al., 2008. Furthermore, Brewer et al., 2008 highlight the benefit of treating
the initial conditions as parameters of the model, such that the error is then defined as
ED(α,x(t0)) and other methods may be employed.
Sensitivity analyses
Once parameters values are estimated for a given model, either from data or existing
literature, the robustness of the model must be investigated. A robust system is one
where perturbations of the parameters or initial conditions, will still result in the same
outcome; however, there are many trade-offs (see Blu¨thgen and Herzel, 2003; Kitano and
Oda, 2006; Stelling et al., 2004). Much research has focused on stability and robustness,
for example, metabolic states (Grimbs et al., 2007) or MAPK-cascade (Blu¨thgen and
Herzel, 2003); however, certain properties of a biological system must also be able to
withstand variations in environment. There are specific techniques for computing total
parameter variation (TPV), see Barkai and Leibler, 1997 and this may be achieved by
analyzing the effects of the parameters on the system by conducting sensitivity analysis
(Gutenkunst et al., 2007).
Local sensitivity analysis determines how a perturbation to a parameter affects the
output of a system. The output of dx/dt = f(x, t,α) (previously introduced as Eq. 3.2)
can be approximated by the first-order Taylor series around the baseline or reference
input values, thus, the local sensitivity coefficient, si,j is the partial derivative of the ith
state to the jth parameter
si,j(t) =
∂xi(t)
∂αj
,
where j = 1, . . .m and i = 1 . . . n. The si,j elements form the sensitivity matrix
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S = ∂x/∂α, which may be calculated by determining the the column sensitivity vector
Sj = ∂x/∂αj at each jth parameter by simultaneously solving the states:
dSj
dt
= J(t) · Sj + Fj , (3.15)
where J = ∂f/∂x is the Jacobian matrix, Fj = ∂f(t)/∂αj is the parametric Jacobian
matrix, x(t0) = x0 and Sj(t0) is a zero vector (Yue et al., 2008). This local deterministic
method should be used for systems of ODEs with a known range of parameter values.
Global sensitivity analyses; conversely, use statistical approaches to investigate how
all the parameters, globally, affect the model output (Saltelli et al., 2000). Methods
employed include partial rank correlation coefficient analysis (PRCC), Sobol’s method,
multi-parametric sensitivity analysis (MPSA), weighted average of local sensitivities
(WALS), and the Fourier amplitude sensitivity test (FAST). Briefly, PRCC is based on
multiple linear regression and uses latin hypercube sampling scheme, Sobol and FAST
are variance-decomposition methods (Sobol uses Monte Carlo integrations and FAST
uses Fourier analysis), MPSA uses a classifier-based discrimination scheme, and WALS
extends local sensitivity analysis; for details, see Bentele et al., 2004; Chan et al., 1997;
Marino et al., 2008; Saltelli et al., 2005; Sobol’, 2001; Tura´nyi, 1990; Zheng and Run-
dell, 2006; Zi et al., 2005. As shown in Fig. 3.8, local and global sensitivity analysis of
the cell cycle model of Eqs. 3.11 and 3.12 has been performed. The sensitivities are each
calculated using a different approach and these results may used for different purposes;
however, overall, the parameters ω and γs are globally significant to the steady-state
Wee1 response. This is clearly the case for ω which was shown in the bifurcation dia-
gram to be responsible for changes in the steady-state; similarly, since the Hill coefficient
may describe the cooperativity, changes in this value often translate into a more sensi-
tive response of the steady-state behavior. Therefore, as demonstrated in the example,
performing sensitivity analysis can identify key parameters that influence the overall re-
sponse of the model system behavior.
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Figure 3.8: Sensitivity of Cdc2-cyclin B complex/Wee1 system. Sensitivity of Wee1 (y) in the Cdc2-cyclin
B / Wee1 system from Eqs. 3.11 and 3.12. Local sensitivity analysis was conducted with a perturbation
coefficient of 0.01 about parameters, whereas parameters are perturbed by one order of magnitude and
103 simulations in the global analyses. The global analyses identify ω and γs as most significant to the
steady-state of Wee1. Note that certain global analyses may be used for different purposes, such as PRCC
and FAST (sampling versus variance), which offer measures of particular model properties.
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3.4 Model selection
When constructing a mathematical representation of a complex system, often more than
one model is developed to describe a particular system; however, steady-state and pa-
rameter analysis may not be sufficient for determining the most appropriate model. This
may happen for a variety of reasons including unknownmechanisms, parameter values or
initial conditions of variables within the network. A cross-disciplinary principle, known
as Occam’s razor or parsimony, that is, the simplest explanation is often correct, may
be used for developing and selecting mathematical models. For example, if two models
accurately describe a system where one model is simple (few unknown parameters and
variables) and the other is more complicated, then by Occam’s razor, the simpler model is
chosen and this principle may serve as a model selection tool. However, discrimination
between models is often not straight forward which has necessitated the development
of more sophisticated techniques (Dzeroski and Todorovski, 2008; Ingram et al., 2008;
Manrai and Gunawardena, 2008; Toni et al., 2009; Xu et al., 2010). Often, model se-
lection may be performed using likelihood ratio tests, Akaike information criterion or
Bayesian information criterion; however, recently, approximate Bayesian computation
(ABC) has become favored since the method employs a simulation procedure that evades
the likelihood calculation. Toni et al., 2009 developed an ABC method based on se-
quential Monte Carlo (SMC) to enable both model selection and parameter fitting by
inferring a posterior distribution of values. Dzeroski and Todorovski, 2008 have devel-
oped a machine learning method which only seems appropriate when the model structure
is completely unknown; however, it is computationally intensive. When the structure of
models is known, for example, mechanisms of multisite phosphorylation followingMan-
rai and Gunawardena, 2008, then steady-state invariants derived using tools from alge-
braic geometry may be used to distinguish between models. Model discrimination may
be performed using model selection tools, and therefore, may enable important model
components to be identified.
3.5 Computational tools
All calculations in this thesis were performed using Maple 12 (Maplesoft, Waterloo,
Ontario, Canada), or MATLAB (and toolboxes therein) versions 7.4.0, R2008bSV, and
R2009b (The MathWorks, Inc., Natick, MA, USA). MATLAB add on toolboxes used in-
clude SBTOOLBOX2 (Schmidt and Jirstrand, 2006) for sensitivity analysis and SBML
export, SBML-SAT (Zi et al., 2008) for sensitivity and robustness analysis, CL MATCONT
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(Dhooge et al., 2003) for bifurcation analysis. Additional bifurcation analysis tools in-
clude XPPAUT (Ermentrout, 2009) and Oscill8 (Conrad). The approximate Bayesian
computation scheme based on sequential Monte Carlo (ABC-SysBio package in Python
with GPU support) (Liepe et al., In press) was used for parameter fitting and model
selection in Chapter 5. The final work in Chapter 7 was performed using Sage 4.2.1
(http://www.sagemath.org/), supplementedwith NumPy/SciPy (http://www.scipy.org/;Oliphant,
2007) for numerical computation and matplotlib (Hunter, 2007) for data visualization.
The Sage worksheet containing all computations described in Chapter 7 can be down-
loaded from http://www.sagenb.org/home/pub/1224/.
3.6 Conclusion
Complex biological systems necessitate a quantitative study. The chosen framework is
highly dependent on available information. Certain mathematical approaches favor spe-
cific methods for studying a system; in the context of understanding systems with re-
actions and feedback mechanisms, dynamical models offer valuable information. To
construct such a model, many factors must first be considered, such as scalability of the
model (cell, population or multi-scale), and complexity of the model (the number of vari-
ables/parameters which is often dependent on the desired scope of the model). Cellular
decisions, specifically the mechanisms of how cells switch between different states may
be modeled using a chemical reaction approach and these interactions can be expressed as
ordinary differential equations. An essential foundation in reaction-based ODE models
requires a basic understanding of the kinetics between reactants or species of a process,
which may be described via mass action or Michaelis-Menten kinetics. While Michaelis-
Menten has its limitations, it is often used to reduce the number of parameters in the
model by eliminating complex formation dynamics. These reaction kinetic models may
use dynamical systems approaches to describe how a systemwith many variables (such as
species or concentrations) evolves over time, provided that certain information is known,
such as interactions between species. Analysis of ODEs may be conducted to determine
the long-term or steady-state behavior, such as the outcome of a system and the num-
ber of steady-states; furthermore, bifurcation analysis complements this by studying the
qualitative changes within a dynamical system as parameter values are varied. Since the
behavior of the system can be highly dependent on parameters values, techniques have
been developed to estimate parameter values from existing information/data and identify
the parameters most sensitive to altering the outcome of a system. Dynamical models
also allow the inclusion of complicated interactions such as feedback loops, to describe
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the behavior of a system; however, discriminating between proposed models presents
many challenges and requires tools for model selection.
Clearly, dynamical systems is a powerful tool to describe a biological system which
may enable a deeper understanding of the inner workings and behavior that might es-
cape intuition; thus, the focus of the work hereafter is a dynamical systems approach to
analyzing and selecting the models developed.
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Chapter 4
Models of Hb:Hp induced macrophage
response
4.1 Overview
The focus of this work is the development of models of the macrophage scavenger re-
ceptor cluster of differentiation 163 (CD163) and the inflammatory response induced
by hemoglobin : haptoglobin (Hb:Hp) complexes. In collaboration with experimental-
ists, this is investigated through the construction of a coupled systems of ODEs. The
first model presented identifies a positive feedback loop between CD163 and interleukin-
10 (IL-10), to be responsible for the observed anti-inflammatory response; furthermore,
steady-state and bifurcation analysis predict an anti-inflammatory phenotypic switch in
the macrophage cell. This model is in agreement with flow cytometric measurements
of plaque macrophages that exhibit a switch-like behavior, from a lipid-laden and pro-
inflammatory phenotype to an anti-inflammatory and atheroprotective (HA-mac) cell
phenotype. This first model is extended to incorporate additional interactions, such as
feedback and cooperativity, that may enable a bistable response. While these models are
not as simple as the former; and therefore, not as easy to analytically investigate, numer-
ical solutions of the extended models reveal that the inclusion of additional factors are
qualitatively better models when compared to data. The proposed models improve the
understanding of the macrophage differentiation in this system by including a switch-
ing mechanism within the macrophage from a pro-inflammatory to anti-inflammatory
response.
This research was conducted in collaboration with Dr. Joseph J. Boyle and co-workers
from the Imperial College London Faculty of Medicine and published (Boyle et al.,
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2009).
4.2 Introduction
Recall from Chapter 2 that immune response is highly dependent on how mononuclear
phagocytes respond to their external environment (Gordon, 2003; Gordon and Taylor,
2005; Mosser, 2003; Mosser and Edwards, 2008). The inflammatory disease, atheroscle-
rosis, characterized by plaque formation along the inner lining of the arterial wall, recruits
monocytes to the arterial plaque. Under certain conditions, these monocytes may differ-
entiate into macrophages with scavenger receptor CD163 surface expression (Buechler
et al., 2000; Philippidis et al., 2004), which acts as a vehicle to import free pro-oxidative
stress hemoglobin-haptoglobin (Hb:Hp) complexes (Kristiansen et al., 2001). Internal-
ized Hb:Hp has been found to induce a response in inflammatory plaques; specifically,
the Hb:Hp-CD163 binding has been found to induce an anti-inflammatory response of
IL-10 (Boyle et al., 2009; Lee and Chau, 2002; Moestrup and Moller, 2004; Otterbein
and Zuckerbraun, 2005; Ugocsai et al., 2006; Van den Heuvel et al., 1999). Recent stud-
ies have also found interactions between HO-1 and IL-10 suggesting the existence of a
positive feedback loop (Abraham and Drummond, 2006; Lee and Chau, 2002; Ricchetti
et al., 2004; Schaer et al., 2006). It has also been found that macrophages stimulated
with IL-10 can induce a high expression of CD163 (Sulahian et al., 2000; Williams et al.,
2002).
It was hypothesized by Dr. Boyle that macrophages originating from hemorrhag-
ing plaques exposed to Hb:Hp participate in a switch-like transition from a CD163low
HLA-DRhigh lipid-laden and proatherogenic phenotype to a CD163high HLA-DRlow (see
Fig. 4.1(a)) (Glass and Witztum, 2001; Hansson et al., 2002). The CD163high HLA-
DRlow cell is referred to as the HA-mac lineage, characteristic of an increase in IL-10.
We investigate the anti-inflammatory and antioxidant phenotype of in vitro differentiated
CD163highHLA-DRlow macrophages.
4.3 Materials and methods
4.3.1 Model formulation
As introduced in Chapter 3, many molecular interactions may be represented as ordinary
differential equations (ODEs) in the form of mass action or Michaelis-Menten kinetics.
The first approximation, from a standard pharmacological modeling approach, is given
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by
Effect = R[Ligand][Ligand]+Kd ,
where R is a constant reflecting total receptor number (how strong the signal produces
the effect), [Ligand] is the concentration of cytokine or stimulant andKd is the dissocia-
tion constant. This ligand-receptor model resembles Michaelis-Menten kinetic equations
described in Chapter 3, rather than mass action since in this case, the ligand concentra-
tion may limit the effect. Specific to the models developed, the variables are [CD163] and
[IL− 10] which describe the time course of the concentrations of the two species. The
rate of change of each species is determined by the production and degradation of each.
As a general relation using standard modeling approaches (Kholodenko, 2006; Tyson
et al., 2003), coupled ordinary differential equations, Eq. 4.1 describe the evolution of
the Xi concentration,
d[Xi]
dt
= [Xi] production− [Xi] degradation, (4.1)
where i denotes the number of variables or species within the system.
4.3.2 Experimental data
Experimental work was conducted specific to the HA-mac and anti-inflammatory re-
sponse induced by Hb:Hp complexes.1 Immunohistochemistry and flow cytometry data
were obtained in conjunction with the model results presented (see Figs. 4.1, 4.2 and 4.7).
4.4 Results and discussion
To investigate the stable regulation into the two macrophage lineages, a positive feedback
loop is hypothesized in which Hb:Hp binding to CD163 leads to IL-10 secretion, in turn
up-regulating CD163. Positive feedback loops have recently been shown to generate sta-
1Erythrocytes were obtained from monocyte purification, subjected to hypotonic lysis in 50mL sterile
endotoxin-freewater (Invitrogen, tissue culture grade water). Cells were centrifuged at 3000rpm to remove
debris (sterile tissue culture 50mL centrifuge tubes), and the supernatant was collected. Hb concentration
was determined by Soret peak spectrophometry, endotoxin-free status by Limulus amebocyte assay and
purity by SDS-PAGE and Coomassie staining. Hb:Hp complexeswere prepared and added at culture outset
as for commercial Hb, after which the macrophages were cultured as before. Flow cytometry staining was
(CD163-FITC, HLA-DR-PE and isotype controls), but without dual-staining to obviate cytometer signal
compensation.
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Figure 4.1: Flow cytometry data (Boyle). Mechanisms causally linking Hb:Hp to HA-mac phenotype.
Human peripheral blood monocytes were incubated in the presence of Hb, Hp, Hb:Hp complexes, and
cytokines, at the indicated concentrations. After 8 days of culture, macrophages were detached and dual
stained for CD163 (FITC) and HLA-DR (PE). Representative flow cytometric dot plots, a technique used
to count and examine the effects of Hb:Hp complexes versus control on the assays. For each, the x axis
is CD163 and the y axis is HLA-DR (isotype controls were in the first quadrant, not shown). (a) Stimulus
effect on HA-mac phenotype. From left to right: unstimulated culture of day 8 macrophages, incubated
with Hb at 100 nM, incubated with Hp at 100 nM, incubated with Hb:Hp complexes at 100 nM. (b)
Concentration-effect curves for IL-10. From left to right: incubated with 50 pM IL-10 from outset of
culture, 500 pM, 5 nM, 50 nM. (c) Concentration-effect curves for Hb:Hp complexes. All are macrophages
culture day 6 cultured in the presence or absence of Hb:Hp complexes at the indicated concentrations from
outset of culture to analysis. From left to right: untreated, 1 nM, 10 nM, 100 nM, 1 µM.
ble divergence and commitment to two steady-states in T-helper cells (Yates et al., 2000)
and in monocytes vs neutrophils (Laslo et al., 2006). More generally, similar regulatory
architectures are being observed in a variety of systems biology contexts (Tyson et al.,
2003).
The feedback loop between CD163 and IL-10 in response to Hb:Hp is shown dia-
grammatically in Fig. 4.3. Simple conceptual models of this loop are developed using
two coupled ordinary differential equations. This is intended to demonstrate the feasibil-
ity of this feedback loop yielding a threshold value of Hb:Hp that differentiates between
CD163highHLA-DRlow phenotype (a lipid-laden macrophage that functions to increase
atherogenicity) (Glass and Witztum, 2001; Hansson et al., 2002) and CD163lowHLA-
DRhigh phenotypes. These models are therefore deliberately kept as simple as possible
and are not meant to provide a complete quantitative description of the regulatory system.
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Figure 4.2: Time course of CD163 fluorescence induced by Hb:Hp. Macrophages treated with Hb:Hp
complexes at 10−7mol/L. CD163 expression (x-axis) and cell number (y-axis) are measured at days 1, 2,
4, and 8.
Since none of the required parameter values have been experimentally determined, the
variables, [CD163] and [IL− 10] and time, are described in arbitrary units and param-
eters assigned illustrative values. This enables a theoretical exploration of a particular
network topology with given dynamics; furthermore, as described later, it is possible to
verify these arbitrary parameter choices do not affect the conclusions.
CD163
IL−10
+ +
Hb:Hp
Figure 4.3: Diagram of CD163/IL-10 feedback loop. Hb:Hp complex (red) initiates CD163 (blue) to
produce IL-10 (blue) which creates a positive feedback loop.
A positive feedback loop between CD163 and IL-10 could generate runaway growth
of both species. To confirm that it could generate a stable switch governed by [Hb:Hp]
levels, conceptual models were constructed with the intention to test the principle that
a threshold level of Hb:Hp could switch the system between two lineages rather than
providing a complete quantitative description.
The motivation, construction, analysis and discussion of each developed model is
presented in this section; the model variables, parameters and dynamical equations are
summarized in Tables 4.2 and 4.1. Models are qualitatively compared to experimental
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Model Equations
4.1
d[CD163]
dt =
p1[IL−10]
[IL−10]+Kd1
− k1[CD163]
d[IL−10]
dt =
[CD163][Hb:Hp]
[Hb:Hp]+Kd2
− k2[IL− 10]
4.2 d[IL−10]dt = [CD163][Hb:Hp][Hb:Hp]+Kd2 − k2[IL− 10] = 0
4.3
d[CD163]
dt = α+
p1[IL−10]
[IL−10]+Kd1
− k1[CD163]
d[IL−10]
dt =
[CD163][Hb:Hp]
[Hb:Hp]+Kd2
− k2[IL− 10]
4.4
d[CD163]
dt = α+
p1[IL−10]
[IL−10]+Kd1
− k1[CD163]
d[IL−10]
dt =
[CD163][Hb:Hp]
[Hb:Hp]+Kd2
+ p1[IL−10][CD163][IL−10]+Kd3 − k2[IL− 10]
4.5
d[CD163]
dt = α+
p1[IL−10]n
[IL−10]n+Kd1
− k1[CD163]
d[IL−10]
dt =
[CD163][Hb:Hp]
[Hb:Hp]+Kd2
− k2[IL− 10]
Table 4.1: Dynamical equations for the models with species [CD163] and [IL− 10].
data, after the construction of the models and comparison of the data to model results are
discussed.
4.4.1 Model 4.1: Simple first model
Motivation and dynamical equations
The intention of constructing this simple model was to test whether a threshold level of
Hb:Hp could be responsible for switching the system between two lineages, rather than
providing a complete quantitative description of the system. The model is described by a
coupled system of differential equations:
d[CD163]
dt
=
p1[IL− 10]
[IL− 10] +Kd1 − k1[CD163], (4.2)
d[IL− 10]
dt
=
[CD163][Hb : Hp]
[Hb:Hp] +Kd2 − k2[IL− 10]. (4.3)
Here [Hb:Hp] is a parameter indicating the strength of the Hb:Hp input (in arbitrary
units) and p1 is a parameter that determines the sensitivity of [CD163] upregulation to
[IL-10] levels. Degradation is modeled using simple exponential decay with rates k1 and
k2, while the parametersKd1 andKd2 determine the saturation of the production rates of
[IL-10] and [CD163] respectively.
Three different limiting factors were considered for the saturation of [IL-10]:
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Variable Description Initial condition
[CD163] CD163 macrophage scavenger receptor 0.1
[IL− 10] Interleukin-10 anti-inflammatory cytokine 1
Parameter Description Baseline value
p1 rate at which IL-10 upregulates CD163 10
Kd1 saturation of CD163 production rate 12
k1 degradation rate of CD163 1
[Hb:Hp] hemoglobin:haptoglobin 10−6 − 100
Kd2 saturation of IL-10 production rate 10−5
k2 degradation rate of IL-10 0.75
α basal production rate of CD163 0.01
p2 strength of IL-10 autoactivation 1
Kd3 saturation of IL-10 autoactivation rate 10−3
n hill coefficient 2
Table 4.2: Description of model variables and parameters, where [-] denotes concentration, pi are synthesis
rates, ki are degradation rates,Kdi denotes saturation constant of variable production.
1. CD163 receptor concentration;
2. CD163-Hb:Hp binding;
3. Hb:Hp only.
From a biological perspective, Dr. Boyle noted that assumption 1 (CD163 acts as
the only limitation) seemed incorrect suggesting Hb:Hp is required to saturate IL-10;
therefore, the remaining assumptions include Hb:Hp. The second case assumes satura-
tion of IL-10 occurs downstream of the CD163-Hb:Hp binding and there are excess free
CD163 receptors. This saturation is most likely to occur upstream, not downstream; con-
sequently, Hb:Hp and not the CD163-Hb:Hp complex may be the limiting factor (where
the formation of IL-10 is linear with respect to CD163 but saturates based on available
Hb:Hp). A biological interpretation is that Hb:Hp may bind to an upstream receptor
and therefore limit its binding to CD163. This in turn, effects the transcription of IL-10.
Eq. 4.2 assumes that IL-10 binds to a receptor, with downstream signaling to CD163 tran-
scription; therefore, a plausible biological interpretation is that the first term of Eq. 4.2
represents the concentration of IL-10 receptors available for CD163 binding on the cell
surface. Similarly, Eq. 4.3 corresponds to the signal saturating to a limited number of
CD163 receptors on the surface but a linear effect on the IL-10 transcription.
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Hb:Hp acts as bifurcation parameter in transcritical bifurcation
An advantage to formulating this simplified model is that the steady-state values can be
derived analytically and it is possible to verify that these arbitrary choices do not affect
conclusions. Conducting steady-state analysis of this system, there are two stationary
points (equilibrium concentrations), one always at the origin, [CD163]∗ = [IL− 10]∗ =
0, which corresponds to a low CD163 concentration and the other explicitly solved for
[CD163]∗ =
p1[Hb:Hp]− k1k2Kd1[Hb:Hp]− k1k2Kd1Kd2
k1[Hb:Hp] ,
[IL− 10]∗ = p1[Hb:Hp]− k1k2Kd1[Hb:Hp]− k1k2Kd1Kd2
k1k2([Hb:Hp] +Kd2),
corresponding to a high [CD163] steady-state. Since only non-negative states are of
biological relevance, the above expressions must satisfy p > k1k2Kd1 and [Hb:Hp] ≥
H∗, where H∗ is a threshold value,
H∗ =
k1k2Kd1Kd2
p1 − k1k2Kd1 , (4.4)
which determines whether the system will reach the low or high CD163 state. For
[Hb:Hp] = H∗, the threshold Eq. 4.4, denotes clearly when the stability of the system
switches: for [Hb:Hp]< H* (Fig. 4.4(a)), the origin is stable and globally attracting (cor-
responding to the low CD163 phenotype); conversely, if [Hb:Hp]> H* (Fig. 4.4(b)) then
the origin is unstable and the positive fixed point attracts all positive solutions. In fact, it
is easily observable that there is a transcritical bifurcation at the origin (see Fig. 4.8(a)).
Phenotypic switch prediction
In simulations, for high Hb:Hp concentrations, CD163 rose to a stable plateau (Fig. 4.5(a),
red curves); however, for low Hb:Hp concentrations, CD163 and IL-10 (not shown)
fell to negligible levels at low levels of Hb:Hp irrespective of starting concentrations
(Fig. 4.5(a), blue curves). Final CD163 was independent of initial CD163. Thus the
model predicts that the CD163-IL-10 positive feedback leads to two binary CD163 high
or CD163 low phenotypes depending on [Hb:Hp] input. The model is sufficiently simple
to analytically determine the final steady-state levels of CD163 and IL-10 (Eqs. 4.2 and
4.3) and hence show that there is a threshold level of Hb:Hp, H∗, given by Eq. 4.4, be-
low which [CD163] drops to negligible levels (e.g., blue curves in Fig. 4.5(a)) and above
which they rise to a stable plateau (e.g., red curves in Fig. 4.5(a)). This threshold is illus-
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(a) CD163low state (b) CD163high state
Figure 4.4: Phase diagram of CD163-Hb:Hp-IL-10 system. The phase diagram re-iterates the transcritical
bifurcation. The graphs show the solutions approaching the equilibrium state. All parameter values equal
one unless otherwise specified. (a) Low steady-state (corresponding to fixed point at origin) where p1 = 2,
satisfying the biological constraint and exhibiting the state below threshold. (b) High steady-state, where
p1 = 10 and exceeds the given threshold (see Eq. 4.4).
trated in Fig. 4.5(b) which shows that the final steady-state level of [CD163] rises rapidly
as Hb:Hp concentration reaches the threshold, before saturating to a fixed level.
The construction of the first simple model provided some insight into how the Hb-
initated CD163-gated macrophage phenotypic switch may become polarized to either a
high or low CD163 state; however, there were significant simplifications and assumptions
which are addressed in the remaining models.
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(a) Phenotypic CD163 switch
(b) Bifurcation Diagram
Figure 4.5: Phenotypic CD163 switch of CD163-Hb:Hp-IL-10 system (a) Representative simulated time
course of CD163 levels in a simple mathematical model describing the positive feedback loop between
CD163 and IL-10 given by Eqs. 4.2 and 4.3. Both axes are in arbitrary units. Blue curves show the
behavior of CD163 for a low [Hb:Hp] input ([Hb:Hp] = 0.01 in arbitrary units) for a number of starting
values ([CD163] = 0, 2, ..., 8). Red curves show behavior for a high [Hb:Hp] input ([Hb:Hp] = 1) with
the same starting levels. Other parameter values are p1 = 10, k1 = 1, k2 = 1, Kd1 = 1, Kd2 = 1
(arbitrary units) and the initial level of IL-10 is 0.5 in all cases. The qualitative behavior is independent
of this choice, and similar threshold behavior can be observed for all choices of k1 , k2 , Kd1 and Kd2 as
long as the sensitivity of [CD163] to [IL− 10] is sufficiently high (p1 > k1 k2Kd1). (b) Variation of final
steady-state values of CD163 and IL-10 with Hb:Hp input (all given in arbitrary units). Parameter values
are p1 = 10, k1 = 1, k2 = 12, Kd1 = 0.75, Kd2 = 10−5. The steady-states were obtained and clearly
illustrate the threshold which for these parameter values occurs at H∗ = 9 x 10−5. Similar qualitative
behavior is seen for all other parameter values as long as p1 > k1 k2Kd1 .
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4.4.2 Model 4.2: Non-feedback
Motivation and dynamical equations
The importance of CD163 on the production of IL-10 and the relationship between this
anti-inflamatory mediator and constant CD163 is important to understand; therefore, the
previous model has been modified in order to explore the IL-10 dynamics without feed-
back from CD163. To implement this,
d[IL− 10]
dt
=
[CD163][Hb:Hp]
[Hb:Hp] +Kd2 − k2[IL− 10]
is set to zero and solved
k2[IL− 10]([Hb:Hp]) = [CD163][Hb:Hp]Hb:Hp+Kd2 , (4.5)
which gives the relationship of IL-10 to Hb:Hp stimulus and concentration of CD163.
Non-feedback condition alters threshold
As shown in Fig. 4.6, the production of IL-10 concentration described by Eq. 4.5 is
heavily dependent on CD163; leading to IL-10 taking on a range of values. Notice that
the IL-10 steady-state levels start rising at much lower levels of Hb:Hp input, suggesting
there is not the same thresholdH∗. This seems reasonable since the system input is taking
higher levels of CD163 than those in the equilibrium CD163 feedback case previously
discussed. Experimental findings also support the functional dependence of IL-10 to
Hb:Hp (see Fig. 4.7(b) obtained from Dr. Boyle and Fig. 2.4 as published by Philippidis
et al. (2004)).
4.4.3 Model 4.3: Inclusion of basal production rate
Motivation and dynamical equations
One of the notable criticisms of the coupled system (Eqs. 4.2 and 4.3) is that the first
equilibrium solution is at the origin, suggesting that both IL-10 and CD163 are absent,
which was an over-simplification of the aforementioned models. The inclusion of a small
basal production rate term, α, to the system (see Eqs. 4.6 and 4.7) introduces a non-zero
low CD163 state.
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Figure 4.6: Simulated dose response of IL-10 under non-feedback conditions. Incremented every 0.1,
[CD163] (arbitrary concentration) input ranges from 0.1,..., 0.7 at baseline parameter values (Table 4.2).
d[CD163]
dt
= α +
p1[IL− 10]
[IL− 10] +Kd1 − k1[CD163], (4.6)
d[IL− 10]
dt
=
[CD163][Hb:Hp]
[Hb:Hp] +Kd2 − k2[IL− 10]. (4.7)
Inclusion of basal rate reveals unfolding transcritical bifurcation
While this parameter addition does not affect any of the subsequent qualitative conclu-
sions (Fig. 4.9), this minor modification complicates the model, and gives the following
analytic expression for the equilibrium points
([CD163]∗, [IL− 10]∗) =
(
1
2k1[Hb:Hp] (β ±
√
γ − δ), 1
2k1k2([Hb:Hp] +Kd2)(β ±
√
γ − δ)
)
(4.8)
where
β = [Hb:Hp] (α + p1 − k1k2Kd1)− k1k2Kd1Kd2,
γ = [Hb:Hp]2 (α2 + 2αp1 + 2αk1k2Kd1p21 − 2p1k1k2Kd1)+ 2α[Hb:Hp]k1k2Kd1Kd2, and
δ = 2p1[Hb:Hp]k1k2Kd1Kd2 + k21k22K2d1[Hb:Hp]2 + 2k21k22K2d1[Hb:Hp]Kd2 + k21k22K2d1K2d2.
The solution is difficult to analytically investigate with arbitrary parameter values; fur-
thermore, it is not possible to write an expression of the threshold in [Hb:Hp].
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(a) Dose response of CD163 by Hb:Hp (b) Dose response of IL-10 by Hb:Hp
Figure 4.7: Dose response of CD163 and IL-10 expression by Hb:Hp. (a) Flow cytometry of CD163
florescence intensity. For low levels of Hb:Hp (0 − 10−10 mol/L) low expression of CD163 is observed,
whereas, values of Hb:Hp above 10−9 mol/L yield high expression of CD163. (b) Concentration-effect
curves for Hb:Hp complexes on macrophage IL-10 production. Supernatant IL-10 levels (y-axis) from
macrophage cultures at 24 hours, adding Hb:Hp (x-axis, concentration log molar) at culture onset. Levels
are normalized by ratio to control wells, for n=5 donors (Boyle et al. (2009)).
In fact, the introduction of this term α causes the transcritical bifurcation to disappear
in a generic way and leave an unavoided crossing. According to Glendinning, 1995, an
unfolding degenerate singularity occurs when adding a parameter, such as α, acts as a
perturbation to the system and breaks the degeneracy and the threshold value H∗ is no
longer explicitly defined. This yields all the possible behaviors in nearby families (see
symmetry breaking bifurcations in Figs. 4.8(b) and 4.8(c)). To satisfy the biological sce-
nario (and in order to maintain a small positive basal level of transcription), α > 0 is
used. When comparing the positive solution set of the numerical bifurcation diagram of
the system for α > 0 (Fig. 4.9) compared to the α = 0 case (Fig. 4.5(b)), the different
families of bifurcations are clear. As expected, the case for α < 0 is biologically implau-
sible since this suggests negative basal production; moreover, the bifurcation diagram in
Fig. 4.8(c) exhibits a range of [Hb:Hp] for which there is no solution.
As the biological interpretation and motivation for this model has been discussed,
experimental data from Dr. Boyle (Fig. 4.7(a)) demonstrates quite clearly the necessity
for the basal production. As confirmed qualitatively by this data, this model’s bifurcation
predicts a low non-zero steady-state and also highlights that the threshold or critical point
is not a definitive value.
4.4.4 Model 4.4: IL-10 autoactivation in the absence of Hb:Hp
Previously proposed models depended in some manner on the amount of [Hb:Hp] present
in the system and this served as the mechanism to determine whether the CD163 phe-
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(a) Bifurcation, α = 0 (b) Unfolding bifurcation,α > 0 (c) Unfolding bifurcation, α < 0
Figure 4.8: Family of transcritical bifurcation diagrams. Family of transcritical bifurcation diagrams (based
on those from Glendinning, 1995 page 278). Solid lines and dashed lines denote stable and unstable
solution curves, respectively. (a) Standard transcritical bifurcation where the solution curves intersect and
change stability, symmetry exists (α = 0); (b) Bifurcation with symmetry-breakingα > 0; (c) Bifurcation
with symmetry-breaking α < 0.
notypic switch occurred. However, as Dr. Boyle (Fig. 4.1(b)) and others (Sulahian
et al., 2000; Williams et al., 2002) have found, IL-10 may instigate the synthesis of
CD163; therefore, this model must be tested to validate if this condition holds. Con-
sider Model 4.3 (Eqs. 4.6 and 4.7) when the parameter [Hb:Hp] = 0, there is a tran-
sient increase in CD163 concentration; however, the steady-state tends to a low value
(Fig. 4.10(a)).
To account for the absence of the Hb:Hp complex and a possiblemechanism for a high
CD163 state, the coupled differential equations are modified. A feedback term by CD163
on IL-10
(
[CD163][IL−10]p2
[IL−10]+Kd3
)
is added, as a possible [Hb:Hp] independent interaction in the
system
d[CD163]
dt
= α +
p1[IL− 10]
[IL− 10] +Kd1 − k1[CD163], (4.9)
d[IL− 10]
dt
=
[CD163][Hb:Hp]
[Hb:Hp] +Kd2 +
p2[IL− 10][CD163]
[IL− 10] +Kd3 − k2[IL− 10], (4.10)
and
[CD163](0) = [CD163]0 and [IL− 10](0) = [IL− 10]0,
where p2 is a parameter that determines the strength of autoactivation by CD163 and
IL-10 interaction on IL-10 and Kd3 is a parameter that determines the saturation of the
autoactivation rates of this IL-10 term.
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Figure 4.9: Bifurcation diagram of system with CD163 basal production. Bifurcation diagram of system
with added basal term. This transcritical bifurcation unfolds when the system is perturbed by the addition
of α; therefore, the solution can only be obtained numerically. The solution is qualitatively similar to
Fig. 4.5(b), except that the CD163 low phenotype value now slightly above the zero y-axis and the behavior
of the switch can no longer be calculated for a threshold valueH∗. The positive quadrant (i.e., biologically
relevant) solution of IL-10 and CD163 concentration (arbitrary units) is shown. In this simulation,α = .01,
p1 = 10, k1 = 1, k2 = 0.75,Kd1 = 12, andKd2 = 1x10−5 (arbitrary units).
Bistability by IL-10 autoactivation is not robust in presence of Hb:Hp
Recall that when exogenous IL-10 is added to CD163, the system behaves in a similar
fashion as to when the [Hb:Hp] complexes activate the macrophage switch (Fig. 4.1). An-
alytical expressions of the steady-states are not simple; therefore, exploration of steady-
states is performed by considering the model without basal transcription or Hb:Hp stim-
ulus, i.e., α = Hb = 0. This reveals a similar structure to the original simple Model 4.1
displaying a high and low level of CD163 determined by the IL-10 interaction parameter
p2, not Hb:Hp (Fig. 4.10(b)). Solving d[CD163]dt = 0 and d[IL−10]dt = 0 simultaneously, the
trivial states where both concentrations are zero are found, i.e., [CD163]∗ = [IL− 10]∗ =
0. To classify the trivial state and analyze its dynamics, the Jacobian is computed:
J =
(
∂ ˙[CD163]
∂[CD163]
∂ ˙[CD163]
∂[IL−10]
∂ ˙[IL−10]
∂[CD163]
∂ ˙[IL−10]
∂[IL−10]
)∣∣∣∣∣
([CD163]∗,[IL−10]∗)
=
(
−k1 p1kd1
0 −k2,
)
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(a) Model 4.3, Hb:Hp= 0 (b) Model 4.4, Hb:Hp= 0
Figure 4.10: Time course of Models 4.3 and 4.4 with no Hb:Hp (parameter [Hb:Hp] set to zero). The
solution of IL-10 and CD163 concentration is shown. In these simulations, [Hb:Hp] = 0, α = .01,
p1 = 10, k1 = 1, k2 = 0.75, Kd1 = 12, Kd2 = 10−5, p2 = 2 and Kd3 = 0.001. (a) Time course of
Model 4.3. (b) Time course of Model 4.4.
which has the characteristic polynomial
p(λ) = λ2 + (k1 + k2)λ+ k1k2,
and solving for eigenvalues,
λ1,2 = −k1,−k2,
where parameters k1 and k2 must be positive; therefore, the trivial state is always a locally
stable state. An intuitive explanation for the stability of the trivial state (independent of
parameter values) may be that for no initial [IL-10], [CD163] will remain at zero.
Depending on the choice of parameters, two, positive, non-trivial steady-states exist:
[CD163]∗ = −1
2
(
− p1p2 + k2k1Kd1 − k2Kd3k1
±
(
p21p
2
2 − 2p1p2k2k1Kd1 − 2p2k1k2Kd3p1 + k22k21K2d1 − 2k22k21Kd1Kd3 + k22K2d3k21
)1/2 )
p2k1
,
[IL− 10]∗ = −1
2
(
k1k2Kd1 + k1k2Kd3 − p2p1
±
(
k21k
2
2K
2
d1 − 2k21k22Kd3Kd1 − 2k1k2Kd1p2p1 + k21k22K2d3 − 2k1k2Kd3p2p1 + p22p21
)1/2 )
k1k2
;
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which yield bistable dynamics, that is, three non-negative steady-states, ceteris paribus2
of the baseline parameter values (Table 4.2) and the autoactivation strength parameter
p2 > p∗ where p∗ = 0.92. By numerically calculating the steady-states and investigating
the nullclines, the smaller of the two states is found to be a saddle (i.e., corresponding
to det|Jacobian| < 0 or eigenvalues are real and have opposite signs), whereas the larger
steady-state is stable (i.e., corresponding to det|Jacobian| > 0 and tr(Jacobian) < 0 or
eigenvalues are negative), thus, this system exhibits a switch as shown in Fig. 4.11. How-
ever, since the combination of parameters yields an unstable state close to the CD163low
state, Fig. 4.11(b) does not clearly elicit the dependence on initial conditions that exists.
To visually explain the two possible outcomes, a bifurcation diagram is presented as the
autoactivation rate parameter p2 is varied (Fig. 4.12). It is clear that the dynamics of the
model change from monostable to bistable behavior and hence, switching for the case
when IL-10 acts as the stimulus, that is, [IL− 10]0 (= 0, for a critical strength of IL-10
feedback with dependence on CD163 interaction, enables both a high IL-10 and CD163
state.
(a) CD163 switching (b) CD163 time course state
Figure 4.11: Dynamics of CD163-IL-10 Model 4.4 (Eqs. 4.9 and 4.10) in the absence of Hb:Hp. Unless
specified, baseline values and initial conditions are those given in Table 4.2. (a) Phase diagram and null-
clines of CD163-IL-10 bistable dynamics where [Hb:Hp] = 2 and p2 = 2. (b) Time course of CD163
exhibiting switching for low and high feedback strengths where the low and high states correspond to
p1 = 0.1 and p2 = 2, respectively.
Next, the Hb:Hp stimulus contribution term is included (with continued absence of
α) and analytically solved for three steady-states. Sampling values of [Hb:Hp] and p2
2“all other factors held constant”
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Figure 4.12: Bifurcation diagram of IL-10 autoactivation strength on CD163. Parameter value denoting
strength of IL-10 positive feedback (with CD163 dependence) is varied from 0 to 7 and the vertical log
axis represents the expression of CD163 (black line) and IL-10 (gold line). Low values reveal the only
non-negative real equilibrium point is (0,0). At approximately p2 = 0.92, two equilibrium points emerge,
corresponding to a CD163high phenotype (solid line). The other equilibrium point (thin line) is an unstable
equilibrium point. Default parameter values Table 4.2 and α = [Hb:Hp] = 0.
provide only two biologically admissible states for large values of [Hb:Hp] ([Hb:Hp] >
0.0001) or small values of p2 (p2 < 0.40 where [Hb:Hp] = 10−5). For small values of
[Hb:Hp] or large p2, three non-negative states exist: the trivial and two positive states; in-
terestingly, for any values of [Hb:Hp], the trivial state, under this parameter combination
is so close to the unstable positive state that the dynamics do not yield the desired bista-
bility hypothesized, such as a solution curve approaching either a low and high stable
state depending on initial condition. Instead, a switch is observed from the trivial stable
state for Hb:Hp absent to a stable CD163 high state, depending only on the parameter
values, not the initial conditions, which is a limitation to the parameter set constructed
thus far.
One should also note that this model assumes the feedback mechanism of IL-10 is
dependent on some initial CD163 present. This may not be biologically faithful, as cells
stimulated with Hb:Hp have been observed to have an increase of IL-10 prior to an eleva-
tion of CD163 expression; therefore, this suggests that the mechanism involved for IL-10
autocatalytic activation (positive feedback) may be independent of CD163. Modifying
the feedback term in Model 4.4
(
[IL−10][CD163]p2
[IL−10]+Kd3
)
to [IL−10]p2[IL−10]+Kd3 enables IL-10 autoac-
tivation independent of CD163 levels. First, a simplified case with no basal or Hb:Hp
stimulus is examined, α = [Hb:Hp] = 0. There are two admissible steady-states, indi-
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cating the existence of CD163low = 0 and CD163high states (Fig. 4.11(b)). Inclusion of
[Hb:Hp] maintains the CD163low = 0 and CD163high states, and introduces a negative
state despite exploration of parameter values. Analysis of the Jacobian reveals that the
trivial steady-state is stable when
k1 + k2 <
k3
Kd3
and k1k2 > p1[Hb:Hp]
kd1([Hb:Hp] +Kd2) +
k1k3
Kd3
.
At the baseline parameters the trivial state is unstable, even for small values of [Hb:Hp]
(order of 10−8), therefore Kd3 = 50 is used to satisfy the above conditions. Moreover,
numericaly, it is found that when [Hb:Hp] is small ([Hb:Hp] ≤ 10−5), the trivial state is
the only non-negative that satisfies the stability condition; for larger values of [Hb:Hp],
two non-negative states exist and the positive is stable whereas the trivial state is unstable.
This model has a similar transcritical behavior as Model 4.1 and lacks the bistability
often necessary for cells initialized at different variable concentrations; therefore, the
additional term merely adds complexity to the system.
The original feedback model (Model 4.4) exhibits bistability for the case when IL-
10 is the driver for CD163 expression and Hb:Hp is absent; furthermore, the models
enable a method by which IL-10 may induce expression of itself as well as CD163. The
model in the absence of Hb:Hp also provides a simplification of the mechanism of IL-
10 binding to its receptor, initiating signal transduction pathways, upregulating its own
synthesis, and resulting in an anti-inflammatory cell phenotype. Through the analysis
presented, the models may not robustly capture the bistability dynamics of elevated IL-
10 when incorporating both IL-10 and Hb:Hp stimuli. Moreover, as experimental data
that finds maintained elevation of stimulus IL-10 by mononuclear phagocytes stimulated
with IL-10 is lacking, the models are unable to provide an explanation for both IL-10
and Hb:Hp stimuli. While feedback of IL-10 by IL-10 may exist, the model may require
other interactions, such as additional variables included in the model by Figueiredo et al.,
2009), biological evidence is not conclusive to support the specific hypothesis, and our
models, despite parameter variation, do not suggest this a robust simplification of the
mechanism; thus, different method for bistability are considered.
4.4.5 Model 4.5: Cooperativity in IL-10
Previous mathematical models of biological switches and bistable systems often include
cooperative binding (Angeli et al., 2004; Bagowski and Ferrell, 2001; Callard et al., 1999;
Ferrell, 2002; Laurent and Kellershohn, 1999; Tyson et al., 2003). In this context, con-
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sider cooperative binding of IL-10 to activate CD163. This minor change to Model 4.3
(Eqs. 4.6 and 4.7) gives the system
d[CD163]
dt
= α+
p1[IL− 10]n
[IL− 10]n +Knd1
− k1[CD163], (4.11)
d[IL− 10]
dt
=
[CD163][Hb:Hp]
[Hb:Hp] +Kd2 − k2[IL− 10], (4.12)
where n is a parameter denoting cooperativity, a Hill coefficient. In developing this
model, cooperativity between Hb:Hp and CD163 was also considered, however, data ob-
tained later from Dr. Boyle confirmed a linear relationship, or a Hill coefficient equivalent
to one. Therefore, only cooperativity between CD163 and IL-10 is considered.
Cooperativity in IL-10 yields bistable system
Steady-state analysis of this system reveals the addition of a positive hill coefficient
n > 1 creates the desirable bistability, i.e., two steady-states representing a CD163low
and CD163high phenotype and one unstable middle state. Visualization of nullclines aids
the switching of stability (Fig. 4.13); furthermore, bifurcation analysis improves our un-
derstanding of the model dynamics and how the parameters [Hb:Hp] and Kd1 affect the
outcome (Fig. 4.15). Interestingly, the range of parameter values ([Hb:Hp], Kd1) yield-
ing the region of CD163 bistability results in a cusp catastrophe, an elementary object
of catastrophe theory, which studies how small perturbations in certain parameters can
lead to large and sudden changes in the behavior of a nonlinear system (Arnol’d, 1992).
A more instructive view of the dependence of the [CD163] state on [Hb:Hp] and Kd1 is
shown in Fig. 4.15. In comparison with the previous models, this model remains sim-
ple in structure while encompassing bistability, cooperativity and a biologically feasible
interpretation.
4.5 Conclusion
Mathematical models were developed with the central aim to explore and predict be-
havior of macrophages in atherosclerotic intraplaque hemorrhages in response to var-
ious stimuli. Immunohistochemistry and flow cytometry data of plaque macrophages
stimulated with hemoglobin - haptoglobin (Hb:Hp) complex and interleukin-10 indi-
cated strong evidence for Hb:Hp induced macrophage differentiation from CD163low
and CD163high phenotypes. This collaboration enabled the development, analysis and
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Figure 4.13: Nullclines of bistable cooperative CD163 system. Nullclines and phase diagram with two
stable equilibrium points representing low and high CD163 phenotypes and one unstable fixed point. The
parameter are baseline values as stated in Table 4.2, except that α = 0.15, k2 = 12, and the stimulus is
[Hb:Hp]=10−3 (arbitrary units).
(a) Stable trivial state (b) Unstable state (saddle) (c) Stable high state
Figure 4.14: Phase field diagram of Model 4.5 steady-states, with baseline parameter values and α = 0 (a)
Stability of trivial state (b) Saddle point of middle state (c) Stability of CD163high state.
comparison of ODE models based on measured data. Through the iterative process of
constructing and revising each model, a deeper insight was gained about the underlying
biology, all the while acknowledging the limitations of each model.
The first model (Model 4.1), a simple coupled ODE, predicted a switch-like behavior,
from a lipid-laden and pro-inflammatory phenotype to an anti-inflammatory and athero-
protective (HA-mac) cell phenotype. This model hypothesized that stable regulation into
these two lineages could be determined by the observed positive feedback loop in which
Hb:Hp binding to CD163 leads to IL-10 secretion, in turn up-regulating CD163. The data
validation of this conceptual model motivated further investigation of the interactions.
A simplification of Model 4.1, the second model (Model 4.2) was formulated to un-
derstand the effect of constant CD163 amount on IL-10. We found that IL-10 levels were
highly dependent on CD163 initially present in the cell, confirming the importance of the
feedback loop. After considering the unlikeliness of monocytes/macrophages existing
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Figure 4.15: Bifurcation diagrams for Model 4.5 and surface of cusp catastrophe. (a) Bifurcation diagram
of [Hb:Hp]; (b) Bifurcation diagram ofKd1; (c) surface of cusp catastrophe in ([Hb:Hp],Kd1) plane.
with absolutely no initial CD163, a basal transcription rate (Model 4.3) was introduced.
This model was intriguing, mathematically, with the observation that this parameter in-
duced an unfolding to the bifurcation structure of the first model (Model 4.1).
The next model (Model 4.4) investigated the role of IL-10 as a stimulus when Hb:Hp
is not present in the system. Two variations of this model were considered, both includ-
ing an autoactivation term on IL-10. It was determined that this feedback could yield to
bistable behavior; moreover, the feedback loop initiated by IL-10 (promoting its own syn-
thesis) facilitated the phenotypic switch of CD163 from low to high states. It was found
however, that many parameter combinations did not yield bistable behavior; thus, the
increased complexity of the model did not warrant the benefits without further parameter
investigation. Another bistable scheme that was considered was cooperativity between
CD163 and IL-10, which was hypothesized to be possible given that many interactions
must occur between IL-10 synthesis and CD163 activation.
The models presented in this chapter are conceptual and mechanistic in nature and
proved useful; however, they have limitations. Extending the conceptual models to a pop-
ulation of heterogeneous macrophages, wherein methods and techniques from Cha´vez-
Ross et al., 1997; Hofbauer, 1988, analogous to Lacker type models (Lacker, 1988), may
render more light on the phenotypic switch and interesting results may come from such
an approach. Another future direction is to include intercellular mediators as data be-
come available to provide additional insight to the pro-inflammatory/anti-inflammatory
balance; thus, models investigating the cellular switching mechanisms and mediators
may lead to an increased understanding and may point to improve medical therapies for
vascular inflammatory diseases.
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Chapter 5
A mechanistic study of
anti-inflammatory response by
macrophages after stimulation with
Hb:Hp complexes/heme
5.1 Overview
The primary focus of this work is motivated by extending the simple extracelluar model
of CD163/IL-10 upregulation driven by Hb:Hp complexes by Boyle et al. (2009) to in-
clude the intracellular mediator heme oxygenase-1. The aim is to gain further insights
into the responsible mechanisms for HA-mac differentiation of this system. To accom-
plish this, four models are presented, which test specific components in the signaling
network and corroborate experimental evidence through data-fitting, sensitivity analy-
sis and model selection techniques. The selected model’s predictions are compared to
experimental data of the response of a different stimulus, heme, on monocytes. More-
over, the model result predicts that an anti-inflammatory stimulus, such as IL-10 also
induces an anti-inflammatory macrophage phenotype. Therefore, this work identifies a
model which describes mechanisms responsible for anti-inflammatory response in mono-
cytes/macrophages under a number of stimuli. Finally, this work provides a mechanistic
insight to the anti-inflammatory response and suggests future experiments to test the pre-
dictions.
This research was conducted in collaboration with Dr. Joseph J. Boyle and co-workers
from the Imperial College London Faculty of Medicine and Dr. Christopher Barnes from
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the department of Bioinformatics. This work is in preparation for submission.
5.2 Introduction
Recall from Chapters 2 and 4 that monocytes and macrophages, present at the site of
the inflammatory disease, atherosclerosis, respond to stimuli to invoke either a pro-
or anti-inflammatory response. Under certain conditions, these monocytes may differ-
entiate into macrophages with scavenger receptor CD163 surface expression (Buechler
et al., 2000; Philippidis et al., 2004), which acts as a vehicle to import free pro-oxidative
stress hemoglobin-haptoglobin (Hb:Hp) complexes (Kristiansen et al., 2001). Internal-
ized Hb:Hp undergoes lysosomal catabolysis into intracellular heme which may synthe-
size its rate limiting enzyme HO-1, resulting in heme degradation and inducing a re-
sponse (Idriss et al., 2008; Immenschuh and Ramadori, 2000; Morita, 2005; Otterbein
and Zuckerbraun, 2005; Pae et al., 2008; Philippidis et al., 2004; Sawle et al., 2005;
Schaer et al., 2006; Takaya et al., 2005). Specifically, the Hb:Hp-CD163 binding has
been found to induce an anti-inflammatory response of IL-10 (Boyle et al., 2009; Lee
and Chau, 2002; Moestrup and Moller, 2004; Otterbein and Zuckerbraun, 2005; Ugocsai
et al., 2006; Van den Heuvel et al., 1999). Recent studies have also found interactions
between HO-1 and IL-10 suggesting the existence of a positive feedback loop (Abraham
and Drummond, 2006; Lee and Chau, 2002; Ricchetti et al., 2004; Schaer et al., 2006).
Additionally, autoactivation of IL-10 via Stat-3 may occur through a positive feedback
loop (Sanjabi et al., 2009). It has also been found that macrophages stimulated with IL-10
can induce a high expression of CD163 (Sulahian et al., 2000; Williams et al., 2002).
Recently, construction of a mathematical model of the stable regulation into the two
lineages (CD163low HLA-DRhigh and CD163high HLA-DRlow) observed positive feed-
back in which Hb:Hp binding to CD163 leads to IL-10 secretion, in turn up-regulating
CD163 Boyle et al. (2009). A coupled ordinary differential equation (ODE) model was
constructed and a positive feedback hypothesizing the phenotypic switch was validated
by experimental evidence; however, the model did not include other possible transport
mechanisms, such as free heme, incorporate additional intracellular players, nor did it
accurately match elevation time of species expression levels. As highlighted previously,
the biological evidence requires a model which includes observed intracellular feedbacks
and incorporation of different possible transport mechanisms to give testable predictions.
Positive feedback loops have been shown to generate stable divergence and commitment
to two steady-states in T-helper cells (Yates et al., 2000) and in monocytes vs neutrophils
(Laslo et al., 2006). Furthermore, identifying specific species in biological positive feed-
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back systems have been shown to govern cell fate, for instance, models of caspase feed-
backs control cell death (Eissing et al., 2004; Legewie et al., 2006). More generally,
similar regulatory architectures are being observed in a variety of systems biology con-
texts (Tyson et al., 2003).
5.3 Results and Discussion
5.3.1 Model formulation
Four models (5.1, 5.2, 5.3 and 5.4) were developed of macrophage response by Hb:Hp
complexes. These models assume a positive feedback loop between species [CD163]
and [IL-10] (see Chapter 4) and the models include the intermediate [HO-1], where [-]
denotes concentration. The stimulus, Hb:Hp complex, is endocytosed by CD163, upregu-
lating HO-1, which instigates the synthesis of IL-10. One difference between the stimulus
in these models than in previous is that Hb:Hp is assumed to degrade exponentially rather
than remain constant. This may be a more realistic assumption in the model since in ac-
tually, the stimulus does not remain constant externally as it is internalized by the cell,
and thus is no longer available to initiate a signal for all time. Furthermore, as Hb:Hp
is internalized, HO-1 degrades Hb:Hp, and thus serves as another interpretation of the
decrease in levels of Hb:Hp. For simplicity, Hb:Hp is kept a model parameter rather than
a model variable. As diagrammatically shown in Fig. 5.1, models consider the intracel-
lular mechanisms that describe the baseline model: Hb:Hp degrades exponentially either
naturally or by HO-1; Hb:Hp binds to CD163 and upregulates HO-1; HO-1 initiates the
synthesis of IL-10; and IL-10 induces expression of CD163 with cooperativity. Although
this complex system includes other regulators and possible feedback mechanisms, the
interactions between these three species are investigated using literature hypotheses of
mechanisms: Model 5.2 extends the baseline model to include an auto-activation IL-10
positive feedback loop (via Stat-3 (Sanjabi et al., 2009)), whereas Model 5.3 extends the
baseline model to investigate the effects of IL-10 inducing HO-1 expression, creating an
HO-1/IL-10 positive feedback loop (Lee and Chau, 2002) and Model 5.4 is the composite
of both mechanisms.
As summarized in Table 5.1, Model 5.1 is the baseline, Model 5.2 includes an autoac-
tivation feedback loop by IL-10, Model 5.3 includes a feedback loop by IL-10 on HO-1
and Model 5.4 is the composite of Models 5.2 and 5.3. Model variables and parameters
are described in Table 5.2.
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Model Equations
d[CD163]
dt = α + v1 − v2
5.1 d[IL−10]dt = v3 − v4
d[HO−1]
dt = v5 − v6
d[CD163]
dt = α + v1 − v2
5.2 d[IL−10]dt = v3 − v4 + v7
d[HO−1]
dt = v5 − v6
d[CD163]
dt = α + v1 − v2
5.3 d[IL−10]dt = v3 − v4
d[HO−1]
dt = v5 − v6 + v8
d[CD163]
dt = α + v1 − v2
5.4 d[IL−10]dt = v3 − v4 + v7
d[HO−1]
dt = v5 − v6 + v8
Reaction velocities
v1 =
p1[IL−10]n
[IL−10]n+Knd1
v2 = k1[CD163]
v3 =
p3[HO−1]
[HO−1]+Kd4
v4 = k2[IL− 10]
v5 =
[CD163][Hb:Hp]
[Hb:Hp]+Kd2
v6 = k3[HO− 1]
v7 =
p2[IL−10]
[IL−10]+Kd3
v8 =
p4[IL−10]
[IL−10]+Kd5
Table 5.1: Dynamical equations for models. Model 5.1 is the baseline; Model 5.2 includes v7, an autoac-
tivation feedback loop by IL-10; Model 5.3 includes v8, a feedback loop by IL-10 on HO-1; and Model
5.4 is the composite of Models 5.2 and 5.3. The reaction in v5 corresponds to an exponential decaying
stimulus: [Hb:Hp] = H · e−λ·t whereH is the original stimulus concentration.
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Variable Description
[HO− 1] Heme oxygenase-1
[IL− 10] Interleukin-10 anti-inflammatory cytokine
[CD163] CD163 macrophage scavenger receptor
Parameter Description
p1 rate at which IL-10 upregulates CD163
Kd1 saturation of CD163 production rate
k1 degradation rate of CD163
[Hb:Hp] hemoglobin-haptoglobin complex
Kd2 saturation of HO-1 production rate by Hb:Hp-CD163 binding
Kd4 saturation of IL-10 production rate by HO-1
k2 degradation rate of IL-10
α basal production rate of CD163
p2 strength of IL-10 autoactivation
Kd5 saturation of HO-1 production rate by IL-10
Kd3 saturation of IL-10 autoactivation rate
k3 degradation rate of HO-1
p3 rate at which HO-1 upregulates IL-10
p4 rate at which IL-10 synthesizes HO-1
n hill coefficient
λ degradation rate of Hb:Hp complexes
Table 5.2: Description of variables and parameters of models, where [-] denotes concentration, and pi, ki,
Kdi are parameters representing synthesis, degradation and saturation rates, respectively.
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Figure 5.1: Diagram of CD163/HO-1/IL-10 feedback loop. Hb:Hp complex initiates CD163 to upregulate
HO-1, which initiates the synthesis of IL-10. Solid arrows represent the known biological behavior that
is incorporated in all models, whereas the dashed arrows represent mechanisms that in included in select
models.
5.3.2 Parameter fitting and model selection
Developing a model capable of exhibiting bistable behavior is often dependent on model
structure, parameters and initial conditions. As investigated in Chapter 4, the structure of
the models (positive feedback with Hill functions) may give rise to multistability. This
switching objective between states is highly dependent on parameter values and initial
conditions. Model parameters k2 and k3 are estimated degradation rates of IL-10 and
HO-1 from the literature and stimulus levels are taken from experimentation (see Ma-
terials and Methods). Remaining parameters are estimated using approximate Bayesian
computation (ABC) based on sequential Monte Carlo (SMC) sampling. This statistical
approach uses an initial prior range which was estimated using many Nelder-Meads (see
Materials and Methods) given in Table 5.3. ABC-SMC provides a posterior distribution
of inferred parameter values. ABC-SMC is also used to estimate initial conditions of the
models, which previously, had been achieved, but not implemented in the ABC-SysBio
package. Simultaneous to inferring parameters, the model selection is performed to dis-
criminate the most appropriate model when compared to published time course data of
monocyte/macrophage response to Hb:Hp complexes (see Materials and Methods). Each
iteration of the algorithm reduces the acceptance tolerance of parameters/models, which
increases the accuracy of the fit and model selection. This gives an output of a pop-
ulation of particles (accepted sampled algorithm inputs) with a given acceptance rate at
each iteration (see Fig. 5.2) which selects Model 5.3 after all remaining models have zero
probability. Please note acceptance rates from one population to the next depends on the
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epsilon schedule. If the next step is small compared to previous step then it can increase.
Ideally the acceptance rate should be fixed between populations so that it is approximately
constant though this is rarely achieved in practice. It does not have to monotonically de-
crease though usually it does. As the model selection runs for the given priors, Model 5.3
Figure 5.2: Model probability as ABC-SysBio algorithm progresses. Order is Model 5.1, 5.2, 5.3, and 5.4.
The final population (45) shows Model 5.3 represents the data best. Each iteration of the algorithm reduces
the distance between simulations and observed data, which increases the accuracy of the fit and model
selection, resulting in a population of particles (accepted sampled algorithm inputs) that approximates the
marginal posterior probability. The small numbers correspond to acceptance rate for each iteration.
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is found to most accurately describe the data (see Fig. 5.2). This result corroborates the
hypothesis by Lee and Chau, 2002 of positive feedback mechanisms between IL-10 and
HO-1. The Model 5.3 time trajectory of the species at the inferred parameter values and
initial conditions which was numerically solved and it fits the IL-10 and CD163 time
course data reasonably well (Fig. 5.3). The curve representing the HO-1 behavior ap-
proaches a higher steady-state than the obtained HO-1 data. This may occur since the
simplicity of the model does not include regulators, rather, the focus is to explore the
specific interactions between IL-10 and HO-1 species. Inspection of the model structure
suggests that elevated IL-10 may only occur if HO-1 levels remain high since the produc-
tion terms of IL-10 and HO-1 are highly dependent on each other. The ABC-SMC result
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Figure 5.3: Model 5.3 time course at inferred parameter values (see Table 5.3). The time course data
(stars and error bars) obtained from Philippidis et al., 2004; Schaer et al., 2006 and Boyle et al., 2009 (see
Materials and Methods) and simulated time course of Model 5.3 (solid lines) of HO-1 mRNA (blue), IL-10
protein (green) and CD163 protein (red) .
provides a posterior distribution over parameters and models (Fig. 5.4). While many pa-
rameters are inferred well, some are not identifiable, such as the initial conditions, as
well as p4, p1, and λ. The identifiability of parameters may be shown by the interquantile
ranges of the posterior, i.e., identifiable parameters converge whereas non-identifiable
which jump around, such as the IL-10 initial condition, α, k1 and λ (Fig. 5.5). However,
the identifiability of parameters may occur as an artifact of insufficient sampling, i.e., the
chosen perturbation kernel may not fully cover the space (see Materials and Methods).
It should be noted that this inference was performed multiple times with different seeds,
which resulted in the same conclusions. With the posterior of inferred parameters and
initial conditions, the model system may be studied in more detail.
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Figure 5.4: Weighted posterior parameter distribution of final Model 5.3 fit at final population for N=2000
particles.
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Figure 5.5: Interquantile ranges of each population. This displays the interquantile ranges of the posterior
as the algorithm passes through the 45 populations. Generally, identifiable parameters will reduce until
the true posterior is reached; however ranges that jump around may indicate non-identifiable parameters or
this output may occur an artifact of insufficient sampling.
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5.3.3 Sensitivity analysis of Model 5.3 parameters
Performing principal component (PC) analysis on the posterior of final population gives
a similar sensitivity as calculating the Hessian (Secrier et al., 2009). The principal com-
ponent coefficients provide a method to measure the sloppiness and sensitivity of the
inferred parameters: the largest PC gives sloppy parameters that have the least infor-
mation whereas the smallest PC gives sensitive parameters which correspond to stiff
combinations (see Material and Methods). Briefly, the eigenvectors νi corresponding
to eigenvalues λi of the corresponding PC (for i = 1, ..., m where m is the number of
eigen-parameters) are ranked and the PC variance (Fig. 5.6(a)) may be used to determine
the most sloppy and sensitive parameters. The PC numbers that explain less than one
percent of the total variance (last two PCs) are taken to correspond to stiff parameter
combinations. As shown in Fig. 5.6(b), the sensitivity of model parameters is shown
by calculating the eigen-parameter projection (pa,b), which represents the square of the
eigenvalue associated with parameter a pointing in the direction of raw parameter b, taken
to be pa,b = ν2a,b/
∑
ν2ai of the final PC. The pie chart describing the eigen-projection
of the fourteenth PC identifies combinations of parameters n and Kd1, which are most
constrained to the data and these parameters do not explain much of the total variance
of the posterior distribution. Performing global sensitivity analysis (Fig. 5.7) also is in
agreement that parameter n is most sensitive. Additionally, the global sensitivity analysis
suggests that the degradation rate k1 which is the third smallest PC in Fig. 5.6(b) and the
interaction parameters p1 and p3 are found to affect the model steady-states. The sloppy
parameters may be determined by examining the largest projections of the largest PC. As
shown in Fig. 5.6(b), the first PC, primarily shades of blue, identifies the initial conditions
to have the least amount of information.
Numerical investigation of Model 5.3 at the inferred parameters for constant Hb:Hp
stimulus has only one real steady-state, corresponding to a (CD163, IL-10, HO-1)high
state, thus the model trajectory will always approach this anti-inflammatory state. Fur-
ther exploration of the parameter values motivated by the principal component analysis
reveals that for the inferred value n = 1.68 at small initial CD163, IL-10, and HO-1,
the other fixed points are complex, which explains why all biologically relevant trajec-
tories approach the (CD163, IL-10, HO-1)high state. For instance, increasing the value
of the Hill coefficient to n = 2 changes the steady-state classification to three real fixed
points. However, inspection of the steady-states which are numerically calculated using
initial conditions ranging from 0 to 20 for all species. This permits only one non-negative
fixed point corresponding to the high anti-inflammatory state. However, as the last PC
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Figure 5.6: Principal component analysis of Model 5.3. The first PC describes 21% of the total variance
with each subsequent PC describing 14%, 12%, 9%, 8.5%, 7.3%, 6.4%, 5.4%, 4%, 3.8%, 2.8%, 1.9%,
0.7%, and 0.1%) of the total posterior variance, respectively. The projections of eigen-parameters onto the
raw parameters gives an account of which parameter combinationsmay be ‘sloppy’ or ‘stiff’ corresponding
to the largest and smallest PCs, respectively. As a heuristic, the number of ‘sloppy’ parameters may equate
to the PC numbers that explain < 1% of total variance, taken as the last two. The eigen-parameter pro-
jections determined by the eigen-direction in the final PC suggest n, and Kd1 are the most stiff parameter
combinations.
suggests, the stiff parameter combinations occur for n and Kd1. While the Nelder-Mead
method restricted many prior choices, the range forKd1 was not easily determined (recall
Kd1 ∼ U(0,1000)); therefore, the values for Kd1 were varied within the prior range for
different initial conditions. As an example, it was found that if Kd1 = 0.3 and n = 2,
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Figure 5.7: Global sensitivity analysis results of Model 5.3. Paremeters are perturbed by half an order of
magnitude and 103 simulations for each analysis.
there exists a (CD163, IL-10, HO-1)low and (CD163, IL-10, HO-1)high state. Inspection
suggests for the inferred parameter values that this bistability is not robust; however,
here, principal component analysis provides a method for determining stiff parameters
and facilitating the exploration of parameter combinations that ultimately lead to multi-
stability. Further experimentation with additional time points performed under the same
experimental conditions would perhaps improve parameter estimation and may provide
the means for developing a more complex model.
Also inspired by the sensitivity analysis, the model, at baseline parameter values and
the inferred initial conditions (as well as at the adjusted parameters n and Kd1), is found
to be somewhat insensitive to changes in the Hb:Hp stimulus (for both constant and
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exponential decay), meaning that if [Hb:Hp] = 0, the steady-state still approaches the
(CD163, IL-10, HO-1)high state and does not afford the same switching effect as ob-
served previously in Chapter 4 or by Model 5.1. This may suggest that if cells initially
have low levels of CD163, IL-10 and HO-1, then the response, nonetheless, may result
in an anti-inflammatory cellular phenotype despite the absence of Hb:Hp stimulus. Inter-
estingly, when there is no stimulus [Hb:Hp] = 0 and absence of initial anti-inflammatory
mediators (CD163, IL-10, HO-1)0 = (0, 0, 0), such as, for example, for cells that are
pro-inflammatory, then the cell remains at a (CD163, IL-10, HO-1)low state. This model,
in fact, predicts that for cells with no initial predisposition to an anti-infammatory pheno-
type that Hb:Hp is necessary to initiate a change in phenotype whereas cells that already
have an anti-inflammatory predilection may not require the additional stimulus.
5.3.4 Comparison of model results to other stimuli
Much research suggests that the heme component of the Hb:Hp complex is responsi-
ble for both the cytotoxic effects (leading to the oxidation of molecules) and the anti-
inflammatory response (Boyle et al., 2009; Kristiansen et al., 2001; Lee and Chau, 2002;
Moestrup and Moller, 2004; Otterbein and Zuckerbraun, 2005; Sawle et al., 2005; Ugoc-
sai et al., 2006). To test the anti-inflammatory effects, experimental time course data of
HO-1, IL-10 and CD163 mRNA transcript expression after stimulation by 10 µM heme
was obtained (see Materials and Methods). The heme stimulus was approximated to be
∼ 9.176× 10−4 g/mL Hb:Hp, which was used as the model stimulus (see Materials and
Methods).
The obtained mRNA time course data of monocytes stimulated with heme is quali-
tatively compared to the simulated model results for the equivalent heme stimulus and
Hb:Hp stimulus (Fig. 5.8). The Hb:Hp simulated time course (solid line) peaks and then
falls to the steady-state level whereas the simulated heme time course (dotted line) does
not have the same peaking behavior. The peaking behavior may indicate that the larger
stimulus concentration (Hb:Hp) overshoots the steady-state before reaching the same
state as the simulated heme model. In comparison to the experimental data (top row), the
peaking behavior also occurs and then the mRNA levels decrease. In the first instance,
the experimental stimulus of heme and simulated Hb:Hp levels may be too large and the
species may initially over-respond before reaching the intended steady-state. Interest-
ingly, the steady-state level of the experimental HO-1 mRNA fold change approaches a
low steady-state after an initial peak ∼ 12 fold change, whereas the Hb:Hp model simu-
lation reaches a peak of∼ 7 fold change and both simulated models remain at an elevated
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Figure 5.8: Time course (mRNA data) of monocyte response to heme stimulus. Time course of HO-1,
IL-10, and CD163 induction by macrophages stimulated with heme (10 µM). Assay was determined by
real-time reverse-transcription polymerase chain reaction (qRT-PCR), an experimental technique which
provides a quantitative measure of mRNA, gene transcription expression, where the each data point is the
mean fold change from n = 3 experiments. Data is qualitatively compared to model predictions
steady-state of approximately 4 fold change. Investigation of the model indicates that the
HO-1 prolonged expression is necessary for prolonged IL-10 activation due to the pos-
itive feedback structure of the model. The IL-10 mRNA response for the heme stimuli
suggests that the larger (Hb:Hp) stimulus gives a better qualitative representation; how-
ever both simulations predict that the fold change is approximately 20. The synthesis
rates (pi), determined to be sensitive parameters by the global sensitivity analysis, may
require adjustment for a heme stimulus as the cellular mechanisms, such as lysosome
catabolism and perhaps signaling to initiate IL-10 differs. Finally, the CD163 mRNA
response peaks and then decays to a low level whereas the simulated model predicts the
steady-state to remain elevated. Perhaps, since the simulation parameters were estimated
using CD163 fluorescence expression rather than mRNA (known to synthesize before
translation), the protein level may eventually reach a low state which was not taken into
account in the parameter estimation.
Interestingly, the activation time of the heme simulation also occurs later than the
Hb:Hp simulation. An explanation may be that a larger stimulus induces a quicker re-
sponse compared to a smaller stimulus that results in a slower response. Contrasting the
activation time of the experimental data to the simulated data shows an earlier activation
peak. This may occur as a result of the initial parameter estimation; specifically, that the
IL-10 and CD163 experimental measurement was protein expression whereas the exper-
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imental set-up of heme recorded mRNA transcript response. Hence, fitting parameters to
protein time course data and then comparing these results to mRNA would cause such
a difference in activation time. This difference may also be extended to deactivation
time, which, could not be taken into account from the protein expression data, and there-
fore, the end behavior could not be included in the parameter inference. The difference
in the time scale may also be improved by obtaining both mRNA and protein data of
Hb:Hp anti-inflammatory response performed under the same experimental conditions.
Nevertheless, since protein synthesis is translated from mRNA, it can be assumed that
the experimental results of protein expression for the heme system would occur at some
time τ later after the given experimental mRNA fold change. Taking this into account as
well as the fact that heme may enter cells by other means such as passive diffusion and
heme carrier protein-1 (Latunde-Dada et al., 2006; Schaer et al., 2008; Tsiftsoglou et al.,
2006), the degradation of heme resulting in anti-inflammatory response may occur on
a slightly quicker time scale; therefore, more comprehensive experimentation would be
welcomed and serve to better identify the difference between different stimuli provoking
an anti-inflammatory cellular phenotype.
Another possible stimulus of the system, as identified in the sensitivity analysis dis-
cussion, is interleukin-10. This cytokine has previously been found to increase CD163
expression (Boyle et al., 2009; Sulahian et al., 2000; Williams et al., 2002). To test if this
model could, in the absence of Hb:Hp stimulus, initiate an anti-inflammatory response,
the trajectory of the system was numerically solved at the initial condition (CD163, IL-
10, HO-1)0 = (0, 1, 0) and baseline parameter values. As shown in Fig. 5.9, the model
does reproduce this finding and the system reaches the anti-inflammatory steady-state.
In comparison to when the system is initiated at (CD163, IL-10, HO-1)0 = (0, 0, 0), the
steady-state of both IL-10 and HO-1 remain at zero. Thus, the initial state of the cell and
the IL-10 stimulus play an important role in the anti-inflammatory response.
5.4 Materials and Methods
5.4.1 Estimation of parameters
Values of model parameters were estimated from the literature and remaining parameters
were fit to published data. A literature search was conducted of the variables: CD163,
IL-10 and HO-1 as well as the stimuli, Hb:Hp complex and heme. The half-life of IL-10
is 3.6± 0.9 hours (Huhn et al., 1997; Marino and Kirschner, 2004), the average of these
values yields the degradation rate 0.193 hours−1. The half-life of HO-1 in RAW 264.7
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Figure 5.9: Time course of IL-10 stimulus prediction
macrophages is 3.41±0.81 hours (Alcaraz et al., 2001); giving an estimated degradation
rate of 0.173 hours−1. The half-life of Hb:Hp was determined to be 20 minutes (Garby
and Noyes, 1959; Van Vlierberghe et al., 2004) giving a degradation rate of 2.079 hours−1
and Hb has been reported to have an extracellular half-life of approximately 30 minutes,
equivalent to a degradation rate of 1.385 hours−1. The stimulus degradation rates were
not used since it was assumed that the stimulus remained for a much longer time within
the cell, thus the a smaller range between 0 and 1 for the degradation of Hb:Hp and heme,
here, taken to be ∼ 0.08 hours−1. In fact, since Hb:Hp may remain longer in the cells
until degraded, an exponentially decaying stimulus is used, [Hb:Hp] = H · e−λ·t where
H is the original stimulus concentration.
All simulations for stimuli were assumed as follows: the most common stoichometry
of Hb:Hp is 1:1, where Hp is type 1-1, known to have anti-inflammatory effects (Guetta
et al., 2007), and each Hb includes four heme subunits. The Hb:Hp stimulus used by
Schaer et al., 2006, Philippidis et al., 2004 and Boyle et al., 2009 were 100 µg/mL,
1 mg/mL and 10−7 mol/L, all of which upregulated HO-1, IL-10 and CD163, respec-
tively. Since the molecular weight of Hb:Hp is ∼ 1.504 × 105 g/mol (Odegaard and
Atassi, 1984), then the Hb:Hp stimulus of 10−7 mol/L is approximately 1.5×10−5 g/mL.
Therefore, the stimulus for simulations was set to [Hb:Hp] ∼ 5×10−3 g/mL, where intu-
itively, this value is large enough to induce an anti-inflammatory response for all species.
In order to compare the effects of heme using these models, an equivalent amount of
Hb:Hp was calculated for a given heme dose: Given there are four heme subunits in each
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Hb, and Heme b has a chemical formula C34H32O4N4Fe with molecular weight of 616.5
g/mol (PubChem, 2009), then a heme dose of 10 µmol/L is equivalent to 9.176 × 10−4
g/mL Hb:Hp.
5.4.2 Data fitting and model selection
The ranges of initial conditions and remaining parameters (priors) were determined using
the Nelder-Mead method. Recall from Chapter 3, direct search algorithms for fitting a
model to data, such as the simplex method developed by Nelder and Mead, 1965, must be
implemented when the derivative of the error function, (ED(α) whereα ∈ Rm is a set of
m parameters) cannot be analytically determined. This nonlinear optimization technique
for multidimensional unconstrained minimization, constructs a simplex S which is itera-
tively reflected, expanded, contracted and reduced. The simplex S = {s1, . . . , sm, sm+1},
is the convex hull of m + 1 vertices such that si ∈ Rm and is sorted, ED(s1) ≤ · · · ≤
ED(sm) ≤ ED(sm+1). The centroid, or average of the lowest, or bestm points is
s¯ =
1
m
m∑
i=1
si,
and the simplex contracts towards s1 by substituting si for s1+si2 to shrink the simplex
(Nocedal and Wright, 2006). The fitting routine convergence is constrained (Lagarias
et al., 1998) for the estimated set of parameters α, which include initial conditions.
This method also requires a range of values to search. The data are presented in fold
change units, similar to that used of IL-10 in Figueiredo et al., 2009; therefore, the same
parameter range is searched for
α = [[HO− 10], [IL− 100], [CD1630], Kd2, p4, Kd5, p3, Kd4,α, p1, n,Kd1, k1] ,
between 10−3 and 100. For each of the four models, 2000 Nelder-Mead simulations
were performed, with initial conditions randomly selected from the logarithmic interval
[−3, 2] and the degradation rate of the exponential stimulus was set to be 0.08 hours−1
since the stimulus is assumed to remain in the cell much longer than the in vitro rate
ranging between 1.38 - 2.08 hours−1 (Garby and Noyes, 1959; Van Vlierberghe et al.,
2004). The five fits of each model with the lowest error were taken as the initial prior
range and given in Table 5.3.
Fitting of the parameters and initial conditions was performed using approximate
Bayesian computation (ABC) based on sequential Monte Carlo (SMC) sampling, a method
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Figure 5.10: Data fitting from Nelder Mead results. Parameters and initial conditions fit to estimated
fold change published data (Boyle et al., 2009; Philippidis et al., 2004; Schaer et al., 2006). Hb:Hp is
initialized at 5×10−3 g/mL (recall experimental results determine the phenotypic switch has been observed
to occur for values as small as [Hb:Hp] > 10−6 for CD163 and 10−4 for HO-1); therefore, the system is
stimulated with initial Hb:Hp concentration comparable to the actual experiments. The fitting of these four
models determined the range of initial condition and parameter priors for the ABC-SysBio model selection
implementation.
developed by (Secrier et al., 2009; Toni and Stumpf, 2010; Toni et al., 2009), and avail-
able using the ABC-SysBio algorithm (Liepe et al., In press). This statistical approach
can infer parameters from experimental data given priors and simultaneously, this ap-
proach can perform model selection. Given the prior range obtained from the Nelder-
Mead optimization and distribution P (α) found in Table 5.3 of parameters:
α = [[HO− 10], [IL− 100], [CD1630], Kd2, p4, Kd5, p3, Kd4,α, p1, n,Kd1, k1,λ] ,
the method provides an approximation of the posterior distributionP (α|xˆ) ∝ f(xˆ|α)P (α)
where f(xˆ|α) is the likelihood ofα given the experimental data xˆ. ABC algorithms sam-
ple a parameter vectorα∗ from a prior distributionP (α), then simulate a dataset x∗ from
the mechanistic model. If the distance between the experimental and simulated dataset,
d(xˆ,x∗), is less than a specified tolerance, ., thenα∗ is accepted. The ABC-SMC param-
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eter inference samples a number of particles from the prior distribution. As the inference
runs, the tolerance of acceptance . is iteratively decreased such that .1 > . . . > .F ≥ 0
where F is the number of tolerances, and each tolerance .i determines an intermediate
posterior distribution. The sampling from one iteration to the next is determined by the
perturbation kernel, taken here to be a standard adaptive uniform kernel.
The ABC-SMC may be extended to parameter inference and model selection simul-
taneously using a joint space approach. This may be performed for M models where
M = [M1, . . . ,M4], by assigning each model (and parameters therein) a prior distri-
bution and perturbation kernel that designates weights for model transition. The algo-
rithm accepts N particles at the .F tolerance, which forms the joint posterior distribution
P (α,M |xˆ) and upon marginalizing over parameters, the marginal posterior distribution
P (M |xˆ) is approximated, providing a measurement for model selection. Bayes model se-
lection, similar to other approaches including the likelihood ratio test or Akaike Informa-
tion Criteria (AIC), also penalizes overparameterization. For example, as the ABC-SMC
algorithm is searching through a larger parameter space for Model 5.4 than Model 5.3 (a
submodel of Model 5.4 with less parameters), then it is more difficult to“hit” good param-
eters for Model 5.4 and thus penalizes models with more parameters. This ABC-SMC
approach serves useful for simultaneous model discrimination and parameter inference.
5.4.3 Experimental data
Published data of HO-1 mRNA, IL-10 protein and CD163 fluoresence expression by
Schaer et al., 2006, Philippidis et al., 2004 and Boyle et al., 2009, respectively, as shown
in Figs. 2.3, 2.4, and 4.2, were used for the development, and refinement of intracellular
mechanistic models presented. Additionally, Dr. Boyle provided time courses of HO-1,
IL-10 and CD163 mRNA transcript expression after stimulation by 10 µM heme (see
Fig. 5.8) to compare the model predictions of the intracellular models developed in the
latter part of the chapter.
5.4.4 Sensitivity analysis
A sensitivity analysis on the estimated posterior of the final population was performed
using principal component analysis (PCA), an approach that provides similar sensitivity
results as computing the Hessian around the mode of the posterior distribution (Secrier
et al., 2009). The posterior of inferred parameter values for the N particles may be
described in a covariance or correlation matrix Σ of rank m where m is the number of
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Initial Conditions Prior Range Estimated Value
[HO− 1] U(0, 1.5) 4.96× 10−2
[IL− 10] U(0, 0.1) 2.77× 10−2
[CD163] U(0, 2) 1.31× 10−1
Parameters Prior range Estimated Value
Kd2 U(0, 1) 3.0× 10−2
p4 U(0, 1) 9.27× 10−1 hours−1
Kd5 U(0, 100) 6.047
p3 U(0, 10) 8.607 hours−1
Kd4 U(0, 10) 5.365
α U(0, 0.01) 7.7× 10−3 hours−1
p1 U(0, 100) 44.231 hours−1
n U(1, 8) 1.689
Kd1 U(0, 1000) 343.48
k1 U(0, 2) 6.57× 10−2 hours−1
λ U(0.07, 0.09) 7.58× 10−2 hours−1
Kd3 U(0, 10) Not included in Model 5.3
p2 U(0, 10) Not included in Model 5.3
k2 0.193 hours−1 hours−1
k3 0.173 hours−1 hours−1
[Hb:Hp] 5× 10−3 g/mL
heme 9.176× 10−4 g/mL
Table 5.3: Initial condition and parameter priors and values for models. Prior distributions taken to be uni-
form (U ) and interval of values taken from Nelder-Mead method (see Materials and Methods). ABC-SMC
parameter inference and model selection gives parameter values relevant to the selected model. Remaining
parameter values taken from the literature and described in text. The measure of species concentration have
no units since these are nondimensional fold change and parameter units correspond.
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inferred parameters. It follows that the set of eigen-parameters Xi = νi1α1 + · · · +
νimαm may be determined where νi is the normalized eigenvector of Σ, corresponding
to its eigenvalue λi. The eigenvectors νis corresponding to their eigenvalues λis are the
principle components of the posterior and the value of λi gives the variance of the ith
principal component, which can be described a proportion of the total variance of all
PCs, λi/trace(Σ), where
∑m
i=1 λi = trace(Σ) is the total variance of all PCs. Often,
the largest principal component, corresponding to the dominant eigenvalue λ1 is most
important; however, in this case, the dominant eigenvalues (and first few PCs) represent
the ‘sloppy’ parameters, that is, parameters that have the least information. The final or
smallest PCs, equivalent to the leading eigenvalues of the Hessian, represent the most
sensitive parameters, corresponding to stiff parameter combinations. The sensitivity of
the parameters described by the smallest PC may be taken as projections of the eigen-
parametersXi onto the raw parameters αi by computing the eigen-directions which have
the largest value (Secrier et al., 2009). Therefore, in this context, performing PCA may
give useful information about the sensitivity and stiff parameter combinations. For further
treatment on PCA used for ABC-SMC results, see Toni et al., 2009 and Secrier et al.,
2009.
Additionally, a global sensitivity analysis is performed of inferred parameter values
using Partial rank correlation coefficient analysis (PRCC) and Fourier amplitude sensi-
tivity test (FAST) methods as described previously in Chapter 3.
5.4.5 SBML implementation
For standards compliance, the Models 5.1 - 5.4 were implemented using the Systems
Biology Markup Language (SBML) Level 2 Version 1 (Finney and Hucka, 2003; Hucka
et al., 2003). The models are named model1.xml, model2.xml, model3.xml and
model4.xml.
5.5 Conclusion
This work presented different models describing intracellular mechanisms between
HO-1, IL-10 and CD163. In these models, cooperativity between IL-10 and CD163
was assumed, and different hypotheses of the interactions were tested. By using the
ABC-SMC method, the posterior distribution of the estimated parameters was obtained,
providing useful information about the identifiability of inferred parameters and thus
serves as a tool for model discrimination. The results of data fitting and model selec-
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tion predicted that IL-10/HO-1 feedback loop plays a key role to anti-inflammatory re-
sponse, supporting the hypothesis by Lee and Chau, 2002. Interestingly, the principal
component analysis also provided a procedure to pinpoint parameter combinations that
are most sensitive to perturbations. Adjusting the value of the two parameters selected
by this analysis facilitated a natural manner to construct a slightly different parameter
space capable of multiple permissible steady-states for the selected model. Furthermore,
parameter estimation determined the system exhibits cooperativity (value of the Hill co-
efficient greater than one) between IL-10 and CD163. The model selection and parame-
ter inference, model selection and sensitivity analysis provided a first step in identifying
the anti-inflammatory mechanisms associated with the CD163 macrophage phenotype.
This model also demonstrates that additional biological work is necessary to determine
the signaling pathways and the regulation of transcription factors that govern the anti-
inflammatory response driven by Hb:Hp/heme stimuli.
The model was then extended to study the effects of heme, the molecule within the
Hb:Hp complex thought to be responsible for initiating an anti-inflammatory response.
Comparing the model results to these data revealed that a higher stimulus effects the peak
behavior and increases the activation time. Taking into account the difference between
data obtained (mRNA expression) compared to the model measurements (protein CD163
and IL-10), the model results gave a relatively good qualitative representation of the
data, suggesting that the mechanisms responsible for heme initiated anti-inflammatory
response are indeed similar to Hb:Hp complexes. Therefore, this work presents a novel
mechanistic model approach of the macrophage response to heme/Hb:Hp complexes.
More sophisticated models may better differentiate the effects of these two stimuli; how-
ever, further experimental work must first be obtained to compare these, such as, for
example mRNA and protein expression time courses of both heme and Hb:Hp stimu-
lated macrophages. As new experimental information becomes available, Model 5.5 may
include the intracellular mediators/regulators of the model species (such as negative reg-
ulator, Bach1), intracellular heme products (such as carbon monoxide, responsible for ac-
tivating known anti-inflammatory pathways p38, PI-3K or STAT3) (Lee and Chau, 2002;
Ricchetti et al., 2004) as well as the including the upstream signalingMAPK cascade and
the downstream anti-inflammatory transcription factors. Looking forward, future models
of macrophage inflammatory response may include the interactions between heme and
the MAPK pathway (Mense and Zhang, 2006) and incorporating the recent model of
the IL-10/ERK/p38 MAPK interactions in nematodes Figueiredo et al., 2009, suggesting
negative regulation of MAPK by IL-10. In addition to the heme/Hb:Hp characterization,
this model also provided a mechanistic explanation of how an anti-inflammatory stimu-
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lus, such as IL-10, affects the phenotype of a neutral cell (such as a monotcyte) that has
neither pro- or anti-inflammatory predisposition.
This work enabled a quantitative study of the effects of Hb:Hp complexes, interleukin-
10 and free heme on macrophage differentiation and response in vascular plaques; hence,
this study may provide insight for future research and medical therapies for vascular in-
flammatory diseases.
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Chapter 6
Modularized model of apoptosis
6.1 Overview
The primary focus of the work in this chapter is to construct a simple model of caspase-3
activation featuring the oligomerization kinetics of the DISC, mitochondrial apoptosis-
induced channel (MAC) and the apoptosome; the dynamics of the extrinsic and intrin-
sic caspase subnetworks, as well as the coupling between the extrinsic and intrinsic
pathways. To accomplish this, three independent functional modules are constructed
(Hartwell et al., 1999; Klipp et al., 2005; Ortega et al., 2008; Watson and Pollack, 2005).
These are implemented for the abstraction of oligomerization kinetics that simplify the
full system. Multiple linear regression analysis is applied to investigate the role of each
module and reduced models are constructed to identify key contributions of the extrin-
sic and intrinsic pathways in triggering apoptosis for different cell lines. Through linear
regression techniques, feedbacks, dissociation of complexes, and negative regulators are
identified as the key components in apoptosis. The analysis and reduced models for the
model formulation reveal that the chosen cell lines predominately exhibit strong extrin-
sic caspase, typical of type I cell, behavior. Furthermore, under the simplified model
framework, the selected cell lines exhibit different modes by which caspase activation
may occur. Finally, the proposed modularized model of apoptosis may generalize behav-
ior for additional cells and tissues, specifically identifying and predicting components
responsible for the transition from type I to type II cell behavior.
This research was conducted in collaboration with Kenneth L. Ho. The inception of
this work commenced at the 2007 Mathematical Biosciences Institute (MBI) Summer
School at Ohio State University, Columbus, OH, USA with workshop participants Samik
Ghosh, and K.C. Tung. Baltzar Aguda and Chiu-Yen Kao supervised the work, and co-
authors gratefully acknowledge the financial support from MBI. In collaboration with
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Kenneth L. Ho, the research was designed and conducted, model analysis (including the
code), manuscript writing, and revisions, with equal contributions of intellectual content.
This work was published (Harrington et al., 2008).
6.2 Introduction
Recall from Chapter 2, apoptosis, or programmed cell death, is a physiological process
critical for development, tissue homeostasis, cell termination and immune response (Hen-
gartner, 2000; Hutchins and Barger, 1998; Jacobson et al., 1997; Leist and Ja¨a¨ttela¨, 2001;
Lockshin and Zakeri, 2001; Meier et al., 2000; Oppenheim, 1991; Raff, 1998; Zuzarte-
Luis and Hurle, 2002). Dysregulation of apoptosis may result in a myriad of conditions
such as autoimmunity, cancer or neurological conditions (Chang and Yang, 2000; Fadeel
et al., 1999; Haass, 1999; Johnstone et al., 2002; Pritchard and Hickman, 1994; Thomp-
son, 1995; Thornberry and Lazebnik, 1998). As shown previously in Fig. 2.5, apoptosis
is mediated by apoptotic complexes along one of two pathways: the extrinsic pathway
(receptor mediated) via the death inducing signaling complex (DISC), or the intrinsic
pathway (mitochondrial) via the apoptosome (Ashkenazi and Dixit, 1998; Budihardjo
et al., 1999; Cain et al., 1999, 2000, 2002; Fumarola and Guidotti, 2004; Hengartner,
2000; Jiang and Wang, 2004). The extrinsic initiator caspase (caspase-8) couples the two
pathways by initiating the mitochondrial apoptosis-induced channel (MAC), leading to
the activation of the intrinsic pathway (Li et al., 1998). The subsequent cell death for ei-
ther pathway is executed through a cascade activation of effector caspases (e.g., caspase-
3) by initiator caspases (e.g., caspase-8 and -9) and the amplification of death signals
implemented by several positive feedback loops and inhibitors in the network (Arends
and Wyllie, 1991; Budihardjo et al., 1999; Nunez et al., 1998; Oppenheim, 1991; Taka-
hashi and Earnshaw, 1996; Thornberry and Lazebnik, 1998; Zimmermann et al., 2001).
While apoptosis can be activated by either pathway, some cell lines are pathway specific.
Cells requiring death receptors (and caspase-8) but not needing help from mitochondria
organelles for apoptosis are classified as type I (such as T cells and thymocytes (Barnhart
et al., 2003)). Conversely, type II cells (i.e., hepatocytes of Bcl-2 transgenic mice (Barn-
hart et al., 2003)) have a reduced DISC formation and predominantly depend on the
mitochondria pathway (formation of apoptosome and caspase-9) to undergo cell death
(Barnhart et al., 2003; Fulda et al., 2001; Scaffidi et al., 1998; Schmitz et al., 2000).
Apoptosis is typically thought of as a bistable system, ideally irreversibly bistable,
with attracting life and death states, and a sharp all-or-none switch in between. This bista-
bility is important for conferring biological robustness (Kitano, 2004). Consequently,
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researchers have used computational models to identify and study potential sources of
bistability in apoptosis, including positive caspase feedback (Eissing et al., 2004), inhi-
bition of DISC by cFLIP (Bentele et al., 2004), cooperativity in apoptosome formation
(Bagci et al., 2006), double-negative caspase feedback through XIAP (Legewie et al.,
2006), and double-negative feedback in Bcl-2 protein interactions (Cui et al., 2008). The
maturity of the field has enabled the proliferation of mathematical models, both mecha-
nistic and integrative, which have, in aggregate, contributed significantly to the theoret-
ical analysis and understanding of the underlying molecular interactions (Albeck et al.,
2008a,b; Bagci et al., 2006; Cui et al., 2008; Eissing et al., 2004, 2005; Fussenegger
et al., 2000; Harrington et al., 2008; Hua et al., 2005, 2006; Janes et al., 2005; Lai and
Jackson, 2004; Legewie et al., 2006; Nakabayashi and Sasaki, 2006; Okazaki et al., 2008;
Rangamani and Sirovich, 2007; Ryu et al., 2008; Stucki and Simon, 2005).
Most of these models focus on specific components of the full apoptotic machinery.
Models by Eissing et al., 2004 and Legewie et al., 2006 emphasized either the extrinsic
or intrinsic caspase pathways, respectively. Both of these models identify inhibitors and
feedback mechanisms of caspase-8, or -9, respectively, and caspase-3 to mediate bista-
bility. The model developed by Fussenegger et al., 2000 implemented both pathways
but did not consider the coupling between them; however, Bagci et al., 2006, Albeck
et al., 2008a and Cui et al., 2008 modeled the mitochondrial apoptosis-induced channel
(MAC). Stucki and Simon, 2005 modeled only the caspase-3 activation and degradation
but none of the aforementioned models closely track the upstream formation dynamics
of the DISC and the apoptosome, which have since been modeled in detail by Lai and
Jackson, 2004, and by Nakabayashi and Sasaki, 2006, respectively. Hua et al., 2005,
2006 formulated complete system models that incorporate the differences in type I and II
signaling as well as include additional species, such as Smac; however not all dynamics,
e.g., feedbacks, are included from previous component models (Eissing et al., 2004; Lai
and Jackson, 2004; Legewie et al., 2006; Nakabayashi and Sasaki, 2006). More recently,
Okazaki et al., 2008 formulated a model based on Hua et al., 2005, 2006 of the pheno-
typic switch from type I and type II apoptotic death, but their model does not incorporate
protein synthesis or degradation.
6.2.1 Models of oligomeric complex formation
The mechanism responsible for initiating apoptosis, oligomerization, is a process of
complex formation to activate the apoptotic pathway (Chang et al., 2003). Recall the
three oligomerizations: DISC, apoptosome and MAC, each of which have corresponding
6.2 Introduction 104
mathematical ordinary differential equation models describing the oligomerization ki-
netics (Albeck et al., 2008a; Bagci et al., 2006; Cui et al., 2008; Lai and Jackson, 2004;
Nakabayashi and Sasaki, 2006).
The Lai and Jackson, 2004 model studies the formation of the Fas/FasL complex,
which feeds directly into the formation of DISC and hence is crucial to its understanding.
The formation dynamics are modeled using a system of ordinary differential equations
that reflects the cross-linking nature of the complex assembly, which are solved to obtain
equilibrium concentrations of the complex and its intermediates. Of particular interest is
that for a given receptor concentration, Lai and Jackson, 2004 predicts the existence of an
optimal ligand concentration for maximum complex production (reproduced in Fig. 6.1);
intuitively, this may be explained by considering a simple combinatorial argument on the
rate of formation of intermediate species. Moreover, their work is the only model that
exists with an explanation Fas trimerization, the complex of three Fas necessary form
the DISC. Experimental methods are unable to elucidate why Fas is a trimer, thus this
mathematical model offers a hypothesis of the interactions.
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Figure 6.1: Optimal ligand (FasL) concentration for DISC formation. Reproduction of Lai and Jackson,
2004 results, optimal ligand concentration for equilibrium crosslinks (representative of the DISC formation
and activation of the apoptotic pathway) for different production rate constants (κ). The model equations
are described in detail in Subsec. 6.3.2.
The model developed by Nakabayashi and Sasaki, 2006 explicitly models the forma-
tion of the apoptosome. Cytochrome c binds and activates Apaf-1, which oligomerize to
form heptamers with 7-fold symmetry; thereafter, the heptamers are activated by a nu-
cleotide exchange to form apoptosomes. The novelty of this work lies in the identification
of an optimal one-to-one ratio of cytochrome c and inactive Apaf-1 for the rate of apop-
tosome formation (reproduced in Fig. 6.2). Similar to Lai and Jackson, 2004, this model
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focuses only on the complex formation without considering downstream activation of the
caspase cascade.
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Figure 6.2: Optimal cytochrome c/Apaf-1 ratio. Reproduction of Nakabayashi and Sasaki, 2006 equilib-
rium results (as data) exhibiting a one-to-one ratio of cytochrome c and innative Apaf-1 for the rate of
apoptosome formation and activation of the apoptotic pathway. Horizontal axis demonstrates the ratio of
initial cytochrome c to that of initial Apaf-1. Vertical axis denotes the ratio of complete Apaf-1 assembled
complexes (heptamers) to initial Apaf-1. The model equations are described in detail in Subsec. 6.3.2.
The Bid-induced Bax oligomerization models of, Albeck et al., 2008a; Bagci et al.,
2006; Cui et al., 2008 study the role of Bax, Bid and Bcl-2 switching mechanisms as
regulators that ensure bistability in the mitochondrial apoptosis-induced channel (MAC).
This work focuses solely on the mitochondrial mediated apoptotic pathway and does not
include the dynamics of other signaling pathway components.
6.2.2 Caspase feedback models
In the Eissing et al., 2004 model, a representation of the extrinsic caspase pathway is
developed based on mass action kinetics; however, the authors do not consider the dy-
namics of the activating stimulus, i.e., the formation of DISC. This work also identifies
the inhibitors of caspase-3 (XIAP and its degradation) to be primarily controlling the
bistable behavior of the death signal rather than the positive feedback between caspase-3
and caspase-8. This bistability finding suggests the important role of the downstream
apoptotic interactions.
The model developed by Legewie et al., 2006 represents the intrinsic pathway behav-
ior through a system of biochemical equations (28 equations and 33 parameters). While
this model also identifies inhibitors that mediate bistability and feedback mechanisms of
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caspase-3 and caspase-9, the model does not include the oligomerization of apoptosome
(from Apaf-1 triggered by cytochrome c).
6.3 Methods
6.3.1 Model formulation
The full reaction network of the model is built from three component subnetworks (see
Fig. 6.3): the extrinsic, coupling, and intrinsic subnetworks; and three oligomerization
modules (represented by gray areas in Fig. 6.3): the DISC, MAC, and apoptosome
modules. Each subnetwork captures a vital part of the full apoptotic reaction network
and borrows heavily from previous work (Bagci et al., 2006; Eissing et al., 2004; Hua
et al., 2005; Legewie et al., 2006; Okazaki et al., 2008), while each module abstracts the
oligomerization kinetics of an apoptotic complex to give a simplified net synthesis func-
tion using steady-state results (Lai and Jackson, 2004; Nakabayashi and Sasaki, 2006).
The extrinsic subnetwork follows Eissing et al., 2004 and captures the dynamics of
the extrinsic pathway. The subnetwork contains the species FasL, FasR, DISC, procaspase-
8 (Casp8), caspase-8 (Casp8∗), procaspase-3 (Casp3), caspase-3 (Casp3∗), XIAP, and
BAR. The subnetwork is driven by DISC, whose formation dynamics from FasL and
FasR are encapsulated by the DISC module using the results of Lai and Jackson, 2004.
DISC induces the cleavage of Casp8 to Casp8∗, which then activates Casp3 to produce
Casp3∗. Positive feedback between Casp8∗ and Casp3∗ is provided by the activation of
Casp8 by Casp3∗. XIAP and BAR act as regulators by binding to Casp3∗ and Casp8∗,
respectively. Furthermore, degradation of XIAP is enhanced by Casp3∗.
The extrinsic subnetwork can drive the intrinsic pathway through the coupling sub-
network, which describes the role of Casp8∗ in inducing mitochondrial membrane per-
meabilization and triggering the release of cytochrome c and Smac. The coupling sub-
network is inspired by a combination of Bagci et al., 2006; Hua et al., 2005; Okazaki
et al., 2008, and contains the additional species Bid, tBid, Bax, cytochrome c (mitochon-
drial, Cytc; cytosolic Cytc∗), and Smac (mitochondrial, Smac; cytosolic, Smac∗). The
subnetwork receives input from Casp8∗, which cleaves Bid to produce tBid. Bax then
dimerizes with tBid to form tBid-Bax2, which is taken as a representation of the MAC
that controls the release of Cytc and Smac from the mitochondria to produce Cytc∗ and
Smac∗, respectively; the formation dynamics of tBid-Bax2 are abstracted in the MAC
module using similar methods as for the DISC module. Morever, Smac∗ acts as a regu-
lator by binding to XIAP.
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Figure 6.3: Extrinsic and intrinsic pathways to caspase-3 activation. Overview of pathways to caspase-3
activation. Each separate gray region represent the three modules: DISC (death-inducing signaling com-
plex), MAC (mitochondrial apoptosis-induced channel) and apoptosome. Species and their symbols are:
FasL (FasL), FasR (FasR), DISC (DISC), procaspase-8 and caspase-8 (Casp8), bifunctional apoptosis
inhibitor (BAR), procaspase-3 and caspase-3 (Casp3), XIAP (XIAP), Bid and truncated Bid (Bid), Bax
(Bax), tBid−Bax2 complex (tBid−Bax2), Smac (Smac), Apaf-1 (Apaf), cytochrome c (Cytc), apop-
tosome (Apop), procaspase-9 and caspase-9 (Casp9). Arrows denote chemical conversions or catalyzed
reactions while hammerheads represent inhibition.
The intrinsic subnetwork follows the intrinsic pathway from the assembly of the apop-
tosome to the resulting caspase interactions. The oligomerization of the apoptosome is
abstracted in the apoptosomemodule using the results of Nakabayashi and Sasaki (2006),
while the remainder of the subnetwork is simplified from Legewie et al. (2006). Addi-
tional species contained in the subnetwork include Apaf-1 (Apaf), apoptosome (Apop),
procaspase-9 (Casp9), and caspase-9 (Casp9∗). The subnetwork is driven by Cytc∗,
which binds to Apaf; activated Apaf then oligomerizes to form Apop, which cleaves
Casp9 to produce Casp9∗. As in the extrinsic subnetwork, positive feedback exists be-
tween Casp9∗ and Casp3∗. Furthermore, Casp9∗ binds XIAP.
Constitutive synthesis and degradation rates are assumed for all appropriate species.
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6.3.2 Steady-state abstraction of oligomerization kinetics
The oligomerization kinetics of the DISC, MAC, and the apoptosome are abstracted us-
ing steady-state results; this abstraction is a demonstration of a simple technique for
modularization and model reduction. For an oligomer X with intermediate structures
X1, . . . , Xn and dynamics
d [X]
dt
= f ([X] , [X]1 , . . . , [X]n)− µ [X] ,
where f is the oligomerization rate function and µ the degradation rate, use the steady-
state approximation f ≈ fss ∝ [X]ss. This allows the modeling of only the final complex
and hence significant simplification of the dynamical equations. Although the time de-
pendence of the oligomerization rate is neglected, information regarding the long-term
behavior is retained. For the present application, f = [X]ss with proportionality constant
µ.
The abstractions for each of the DISC, MAC, and apoptosome modules are described
below, where the notation is understood to apply only within each module.
DISC module
The DISC oligomerization kinetics are simplified from the crosslinking model (Delisi,
1980; Perelson, 1984, 1981) of Lai and Jackson, 2004 and follow the reactions
FasL + FasR
3kf−−⇀↽−
kr
FasL-FasR,
FasL-FasR + FasR 2kf−−⇀↽−
2kr
FasL-FasR2,
FasL-FasR2 + FasR
kf−−⇀↽−
3kr
FasL-FasR3,
Chapter 6. Modularized model of apoptosis 109
describing the trimerization of FasR to FasL. With l ≡ [FasL], r ≡ [FasR], and ci ≡
[FasL-FasRi], the corresponding dynamics are

dl/dt = −v1,
dr/dt = −v1 − v2 − v3,
dc1/dt = v1 − v2,
dc2/dt = v2 − v3,
dc3/dt = v3,


v1 = 3kf lr − krc1,
v2 = 2kfc1r − 2krc2,
v3 = kfc2r − 3krc3,
which reduces at steady-state to,
c1,ss = 3lss
(
rss
KD
)
, c2,ss = 3lss
(
rss
KD
)2
, c3,ss = lss
(
rss
KD
)3
,
whereKD = kr/kf . Applying the conservation relations,
l0 = l + c1 + c2 + c2, r0 = r + c1 + 2c2 + 3c3
to obtain
lss =
l0
1 + 3 (rss/KD) + 3 (rss/KD)
2 + (rss/KD)
3 ,
where rss is given by solving
r4ss + αr
3
ss + βr
2
ss + γrss −K3Dr0 = 0,


α = 3l0 − r0 + 3KD,
β = 3KD (2l0 − r0 +KD) ,
γ = K2D (3l0 − 3r0 +KD) ,
which has at most one positive root. Assume now that FADD is in excess (see, e.g., Hua
et al., 2005; Okazaki et al., 2008) to obtain
[DISC]ss = c2,ss + c3,ss ≡ f (l0, r0;KD) ,
where it is assumed that bothFasL-FasR2 andFasL-FasR3 can propagate the death signal
(Lai and Jackson, 2004). Externally, in the full reaction network, the oligomerization
rate function will be called fDISC ([FasL]0 , [FasR]0 ;KDISC). This abstraction reduces
the order of the system by four.
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MAC module
The oligomerization kinetics of theMACmodule are assumed to follow a similar crosslink-
ing model and therefore obey the reactions
tBid + Bax
2kf−−⇀↽−
kr
tBid-Bax, tBid-Bax + Bax kf−−⇀↽−
2kr
tBid-Bax2.
With analogous notation l ≡ [tBid], r ≡ [Bax], and ci ≡ [tBid-Baxi], the dynamics are

dl/dt = −v1,
dr/dt = −v1 − v2,
dc1/dt = v1 − v2,
dc2/dt = v2,

v1 = 2kf lr − krc1,v2 = kfc1r − 2krc2,
so
c1,ss = 2lss
(
rss
KD
)
, c2,ss = lss
(
rss
KD
)2
.
Similar conservation relations then give
lss =
l0
(1 + rss/KD)
2
with
r3ss + αr
2
ss + βrss −K2Dr0 = 0,

α = 2l0 − r0 + 2KD,β = KD (2l0 − 2r0 +KD) ,
which again has at most one positive root. Therefore,
[tBid-Bax2]ss = c2,ss ≡ f (l0, r0;KD) ,
and externally this will be denoted by ftBid-Bax2([tBid] , [Bax]0 ;KtBid-Bax2), where the
dynamical concentration of tBid is used as input. This abstraction reduces the order of
the system by three.
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Apoptosome module
The oligomerization kinetics of the apoptosome follow the model of Nakabayashi and
Sasaki, 2006 with no dissociation, which considers bimolecular interactions of the form
Apaf + Cytc∗
k1−→ Apaf-Cytc∗,
(Apaf-Cytc∗)i + (Apaf-Cytc∗)j
k2−→ (Apaf-Cytc∗)k , i+ j = k ≤ 7,
where Apop ≡ (Apaf-Cytc∗)7. With the nondimensionalizations
c ≡ [Cytc
∗]
[Apaf]0
, a ≡ [Apaf]
[Apaf]0
, xi ≡ [(Apaf-Cytc
∗)i]
[Apaf]0
,
the dynamics are
da
dτ
=
dc
dτ
= −ac,
dx1
dτ
= ac− λx1 (2x1 + x2 + · · ·+ x6) ,
dxi
dτ
= λ

$i/2%∑
j=1
xjxi−j − xi
7−i∑
j=1
(1 + δij) xj

 , i = 2, . . . , 7,
where τ = αa0t, λ = k2/k1, and δ is the Kronecker delta. Integration of this system
until steady-state over a range of c0 generates a curve for x7 that may accurately fit with
a piecewise exponential function
g (c0) =

g1 (c0) , c0 ≤ 1,g2 (c0) , c0 > 1, gi (c0) = αie
βic0 + γi.
Continuity at c0 = 1 and boundary conditions at c0 = 0 and∞ give
g1 (c0) =
(
eβ1c0 − 1
eβ1 − 1
)
x7,ss (1) , g2 (c0) = [x7,ss (1)− x7,ss (∞)] eβ2(c0−1) + x7,ss (∞) ,
where β1 and β2 may be fitted for any prescribed λ. The apoptosome oligomerzation rate
function is then f(c0;λ) = a0g(c0;λ), and externally this is fApop([Cytc∗] / [Apaf]0 ;λApop).
This abstraction reduces the order of the system by eight.
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Remarks on modularization
The steady-state profiles of the oligomerization kinetics (as shown in Fig. 6.4) are sup-
ported by the models that motivated this simplification (Lai and Jackson, 2004; Nakabayashi
and Sasaki, 2006) and experimentally for tBid inducing a switch (Madesh et al., 2002).
The abstraction enables these module simplifications to operate as inputs into the full
dynamical system of apoptosis.
Figure 6.4: Steady-state concentrations of DISC, tBid-Bax2, and apoptosome, used for modularization of
the DISC, MAC, and apoptosomemodules, respectively. (a) The steady-state DISC concentration [DISC]ss
as a function of the initial death ligand ([FasL]0) and receptor ([FasR]0) concentrations. (b) The steady-
state tBid-Bax2 concentration [tBid-Bax2]ss as a function of the initial Bax ([Bax]0) and tBid ([tBid]0)
concentrations. (c) The steady-state apoptosome concentration [Apop]ss as a function of the initial Apaf-1
([Apaf]0) and cytochrome c ([Cytc]0) concentrations.
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6.3.3 Model dynamical equations
The model species and reactions are summarized in Tables 6.1 and 6.2. Reaction kinet-
ics are described by mass action, with the corresponding ordinary differential equation
(ODE) system given in Table 6.3. Initial conditions to solve the ODEs for HeLa cells
(from Eissing et al., 2004) and Jurkat T cells (based on Hua et al., 2005; Okazaki et al.,
2008), as well as steady-state abstraction parameters, are given in Table 6.4, where in
particular the baseline value of [FasL]0 = 2 nM corresponds to a dose which has been
used to experimentally induce apoptosis (see Hua et al., 2005. Table 6.5 summarizes
all model parameters (forward and reverse reactions, synthesis and degradation rates and
parameters for the steady-state abstractions). Additionally, a variant of the Jurkat T cell,
denoted Jurkat T∗, is considered, which has the the same parameter values as Jurkat T
but with k2 = k5 = k12 = 0 following Hua et al., 2005; Okazaki et al., 2008.
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Species Description Synthesis rate (nM/s) Degradation rate (s−1)
DISC DISC 8.807× 10−3
Casp8 procaspase-8 adjusted 6.5× 10−5 (Eissing et al., 2004)
Casp8∗ caspase-8 9.667× 10−5 (Eissing et al., 2004)
Casp3 procaspase-3 adjusted 6.5× 10−5 (Eissing et al., 2004)
Casp3∗ caspase-3 9.667× 10−5 (Eissing et al., 2004)
XIAP XIAP adjusted 1.933× 10−4 (Eissing et al., 2004)
Casp3∗-XIAP Casp3∗-XIAP complex 2.883× 10−4 (Eissing et al., 2004)
BAR BAR 1.111 × 10−3 ([BAR]0 = 66.67 nM (Eissing et al., 2004)) 1.667× 10−5 (Eissing et al., 2004)
Casp8∗-BAR Casp8∗-BAR complex 1.933× 10−4 (Eissing et al., 2004)
Bid Bid 4.168× 10−4 ([Bid]0 = 25 nM (Hua et al., 2005; Okazaki et al., 2008)) 1.667× 10−5 (µBAR)
tBid truncated Bid 1.667 × 10−5 (µBid)
tBid-Bax2 tBid-Bax2 complex 0.0264
Cytc cytochrome c (mitochondrial) 10−3 ([Cytc]0 = 100 nM (Hua et al., 2005; Okazaki et al., 2008)) 10−5
Cytc∗ cytochrome c (cytosolic) 10−5
Smac Smac (mitochondrial) 0.0167 ([Smac]0 = 100 nM (Hua et al., 2005; Okazaki et al., 2008)) 1.667× 10−5 (µBAR)
Smac∗ Smac (cytosolic) 1.667× 10−5 (µSmac)
Smac∗-XIAP Smac-XIAP complex 1.933× 10−4 (µCasp8∗-BAR)
Apop apoptosome 1.487× 10−5
Casp9 procaspase-9 1.3× 10−3 ([Casp9]0 = 20 nM (Hua et al., 2005; Okazaki et al., 2008)) 6.5× 10−5 (µCasp8)
Casp9∗ caspase-9 9.667× 10−5 (µCasp8∗ )
Casp9∗-XIAP Casp9∗-XIAP complex 2.883 × 10−4 (µCasp3∗-XIAP)
Table 6.1: Species description, synthesis and degradation rates for the model equations. Model species and description are given. In the model, synthesis and
degradation rates are given for the model system and labeled α and µ, respectively.
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Number Reaction Forward rate (nM−1 s−1) Reverse rate (s−1)
DISC (FasL,FasR) −−→ DISC fDISC
1 DISC + Casp8 −−→ DISC + Casp8∗ 10−4 (k2)
2 Casp3∗ +Casp8 −−→ Casp3∗ + Casp8∗ 10−4 (Eissing et al., 2004)
3 Casp8∗ +Casp3 −−→ Casp8∗ + Casp3∗ 5.8× 10−4 (Eissing et al., 2004)
4 Casp3∗ +XIAP −−−⇀↽ − Casp3∗-XIAP 3× 10−3 (Eissing et al., 2004) 0.035 (Eissing et al., 2004)
5 Casp3∗ +XIAP −−→ Casp3∗ 3× 10−3 (Eissing et al., 2004)
6 Casp8∗ +BAR −−−⇀↽ − Casp8∗-BAR 5× 10−3 (Eissing et al., 2004) 0.035 (Eissing et al., 2004)
7 Casp8∗ +Bid −−→ Casp8∗ + tBid 5× 10−4 (est. (Hua et al., 2005; Okazaki et al., 2008))
tBid-Bax2 (tBid,Bax) −−→ tBid-Bax2 ftBid-Bax2
8 tBid-Bax2 +Cytc −−→ tBid-Bax2 +Cytc∗ 10−3 (Hua et al., 2005; Okazaki et al., 2008)
9 tBid-Bax2 + Smac −−→ tBid-Bax2 + Smac∗ 10−3 (Hua et al., 2005; Okazaki et al., 2008)
10 Smac∗ +XIAP −−−⇀↽ − Smac∗-XIAP 7× 10−3 (Hua et al., 2005; Okazaki et al., 2008) 2.21× 10−3 (Hua et al., 2005; Okazaki et al., 2008)
Apop (Cytc∗,Apaf) −−→ Apop fApop
11 Apop + Casp9 −−→ Apop + Casp9∗ 2× 10−4 (est. (Legewie et al., 2006))
12 Casp3∗ +Casp9 −−→ Casp3∗ + Casp9∗ 2× 10−4 (Legewie et al., 2006)
13 Casp9∗ +Casp3 −−→ Casp9∗ + Casp3∗ 5× 10−5 (Legewie et al., 2006)
14 Casp9∗ +XIAP −−−⇀↽ − Casp9∗-XIAP 1.06 × 10−4 (Hua et al., 2005; Okazaki et al., 2008) 10−3 (Hua et al., 2005; Okazaki et al., 2008)
Table 6.2: Reactions for the model equations. Each reaction described highlights whether the reaction is a forward or reversible reaction by the arrows. The rates
are provided from previous work. Reactions are illustrated in Fig. 6.3.
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d [DISC] /dt = µDISC(fDISC([FasL]0 , [FasR]0 ;KDISC)− [DISC]) v1 = k1 [DISC] [Casp8]
d [Casp8] /dt = −v1 − v2 + αCasp8 − µCasp8 [Casp8] v2 = k2 [Casp3∗] [Casp8]
d [Casp8∗] /dt = v1 + v2 − v6 − µCasp8∗ [Casp8∗] v3 = k3 [Casp8∗] [Casp3]
d [Casp3] /dt = −v3 − v13 + αCasp3 − µCasp3 [Casp3] v4 = k4 [Casp3∗] [XIAP]− k−4 [Casp3∗-XIAP]
d [Casp3∗] /dt = v3 − v4 + v13 − µCasp3∗ [Casp3∗] v5 = k5 [Casp3∗] [XIAP]
d [XIAP] /dt = −v4 − v5 − v10 − v14 + αXIAP − µXIAP [XIAP] v6 = k6 [Casp8∗] [BAR]− k−6 [Casp8∗-BAR]
d [Casp3∗-XIAP] /dt = v4 − µCasp3∗-XIAP [Casp3∗-XIAP] v7 = k7 [Casp8∗] [Bid]
d [BAR] /dt = −v6 + αBAR − µBAR [BAR] v8 = k8 [tBid-Bax2] [Cytc]
d [Casp8∗-BAR] /dt = v6 − µCasp8∗-BAR [Casp8∗-BAR] v9 = k9 [tBid-Bax2] [Smac]
d [Bid] /dt = −v7 + αBid − µBid [Bid] v10 = k10 [Smac∗] [XIAP]− k−10 [Smac∗-XIAP]
d [tBid] /dt = v7 − µtBid [tBid] v11 = k11 [Apop] [Casp9]
d [tBid-Bax2] /dt = µtBid-Bax2 v12 = k12 [Casp3∗] [Casp9]
(ftBid-Bax2([tBid] , [Bax]0 ;KtBid-Bax2)− [tBid-Bax2]) v13 = k13 [Casp9∗] [Casp3]
d [Cytc] /dt = −v8 + αCytc − µCytc [Cytc] v14 = k14 [Casp9∗] [XIAP]− k−14 [Casp9∗-XIAP]
d [Cytc∗] /dt = v8 − µCytc∗ [Cytc∗]
d [Smac] /dt = −v9 + αSmac − µSmac [Smac]
d [Smac∗] /dt = v9 − v10 − µSmac∗ [Smac∗]
d [Smac∗-XIAP] /dt = v10 − µSmac∗-XIAP [Smac∗-XIAP]
d [Apop] /dt = µApop(fApop([Cytc∗] / [Apaf]0 ;λApop)− [Apop])
d [Casp9] /dt = −v11 − v12 + αCasp9 − µCasp9 [Casp9]
d [Casp9∗] /dt = v11 + v12 − v14 − µCasp9∗ [Casp9∗]
d [Casp9∗-XIAP] = v14 − µCasp9∗-XIAP [Casp9∗-XIAP]
Table 6.3: Ordinary differential equations for the full system are given in the left hand column. Corresponding reaction velocities use mass-action kinetics and are
found in the right hand column.
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Initial concentration (nM)
Species HeLa Jurkat T Parameter Value
Casp8 216.67 (Eissing et al., 2004) 33.33 (Hua et al., 2005; Okazaki et al., 2008) [FasL]0 2 nM (Hua et al., 2005; Okazaki et al., 2008)
Casp3 35 (Eissing et al., 2004) 200 (Hua et al., 2005; Okazaki et al., 2008) [FasR]0 10 nM (Hua et al., 2005; Okazaki et al., 2008)
XIAP 66.67 (Eissing et al., 2004) 30 (Hua et al., 2005; Okazaki et al., 2008) KDISC 1.032 nM (Hua et al., 2005; Okazaki et al., 2008)
BAR 66.67 (Eissing et al., 2004) 66.67 (Eissing et al., 2004) [Bax]0 83.33 nM (Hua et al., 2005; Okazaki et al., 2008)
Bid 25 (Hua et al., 2005; Okazaki et al., 2008) 25 (Hua et al., 2005; Okazaki et al., 2008) KtBid-Bax2 100 nM (Hua et al., 2005; Okazaki et al., 2008)
Cytc 100 (Hua et al., 2005; Okazaki et al., 2008) 100 (Hua et al., 2005; Okazaki et al., 2008) [Apaf]0 100 nM (Hua et al., 2005; Okazaki et al., 2008)
Smac 100 (Hua et al., 2005; Okazaki et al., 2008) 100 (Hua et al., 2005; Okazaki et al., 2008) λApop 1 (Nakabayashi and Sasaki, 2006)
Casp9 20 (Hua et al., 2005; Okazaki et al., 2008) 20 (Hua et al., 2005; Okazaki et al., 2008)
Table 6.4: Initial conditions for the model variables and oligomerization parameters. Some species initial conditions differ between HeLa or Jurkat T cell type.
Parameters and values are given for steady-state oligomerization modules.
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Forward rate Reverse rate Synthesis rate Degradation rate Parameter
1 k1 15 k−4 19 αCasp8 27 µDISC 48 [FasL]0
2 k2 16 k−6 20 αCasp3 28 µCasp8 49 [FasR]0
3 k3 17 k−10 21 αXIAP 29 µCasp8∗ 50 KDISC
4 k4 18 k−14 22 αBAR 30 µCasp3 51 [Bax]0
5 k5 23 αBid 31 µCasp3∗ 52 KtBid-Bax2
6 k6 24 αCytc 32 µXIAP 53 [Apaf]0
7 k7 25 αSmac 33 µCasp3∗-XIAP 54 λApop
8 k8 26 αCasp9 34 µBAR
9 k9 35 µCasp8∗-BAR
10 k10 36 µBid
11 k11 37 µtBid
12 k12 38 µtBid-Bax2
13 k13 39 µCytc
14 k14 40 µCytc∗
41 µSmac
42 µSmac∗
43 µSmac∗-XIAP
44 µApop
45 µCasp9
46 µCasp9∗
47 µCasp9∗-XIAP
Table 6.5: Summary of all rates and parameters for the system. The counter on the left hand columns totals
the 54 model rates and parameters for the full system. Each subscript for k, α and µ corresponds to its
reaction number. The final column are the parameters used in the abstraction of oligomerization kinetics
for the three modules.
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6.3.4 Regression analyses and model reduction
Integration of themodel ODEs at baseline parameter values (Table 6.5) gives the [Casp3∗]
time courses shown in Fig. 6.5. Both the HeLa and Jurkat T cells (the Jurkat T∗ case
which differs from the other two cells will be addressed in the results) demonstrate a
characteristic behavior, whereby [Casp3∗] stays low initially, then quickly switches to
a high state at some threshold time. Furthermore, the steady-state values of [Casp3∗] in
HeLa cells is consistent with experimental findings 1 (Albeck et al., 2008a) and the Jurkat
T cell steady-state value is in line with the results from previous models of Jurkat T cells
(Hua et al., 2006; Legewie et al., 2006).
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Figure 6.5: Time course of caspase-3 activation ([Casp3∗]) in HeLa and Jurkat T cells represented by
solid and dashed lines, respectively. The time course for a modification of the Jurkat T cell with k2 =
k5 = k12 = 0 based on the formulation of Hua et al., 2005; Okazaki et al., 2008 is denoted Jurkat T∗ and
represented by the dotted line.
Two quantitative descriptors are used to capture the form of these time courses: the
peak activation, the maximum value of [Casp3∗] attained over the time course; and the
activation time, the time at which this peak is achieved. To determine the most significant
aspects of the model within a given parameter regime, sensitivity analysis is performed
with respect to these descriptors according to the following procedure: for a given set of
1Eissing et al., 2004 assume that the volume of an individual cell of approximately 1 picoliter shows
that 600 molecules/cell ∼ 1nM and Albeck et al., 2008a find that after stimulation there are 104 − 105
molecules of Casp3∗/ HeLa cell ∼ 16.6 -166 nM.
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baseline parameter values, normally distributed random parameters are generated about
the baseline with a standard deviation of 5% of the baseline values. The model is simu-
lated at these parameters, descriptors are computed and the process is repeated 100 times
(the model has 54 parameters) to collect a set of synthetic data.
Since only local parameter perturbations have been considered, the linear relation-
ship y = (1X)b is assumed between the standardized descriptors y (y being one of
[Casp3∗]max and τ in standardized form) and the standardized random parameters X ,
where each row of X is a concatenation of the 54 model parameters in the order given
by Table 6.5. The relation b is solved by multiple linear regression and large regression
coefficients are taken to indicate essential components of the network. This information
is used to guide the formulation of reduced models.
6.4 Results and Discussion
6.4.1 Regression analyses and reduced models for FasL induction
Regression analysis as described previously is performed for baseline HeLa parameter
values. Regression coefficients for each of the descriptors show isolated peaks, indicating
that only a small subset of the network is responsible for the system behavior. Particu-
larly, the coefficients for the peak activation (r2 = 0.9991) show strong components only
at the synthesis and degradation rates αCasp3 and µCasp3, which together control the initial
concentration [Casp3]0; evidently, this turns out to largely be the case for all parameter
sets considered; thus, the peak activation will not be further discussed. More interesting
is the result for the activation time (r2 = 0.9958; see Fig. 6.6a), which, notably, shows
that only the reactions of the extrinsic subnetwork appear to be essential. Accordingly, a
reduced model (Fig. 6.7a) consisting only of the extrinsic subnetwork is formulated, and
validation of the reduction is given by comparison of the [Casp3∗] time courses between
the full and reduced models.
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Figure 6.6: Regression analyses of apoptosis under various conditions. Activation time regression coef-
ficients for sample model cases. The activation time is defined as the time at which the peak caspase-3
concentration over the time course occurs. The regression coefficients are ordered by their parameter
indices as shown in Table 6.5. Induction by FasL ([FasL]0 = 2 nM unless noted) corresponds to receptor-
mediated apoptosis, while induction by tBid corresponds to mitochondrial apoptosis ([tBid]0 = 25 nM
and [FasL]0 = 0 unless otherwise noted). (a) HeLa cell induced by FasL (r2 = 0.9958). (b) Jurkat T cell
induced by FasL (r2 = 0.9903). (c) Jurkat T∗ cell induced by FasL (r2 = 0.9846). (d) Jurkat T∗ cell
induced by low FasL ([FasL]0 = 0.01 nM; r2 = 0.9569). (e) HeLa cell induced by tBid (r2 = 0.9705).
(f) Jurkat T cell induced by tBid (r2 = 0.9879). (g) Jurkat T∗ cell induced by tBid (r2 = 0.8873). (h)
Predicted type II apoptosis cell parameters (k−4 = k−6 = 10−3 s−1, [XIAP]0 = 200 nM, [FasR]0 = 1
nM) induced by FasL (r2 = 0.9264).
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Figure 6.7: Reduced models under induction by FasL (receptor-mediated apoptosis; [FasL]0 = 2 nM
unless noted), with time course validations. In (a) and (c), the time courses of the full and reduced models
essentially overlap. (a) HeLa cell induced by FasL. (b) Jurkat T cell induced by FasL. (c) Jurkat T∗ cell
induced by low FasL ([FasL]0 = 0.01 nM).
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Note that this result should be expected since the HeLa cell was used in Eissing et al.,
2004 to study type I apoptosis. Surprisingly, a similar analysis of the Jurkat T cell, whose
initial concentration parameters were used to study type II apoptosis by Hua et al., 2005;
Okazaki et al., 2008, leads to a similar reduction. The regression coefficients (for the
activation time; r2 = 0.9903) are shown in Fig. 6.6b, with reduction shown in Fig. 6.7b,
which is just that for the HeLa case but with XIAP omitted. It should be noted that the
regression analysis does not show a strong component at k2, perhaps due to the corre-
sponding reaction occurring at saturation; therefore not sensitive to small perturbations.
Nevertheless, simulations show the necessity to capture the correct dynamics.
Review of the literature reveals that Hua et al., 2005 and Okazaki et al., 2008 used the
model variant denoted as Jurkat T∗ in this work; for completeness, analysis of the Jurkat
T∗ was hence considered. While induction of the Jurkat T∗ cell by baseline FasL returns
characteristic type I behavior (Fig. 6.6c, r2 = 0.9846; see also the delayed activation in
Fig. 6.5), a transition to type II apoptosis is observed for low FasL ([FasL]0 = 0.01 nM),
in accordance with the transition reported in Okazaki et al., 2008. This is to be compared
against the low FasL cases for the HeLa and Jurkat T cells, which do not exhibit such
a transition. The activation time regression coefficients for the Jurkat T∗ cell induced
by low FasL case are shown in Fig. 6.6d (r2 = 0.9569), which in particular has strong
components at k7 and k8, which describe Bid truncation and the release of Cytc. More-
over, the peak activation regression coefficients (r2 = 0.9972, not shown) exhibit a strong
contribution by αSmac. The reduced model (Fig. 6.7c) is correspondingly dominated by
the intrinsic pathway; indeed, there is no direct interaction between Casp8 and Casp3.
Furthermore, as implicated by the synthesis rate of its inactive form, Smac∗, and corre-
spondingly its target XIAP, plays a vital role in achieving the correct activation level,
which in particular illustrates the critical role of the shared-inhibitor motif in apoptosis
as discussed by Legewie et al., 2006.
6.4.2 Regression analysis and reduced models for mitochondrial apop-
tosis
The behavior of the system pathways under mitochondrial apoptosis have also been stud-
ied. Cell stressors that cause the depolarization and permeabilization of the mitochondrial
membrane are functionally represented in the model by an input [tBid]0 = 25 nM (now
[FasL]0 = 0). As for the FasL case, peak activation regression coefficients for the cases
considered below are dominated by αCasp3 and µCasp3; therefore, there will not be further
discussed.
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Performing the regression analysis on the HeLa cell induced by tBid produces the
activation time regression coefficients shown in Fig. 6.6e (r2 = 0.9705). Strong compo-
nents corresponding to the reactions of the intrinsic subnetwork are observed; interest-
ingly, the system behavior is sensitive to several extrinsic reactions as well. The model
reduction is shown in Fig. 6.8a, which demonstrates that the extrinsic caspase feedback
between Casp8 and Casp3 is essential to capturing the correct dynamics (compare the
time course with k2 = 0). Thus, the HeLa cell displays an apoptotic mechanism that
involves the intrinsic pathway triggering the extrinsic pathway. Furthermore, the role of
Smac∗ as an indirect activator of Casp3 through the sequestration of XIAP is recovered.
Although Casp9∗ possesses a similar sequestration ability, this analysis reveals that the
primary role of Casp9∗ is through direct activation of Casp3.
Figure 6.8: Reduced models of apoptosis under induction by tBid (mitochondrial apoptosis; [tBid] = 25
nM and [FasL]0 = 0), with time course validations. In both cases, the time courses of the full and reduced
models essentially overlap. (a) HeLa cell induced by tBid. (b) Jurkat T∗ cell induced by tBid.
Analysis of the Jurkat T cell induced by tBid gives similar results (Fig. 6.6f, r2 =
0.9879; reduced model not shown), though the magnitude of the regression coefficient of
k13, which describes the activation of Casp3 by Casp9∗, is larger than in the HeLa case,
suggesting a stronger role for the intrinsic caspase.
For completeness, the Jurkat T∗ cell induced by tBid is also considered. The activa-
tion time regression coefficients are shown in Fig. 6.6g. In this case, the fit is relatively
poor (r2 = 0.8873) and some parameters are selected in error (e.g., k1, which has no
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effect on the system by construction; also note the larger number of significant compo-
nents). Nevertheless, the regression serves to guide the model reduction, which in this
case required manual correction. The reduced model (Fig. 6.8b) reveals a purely intrinsic
mechanism of caspase activation. Similarly to the HeLa and Jurkat T cells, the seques-
tration of XIAP by Smac∗ is essential, while that by Casp9∗ may be neglected.
Although the peak activation for each of the HeLa, Jurkat T, and Jurkat T∗ cells is
essentially identical to that obtained under FasL induction, the activation time shows a
significant increase (factor increase of 2.1457, HeLa; 1.3003, Jurkat T; 1.9920, Jurkat T∗).
This is in general agreement with experimental evidence that caspase activation through
the intrinsic pathway is delayed relative to that through the extrinsic pathway (Scaffidi
et al., 1998).
Type II apoptosis prediction
In the preceding cases considered, type II apoptosis was observed only for the Jurkat
T∗ cell under low FasL induction. This may be unsatisfactory since the Jurkat T∗ cell
omits caspase feedback interactions which suggest potentially questionable biological
relevance. Thus, a natural idea is to determine whether parameters leading to type II
apoptosis may be predicted for the full reaction network rather than resorting to the Jurkat
T∗ formulation.
An attempt to use the regression analysis for this task was made based on the idea
of performing regression with respect to differences in the peak activation and in the
activation times between a given parameter set and the corresponding set with k7 = 0
(no Bid truncation, i.e., no extrinsic-intrinsic coupling). The intuition in this analysis is
that strong regression coefficients (assuming the modified descriptors are taken with the
appropriate sign) now select parameters whose increase may affect a transition from type
I to type II behavior. Furthermore, the parameters randomly perturbed are now restricted
to only the synthesis and degradation rates, and to [FasL]0, [FasR]0, [Bax]0, and [Apaf]0,
i.e., the parameters that control only the initial concentration, referred to as cell-specific
parameters, as these are assumed to be the only parameters which may vary between
different cell types.
Unfortunately, the regression coefficients for this analysis give poor fits (0.3884 ≤
r2 ≤ 0.7714 for the activation time difference) for the cases considered, so the method
fails. However, progress may nevertheless be made by considering the result from the
case of Jurkat T∗ induced by low FasL. The strategy is to transform the conditions of
that case into equivalent cell-specific parameter conditions. For example, the Jurkat T∗
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cell mutes the reactions involving the action of Casp3∗ on other molecules. This effect
may be achieved in principle by increasing [XIAP]0 and hence the inhibition of Casp3∗.
However, this turns out to be insufficient as a result of the strong positive feedback be-
tween Casp8 and Casp3. Therefore, it is further necessary to decrease the rate at which
Casp8 is activated. This may be controlled at the DISC module, so accordingly decrease
[FasR]0 (for the dependence, see Fig. 6.4a).
At the assumed rate parameters, however, the changes in [XIAP]0 and [FasR]0 re-
quired to achieve type II apoptosis are rather dramatic. Note that the dissociation rates
k−4 and k−6 of Casp3∗-XIAP and Casp8∗-BAR, respectively, as estimated from Eissing
et al., 2004 seem large; if the estimate k−4 = k−6 = 10−3 s−1 is taken instead, more
consistent with, e.g., Hua et al., 2005; Legewie et al., 2006; Okazaki et al., 2008, then
the changes required are no more than an order of magnitude. Specifically, starting with
Jurkat T parameters, increasing [XIAP]0 from 20 to 200 nM, and decreasing [FasR]0
from 10 to 1 nM gives a cell type for which the intrinsic pathway is significant even
under high FasL induction. The sensitivity regression analysis for this cell is shown in
Fig. 6.6h (r2 = 0.9264), which displays significant components corresponding to the in-
trinsic subnetwork, notably at k13. The influence of the intrinsic pathway demonstrated
by the comparison of time courses in Fig. 6.9 shows a significant delay of caspase acti-
vation upon disabling the pathway coupling through tBid. In comparison, control results
for the HeLa and Jurkat T cells show no such dependence (not shown).
Perhaps in light of this result, an alternative interpretation of the fact that the modified
regressions produced poor fits occurs due to type II transitions requiring large changes
that the local character of the linear regression cannot capture. This is consistent with
the changes that Hua et al., 2005 and Okazaki et al., 2008 report to effect transitions in
their models (without caspase feedback), where, effectively, [Casp8]0 was modified by a
similar amount. As a final note, changes of this magnitude are expected to be reasonable
given the inherent variability observed experimentally (see, e.g., Svingen et al., 2004).
6.4.3 Activation thresholds and stability
It should be noted that the model in its present formulation is unstable, even to transient
signals, as Fig. 6.9 suggests. However, some notion of stability may nevertheless be
achieved by considering activation times. This is shown for HeLa, Jurkat T, and Jurkat
T∗ cells in Fig. 6.10.
Consider first the case of receptor-mediated apoptosis, i.e., by FasL induction. For
HeLa and Jurkat T cells, the peak activation is essentially constant (Fig. 6.10a) with
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Figure 6.9: Type II prediction. Time course of caspase-3 activation ([Casp3∗]) for the type II apoptosis
cell prediction parameters (k−4 = k−6 = 10−3 s−1, [XIAP]0 = 200 nM, [FasR]0 = 1 nM) induced by
[FasL]0 = 2 nM. The solid line gives the time course of the full model, while the dashed line gives the
time course with k7 = 0 (i.e., noBid truncation, hence no extrinsic-intrinsic coupling). Note the significant
delay in caspase activation.
[FasL]0, in accordance with the observation from the regression analysis that the peak
activation is relatively insensitive. However, the activation time (Fig. 6.10b) varies sig-
nificantly, showing first a sharp decrease with [FasL]0 for low [FasL]0, then a gradual
leveling-off as [FasL]0 increases thereafter. Clearly, this latter portion may be interpreted
as the cell undergoing apoptosis in a saturated manner, in which further increase of the
death signal no longer affects the response time. Analogously, the initial drop appears to
define a transition region, wherein the cell switches from slow to fast apoptotic dynamics
over a narrow range of the death signal input; this is indicative of some threshold-like
behavior. Although this is not bistability, a sense of the existence of both low and high
apoptotic states is nevertheless furnished, which, may be made precise by introducing
an artificial cutoff on the activation time to discount activations which take too long to
occur. The case of the Jurkat T∗ cell is similar, though now the peak activation does show
nontrivial variation with [FasL]0. However, the peak activation remains uniformly high
which questions the biological significance.
Corresponding data for mitochondrial apoptosis (variable [tBid]0 with [FasL]0 = 0)
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Figure 6.10: Peak caspase-3 activations and activations times for HeLa (dots), Jurkat T (circles), and Ju-
rkat T∗ (asterisks) cells under receptor-mediated apoptosis (variable [FasL]0) and mitochondrial apoptosis
(variable [tBid]0 with [FasL]0 = 0). (a) Peak activations for receptor-mediated apoptosis. (b) Activation
times for receptor-mediated apoptosis. (c) Peak activations for mitochondrial apoptosis. (d) Activation
times for mitochondrial apoptosis.
are shown in Fig. 6.10c, d. The cases for the HeLa and Jurkat T cells are similar to
the receptor-mediated case; however, the Jurkat T∗ cell appears to exhibit bistability
(Fig. 6.10c). For low FasL (approximately [FasL]0 < 10−2 nM), the peak activation stays
low (near zero), whereas for high FasL ([FasL]0 > 1 nM), the peak activation reaches a
high state around 145 nM. Intermediate concentrations define a transition region where
the cell may be interpreted to switch from life to death.
The present data was computed with a constant input for the receptor-mediated case
and an exponentially decaying (i.e., transient) input for the mitochondrial case (since
tBid has a constitutive degradation rate in the model). Interestingly, instituting a transient
FasL signal, with estimated degradation rate µFasL = 10−5 s−1, produces no discernible
change to the receptor-mediated data, while setting µtBid = 0 degrades the quality of
the bistability result of the Jurkat T∗ case for mitochondrial apoptosis (not shown). This
affords some insight into why the noted bistability is observed: by virtue of the delay of
apoptosis incurred by the intrinsic pathway through the necessary activation of the mito-
chondrial apoptogenic factors and the assembly of the apoptosome (compare Figs. 6.10b
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and d), the intrinsic pathway is able to better filter out transient signals.
With regard to stability, perhaps these results imply that future models of apoptosis
should be careful to include potentially important regulators such as cFLIP, which inhibits
DISC and hence imposes a delay on Casp8 activation (Hua et al., 2005; Okazaki et al.,
2008). Moreover, it may likewise be prudent to expand in full any series of activations
occuring sequentially; an example might be the interactions between Bid and Bax to
form the MAC, which currently is not mechanistically understood and consequently may
be inappropriately abstracted; although in defense of the abstraction, it is experimentally
suggested that component levels (such as Apaf-1 or Casp9) may determine how quickly
some cells die (Svingen et al., 2004). Finally, the steady-state abstractions presented
are unsuitable for the purposes of model stability; however, modulation of the given
abstracted dynamics by appropriate time-dependent functions (e.g., by an appropriate
Heaviside function) may suffice.
6.5 Conclusion
This study has presented a methodological construction of a straightforward and informa-
tive mathematical model of apoptosis. This was done by combining both the extrinsic and
intrinsic pathways through the implementation of functional modules and subnetworks
motivated by previous models and findings (Eissing et al., 2004; Fussenegger et al., 2000;
Hua et al., 2005, 2006; Lai and Jackson, 2004; Legewie et al., 2006; Nakabayashi and
Sasaki, 2006; Okazaki et al., 2008). The subnetworks, responsible for the activation of
Casp3 and ultimately apoptosis, included descriptions of both the extrinsic and intrinsic
pathways as well as the coupling between them. Modularization of the oligomerization
kinetics of the DISC, MAC, and apoptosome were achieved through the implementation
of steady-state abstraction techniques.
Sensitivity analysis by linear regression was used to identify key components of the
apoptotic network under various cell conditions. This allowed for the formulation of
reduced models to capture the essential dynamics of the system. Importantly, these re-
ductions allowed the extraction of biological insight and helped clarify the roles of spe-
cific molecular components. For example, the model predicts, for the parameter regimes
considered, that Casp9∗ contributes to the activation of Casp3 by direct catalytic acti-
vation rather than through sequestration of their common inhibitor XIAP. Furthermore,
the reduced models validated many previous findings, including the critical role ofXIAP
and the shared-inhibitor motif in mediating apoptosis (Chauhan et al., 2001; Deveraux
et al., 1998; Legewie et al., 2006; McNeish et al., 2003; Oost et al., 2004), as well as
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the transition from type I to type II apoptosis as the induction of the extrinsic pathway is
decreased (Hua et al., 2005; Okazaki et al., 2008). Finally, the analysis revealed the vari-
ety of modes through which caspase activation can be achieved. In the cases considered,
caspase activation was observed to occur in four modes: 1) solely through the extrinsic
pathway; 2) solely through the intrinsic pathway; 3) through the extrinsic triggering the
intrinsic pathway; and 4) through the intrinsic triggering the extrinsic pathway. Whether
cells employ all of these modes is an interesting experimental question, with possibly
profound biological significance.
The results of the regression analysis were also used to predict cell parameters (i.e.,
initial concentrations) that would elicit type II apoptosis, even under highFasL induction,
without having to use the Jurkat T∗ model of Hua et al., 2005; Okazaki et al., 2008, which
omits important caspase feedback interactions (Eissing et al., 2004; Legewie et al., 2006).
This adheres to the notion of highly conserving the apoptosis pathway (Hengartner, 2000;
Lockshin and Zakeri, 2001; Thornberry and Lazebnik, 1998), and in principle, achieving
both type I and type II apoptosis using the same network. Naturally, the type II cell
prediction invites experimental investigation.
Furthermore, remarks on caspase activation thresholds and stability were given. The
critical element in achieving bistability in the system (at least to transient signals) ap-
pears to be related to whether sufficient delays are included. In particular, this implies
the importance of modeling regulators, especially inhibitors, of the system, as well as the
correct dynamical description of complex formation. Specifically, for this latter point,
the present formulation neglects the time dependence of the oligomerization rate and
assumes that the formation of a given final complex proceeds without delay. This, how-
ever, does not reflect actual dynamics; for example, the model of apoptosome assembly
by Nakabayashi and Sasaki, 2006 at the parameter values considered in this study ex-
hibits a characteristic time delay on the order of 100 minutes. A simple improvement
is the delayed initiation of the present approximation by an appropriate time. A general
theory of oligomerization that gives such a time would be particularly useful. Finally, of
special interest is whether the incorporation of such delays can recover the expected type
II behavior of the Jurkat T cell while maintaining the type I behavior of the HeLa cell.
Future directions for model refinement include more sophisticated treatment of oligomer-
ization kinetics as described. A more comprehensive procedure for model reduction
would also be helpful. The current method of sensitivity analysis is unable to eliminate
reactions near saturation; however these cases should intuitively be treatable analytically.
Moreover, the implementation of a faithful model exhibiting bistability is of primary bi-
ological interest as this would allow the formal definition and investigation of “a point of
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no return” in apoptosis. Furthermore, it may be profitable to adapt and apply the model to
other cell types, e.g., mature neurons, which have repressed Apaf-1 expression and hence
apoptosome formation (Wright et al., 2004; Yakovlev et al., 2001). Extending the pre-
sented work to model apoptosis at a cell population level may predict key mechanisms;
and perhaps, prove fruitful for understanding drug sensitivity in various cell lines.
The model thus presented serves as a guide for future theoretical and experimental
work in analyzing apoptosis and achieves progress toward a full model of this important
biological process.
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Chapter 7
Fas trimerization model
7.1 Overview
In this work, a simple model of death ligand-receptor interaction in apoptosis is devel-
oped based on recent structural data (Scott et al., 2009) that exhibits hysteresis. Thus,
formal demonstration that the data are compatible with bistability is provided, which is
important for enabling robust threshold switching between coherent life and death states.
The model is kept deliberately simple, both for analytical tractability and for lack of
mechanistic specificity. The model offers an explanation for the homotrimeric character
of the death ligand FasL in terms of bistability. This chapter is heavy on mathematical
analysis, which has, as yet, not been confirmed by experimentation. Though purely theo-
retical at this stage, the conclusion that death receptors are potentially capable of bistabil-
ity is significant, particularly as it implies an additional life-or-death decision in apoptosis
operating upstream of all other identified components. The lack of data notwithstanding,
parameter-free measures are also derived that may be used for model assessment or selec-
tion when data becomes available. Notably, the analysis was done using computational
algebraic geometry, which may prove a welcome partner for mathematical and systems
biology. This work, therefore, also serves to motivate the use of novel mathematical tools
within the biological community.
The work presented in this chapter was a joint collaboration with Kenneth L. Ho. The
fas-trimer model idea commenced after a conversation questioning the receptor-ligand
activation dynamics in the modularized model. Following biological developments, an
initial exploration of the hypothesis was conducted and led to an invitation to spend a
summer working with Kenneth L. Ho at NYU Courant Institute of Mathematical Sci-
ences. The model was jointly developed, and my contribution was exploring model dis-
crimination, determining that the most suitable model selection tool and adapting this
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technique, performing sensitivity and robustness analysis, and SBML implementation.
Throughout the project, code was shared through an interactive and collaborative on-
line mathematics software environment Sage (http://www.sagemath.org/). The initial
manuscript was drafted by Kenneth L. Ho, revisions were made jointly and this work
has been accepted by PLoS Comput Biol for publication.
7.2 Introduction
Recall from Chapters 2 and 6 that the current model of death ligand-receptor dynam-
ics supposes that FasL recruits Fas independently at each of three binding sites, thereby
producing a steady-state DISC concentration that varies smoothly with the input ligand
concentration (Harrington et al., 2008; Lai and Jackson, 2004). However, recent struc-
tural data by Scott et al. (2009) suggests a different view. Briefly, Fas was found to exist
in both closed and open forms, only the latter of which allows FADD binding and hence
transduction of the apoptotic signal. Moreover, open Fas were shown to be capable of
self-stabilization through stem helix and globular interactions; this immediately affords
a mechanism for bistability. Open Fas are disfavored relative to their native closed forms
and are able to sustain their conformations even after removal of the initial stimulus.
This process may promote receptor opening and, past a certain critical density of open
Fas, may induce hysteretic behavior in the concentration of active, signaling receptors.
Therefore, this stabilized open form may activate the signaling cascade that induces apop-
tosis. The Fas trimer hysteron model is a mathematical formulation of this idea, which
provides a possible rationale for the observed 1:3 binding stoichiometry. The essential
interpretation is that FasL acts as a clustering platform for Fas (Fig. 7.1A), which then
establish contacts through pairwise and higher-order interactions to form units capable
of hysteresis, i.e., hysterons. In this work, we propose that bistability may be induced
upstream by the death receptors themselves.
7.3 Results
7.3.1 Model formulation and bistability
The bistable character of the hysteron model is contingent on the necessity of receptor
clustering by FasL for high-order Fas interactions (i.e., termolecular and above); thus,
a simple estimate of Fas density in the membrane is needed. Previous models incor-
porating ligand-receptor dynamics have all used Fas cell surface receptors, not soluble
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Figure 7.1: The Fas trimer hysteron model. All parameters were set at baseline values (Table 7.1) unless
otherwise stated. (a) The transmembrane death receptor Fas natively adopts a closed conformation, but
can open to allow the binding of FADD, an adaptor molecule that facilitates apoptotic signal transduction.
Open Fas can self-stabilize via stem helix and globular interactions, which may be enhanced by receptor
clustering through association with the ligand FasL. (b) Process diagram (complying with the SBGN Pro-
cess Description language Level 1 (Le Nove`re et al., 2009)) of the hysteron model with n = 3. Fas exists
in three forms: closed; open, unstable; and open, stable. Green entities are capable of ligand-independent
processes, where we have marked ligand-induced receptor opening as uncertain; blue, ligand-catalyzed
processes of molecularity two; and red, ligand-necessary processes of molecularity three. (c) Variational
effects of model parameters on the steady-state signaling Fas fraction ζ∞ as a function of the scaled FasL
concentration λ. Full and dashed lines indicate stable and unstable steady-states, respectively. Bistability
requires n ≥ 3 (n = 3 for receptor trimerization). (d) Time courses at baseline parameters for λ fixed
within the bistable regime and variable ζ0, the initial signaling Fas fraction (top); and fixed ζ0 and variable
λ (bottom).
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Fas, where the number of receptors have been estimated in terms of concentrations of
the order 10–100 nM (Albeck et al., 2008a,b; Bentele et al., 2004; Harrington et al.,
2008; Hua et al., 2005; Okazaki et al., 2008), so conservatively taking an estimate of 100
nM (approximately 60,000 receptors) gives an areal density of ∼ 10−4 molecules/nm2
(see Methods). Receptors are found to be sparsely distributed, with only about one Fas
molecule in the area accessible around each receptor, assuming a characteristic size of
100 nm. High-order Fas interactions in the absence of FasL were therefore neglected.
The model includes constitutive receptor opening and closing, pairwise open Fas sta-
bilization, higher-order open Fas stabilization enabled by FasL, and ligand-induced re-
ceptor opening (Fig. 7.1). According to its conformational states, Fas is assumed to be
one of three species: closed (X); open, unstable (Y ); and open, stable (Z), i.e., active
and signaling. Furthermore, let the ligand FasL be denoted by L. For a general clustering
parameter n, giving the maximum number of receptors that each ligand can coordinate,
assign the reactions
Y
k1−−⇀↽−
k−1
X, (7.1)
{2Y, Y + Z} k2−→ 2Z, (7.2)
Z
k3−→ Y, (7.3)
L+X
k4−→ L+ Y, (7.4)
L+ jY + (i− j)Z k
(i)
l−−→ L+ iZ, (7.5)
where i = 2, . . . , n, and j = 1, . . . , i. The first reaction describes spontaneous receptor
opening and closing. The second reaction describes pairwise stabilization by open Fas,
irrespective of the presence of FasL; higher-order analogues, though in principle avail-
able, are neglected as justified by the low estimated receptor density. The third reaction
describes the constitutive destabilization of open Fas; and the fourth, ligand-induced re-
ceptor opening. Finally, the fifth reaction captures all cluster-stabilization events enabled
by FasL, the order being limited by n.
Throughout earlier chapters, concentrations were denoted by [−] to avoid confusion
with gene names; however, normal convention is that lowercase letters denote the con-
centrations of their uppercase counterparts and is used in this chapter. The five reaction
forms of the model dynamics, given by mass action for simplicity, are
dx
dt
= v1 − v4, dy
dt
= −v1 − v2 + v3 + v4 − vl, dz
dt
= v2 − v3 + vl,
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where
v1 = k1y − k−1x,
v2 = 2k2y
2 + k2yz,
v3 = k3z,
v4 = k4lx,
vl = l
n∑
i=2
k(i)l
i∑
j=1
jyjzi−j .
Clearly, ligand is conserved and may be treated as a parameter. The system can be
rescaled by introducing the nondimensional variables
ξ =
x
s
, η =
y
s
, ζ =
z
s
, λ =
k(2)l ls
k−1
, τ = k−1t,
where s ≡ x+ y + z is the conserved receptor concentration. Further, let
α =
k1
k−1
, β =
k2s
k−1
, δ =
k3
k−1
, θ =
k4
k(2)l s
,
and, for simplicity, enforce the uniformity condition
γ =
k(i)l s
i−2
k(2)l
, i = 3, . . . , n.
Then the steady-state, denoted by the subscript∞,
ξ∞ =
αη∞
1 + θλ
, η∞ =
1− ζ∞
1 + α/ (1 + θλ)
, (7.6)
so ζ∞ is given by considering
dζ
dτ
= 2 (β + λ) η2 + (β + λ) ηζ + γλ
n∑
i=3
i∑
j=1
jηjζ i−j − δζ (7.7)
and solving dζ/dτ = 0 with η -→ η∞ and ζ -→ ζ∞. The steady-state is obtained by
solving a polynomial equation in ζ∞ of degree n, denoting the number of receptors that
each ligand can coordinate, which admits bistability only if n ≥ 3. In the context of
this model, the biologically observed value of n = 3 demonstrates the lowest order
complexity required for bistability; therefore, the biological case of n = 3 is considered
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Model Parameter Value
hysteron
n 3
α 500
β 1
γ 5
δ 0.01
θ 0
crosslinking κ 0.1
caspase
piφ 10
piψ 10
piδ 1
σ 0.1
Table 7.1: Baseline nondimensional parameter values for models. Baseline nondimensional parameter
values for the hysteron, crosslinking, and caspase models.
in further detail. The model was shown to exhibit bistability (Figs. 7.1C and D) for
reasonable parameter choices (see Table 7.1). Notably, the bistability is reversible, as
the governing polynomial reduces to a quadratic in the absence of ligand; alternatively,
from a dynamical systems perspective, the steady-state structure undergoes a saddle-
node bifurcation as FasL is decreased. Moreover, intuition suggests that ligand-induced
receptor opening is not crucial for bistability, hence for simplicity, we further set θ =
0, with the understanding that the error incurred is only cursory at this level and thus
unlikely to change the essential character of the following results.
7.3.2 Bistability thresholds, parameter identification and robustness
Having established the capacity of themodel for bistability, a study of its defining features
in more detail was sought by using a combination of analytical and numerical tools. In
particular, focus was given to the activation and deactivation thresholds λ±, respectively,
that define the bistable regime; these are the points at which the steady-state switches
discontinuously from one branch to the other, and are given by the values of λ at which
the hysteresis curve turns, i.e., at ∂λ/∂ζ∞ = 0 (Fig. 7.2A). These critical values of λ
imply a polynomial equation in ζ∞ of order four, which, through an asymptotic analysis
with α = O(1/ε), β, γ = O(1), and δ = O(ε) for ε . 1, we showed to have at most
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Figure 7.2: Bistability thresholds and robustness. (A) Definition of the activation and deactivation thresh-
olds λ±, which bound the bistable regime of the model. (B) Parameter and threshold variation forN = 103
samples (Appendix D, Dataset 1), where the parameters α, β, γ, and δ were drawn independently from
log-normal distributions with scaled standard deviationχ = 0.25 about baseline median values (Table 7.1).
Parameters are expressed relative to their baseline values, and thresholds relative to their values at baseline
parameters. Scatter plots reveal relationships between the parameters and their induced thresholds (green,
linear regressions), and marginal probability distributions (top, parameters; side, thresholds) characterize
the total variation of each quantity. For both visualizations, blue corresponds to samples with bistability,
and red to those without. (C) Threshold variation with the intrinsic deactivation strength∆ (data and visu-
alization as in B). (D) Robustness of bistability. Data were generated over 0 ≤ χ ≤ 10 (N samples each;
protocol as in B), and the fraction of bistable samples recorded (Appendix D, Dataset 2). The bistable
proportion remains substantial at≈ 0.5 even under extreme variation.
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two nonnegative roots, namely
ζ+ ∼
√
2∆
α [γ (∆− 1)−∆] , (7.8)
ζ− ∼
√
∆Θ
γ
− (∆− 1) , (7.9)
where
∆ =
αδ
β
, (7.10)
Θ = γ (∆− 1)− 1, (7.11)
with the consistency requirement that ζ+ = O(√ε) and ζ− = O(1) (Appendix A). These
correspond to
λ+ ∼ β (∆− 1) , (7.12)
λ− ∼ β
γ∆+Θ− 2√γ∆Θ , (7.13)
respectively, which are both ofO(1). This fully characterizes the bistability in the asymp-
totic limit (Appendix A.1).
The values of the thresholds ζ± and λ± may be used to estimate the model parameters
in the asymptotic limit (A.1). To facilitate the estimation, we further require the unique
value ζ0 of ζ∞ at λ = 0, which is given by solving pλ = 0. Performing an order balance
for pλ as in Appendix Sec. A, it was found that ν = 0 and 1 (Table 7.2), so
ζ0 ∼

2/ [α (∆− 1)] , ∆ > 1,1−∆, ∆ ≤ 1. (7.14)
As the ζ± and λ± are assumed to exist; therefore, it was defined ζ0 by the first formula.
The parameters, for example, ζ0, λ+, and ζ+ for α, β, and γ, respectively may be
solved for as functions of∆, i.e.,
α =
2
(∆− 1) ζ0 , β =
∆− 1
λ+
, γ =
∆
∆− 1
(
1 +
2
αζ2+
)
, (7.15)
and finally, obtain ∆ by simultaneous optimization of both ζ− and λ−, subject to the
bistability constraint∆ > ∆∗. The value of δ is recovered through∆.
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c2 = O(ε2ν−2) c1 = O(εν−2) c0 = O(ε−1)
c2 — 0 1/2
c1 — 1
c0 —
(1) 0 (−1) (−1)
1/2 −1 −3/2 −1
(0) (−2) (−2) −1
Table 7.2: Order balance of pλ =
∑2
i=0 ciζ
i
∞. Top, critical values of ν, where ζ∞ = O(εν) for ε . 1,
balancing each pair of terms in pλ; bottom, corresponding ε-exponent of the order of each term. Admissible
balances are enclosed in parentheses.
To set the nondimensional timescale k−1, the characteristic time was considered for
convergence to the steady-state. The Jacobian matrix
J =
(
ξτξ ξτζ
ζτξ ζτζ
)∣∣∣∣∣
∞
evaluated at steady-state, i.e., at η = (1− ζ∞)/(1 + α), has the eigenvalues
µ1 = −1, µ2 = −δ
ε
+O (ε) , (7.16)
where it was assumed ζ∞,λ = O(1) for cell death. Therefore, the nondimensional
relaxation time is τrelax = max{−1/µ1,2} = O(1), so by rescaling, k−1 = τrelax/trelax =
O(1/trelax), where trelax is the experimentally measured relaxation time. This leaves only
one of k(2)l and k(3)l undetermined.
Note that α and δ only enter these expressions through ∆; which also explains their
similar variational effects (see Fig. 7.2C). The asymptotic forms of the thresholds reveal
their critical dependence on ∆, the relative intrinsic deactivation strength. In particular,
provided that γ > 1, all thresholds are real and nonnegative if
∆ > ∆∗ ≡ max
{
γ
γ − 1 ,
γ + 1
γ
}
> 1. (7.17)
Hence it is assumed that γ > 1, which quantifies the intuition that ligand-enabled higher-
order receptor cluster-stabilization is favored over the corresponding pairwise stabiliza-
tion, as due to, e.g., aggregate globular interactions. Thus, given the well-ordering of the
ζ±, the asymptotic bistability condition is∆ > ∆∗. Robustness of bistability is therefore
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immediate if ∆ 0 ∆∗ at baseline values; in this regime, the model is expected to retain
sharp switching behavior, and hence a robust distinction between coherent life and death
states over a wide operating range.
To study the bistability thresholds in general, numerical computation was undertaken.
Parameters were drawn independently from log-normal distributions with scaled standard
deviations of χ = 0.25 relative to baseline median values (Table 7.1 and Appendix Ta-
ble A.3; Appendix D, Dataset 1). The resulting thresholds are not particularly robust,
exhibiting variations of χ(λ±) ≈ 0.5. However, robustness to specific parameters was
observed, notably both λ± to β, and λ+ additionally to γ (Fig. 7.2B and Appendix Ta-
ble A.4).
Almost 99% of parameter sets were bistable, despite significant variation in the pa-
rameters and corresponding thresholds. Thus, the model exhibits robustness of bistability.
While none of the natural system parameters provided effective discrimination for bista-
bility, consistent with the analysis, we found that the simplified condition ∆ > 1 accu-
rately characterizes the data, correctly classifying over 98% of parameter sets (Fig. 7.2C).
Our baseline parameters give ∆ = 5, so the expected robustness is substantial, as ob-
served. A simple argument further suggests that, given γ > 1, this robustness asymp-
totes toward 50% bistability as χ → ∞ (Table 7.2). Parameters sampled widely over
0 ≤ χ ≤ 10 support this (Fig. 7.2D and Appendix D, Dataset 2).
7.3.3 Cell-level analysis using relay hysterons
The model thus far has been formulated based on constant parameters. At the level of the
cell, however, this is unlikely to be true due to local inhomogeneities, e.g., variations in
receptor concentration, lipid composition, and other membrane factors. These issues may
be treated simultaneously by applying the model locally within a membrane patch—i.e.,
by dividing the cell into individual hysteretic units—and positing the cell as an array of
such hysterons, each with parameters drawn randomly from an appropriate distribution.
For ease of analysis, a digital abstraction was applied, whereby each hysteron is either
active or inactive, depending on the local ligand concentration and its activation and
deactivation thresholds. More precisely, the abstracted activity of a given hysteron is
ζˆ =


0, λ ≤ λ−,
1, λ ≥ λ+,
ζˆ0, λ− < λ < λ+,
(7.18)
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where ζˆ0 is its previous activity level and hence accounts for its memory (Fig. 7.3A).
Thus, the cell is viewed as a set of relay hysterons connected in parallel, whose sum
activity gives the total (normalized) cell response
ζcell =
1
N
N∑
i=1
ζˆi, (7.19)
where ζˆi is the activity of hysteron i (Fig. 7.3B). Observe that this is simply the classical
Preisach model (Preisach, 1935), which has enjoyed remarkable success in describing
magnetic hysteresis (Barker et al., 1983).
Previously generated data was used at χ = 0.25 (Appendix D, Dataset 1) to trace
out a cell-level hysteresis curve under the assumption of a uniform ligand distribution
(Fig. 7.3C). Clearly, this is a smoothing operator, averaging over the sudden shifts as-
sociated with each hysteron. Indeed, this idea has been applied previously to explain
experimentally measured population-level data: by summing over individual hysteretic
cells, sharp thresholds are smeared out, producing a smooth, graded population response
(Eissing et al., 2004). Note, though, that the current analysis predicts a graded response at
the cell level; whether this is true remains as yet beyond the reach of experiment. More-
over, the lack of a sharp switch from low to high Fas signaling does not necessarily imply
the same at the level of the caspases which ultimately govern cell death, as downstream
components may possess switching dynamics (see, e.g., Bagci et al., 2006; Bentele et al.,
2004; Cui et al., 2008; Eissing et al., 2004; Legewie et al., 2006). In principle, the bista-
bility thresholds may be distributed randomly on the Preisach plane, but in fact a strong
linear dependence was observed between the λ± (r > 0.95; Fig. 7.3D). This suggests an
intrinsic ordering of the thresholds that promotes bistability and hence robustness.
7.3.4 Comparison with the crosslinking model
The prevailing model of ligand-receptor interaction in apoptosis is based on a crosslink-
ing formulation, whereby FasL recruits Fas independently at each of three binding sites.
As a representative of such models, we analyzed a variant of that by Lai and Jackson,
2004, as introduced in Chapter 6 as well as Harrington et al., 2008; other formulations
include Hua et al., 2005 and, for more simplified versions, see Albeck et al., 2008a,b;
Bentele et al., 2004; Fussenegger et al., 2000.
Recall the crosslinking model (Fig. 7.4A) assumes five species: FasL (L), Fas (R),
and the complexes FasL:Fas (C1), FasL:Fas2 (C2), and FasL:Fas3 (C3). These obey the
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Figure 7.3: Cell-level analysis using relay hysterons. (A) Digital abstraction as a relay hysteron, defined as
either active or inactive, corresponding to high or low Fas signaling, respectively (thick black lines). State
switching occurs according to the activation and deactivation thresholds (red and blue arrows, respectively)
and the local FasL concentration. (B) Schematic diagram of the Preisach model. The activities of an
ensemble of independent relay hysterons are summed to give the total output activity; in our case, due to
normalization, the total activity is an average. (C) and (D) Cell analysis using Preisach averaging on relay
hysterons defined on the threshold variation data (Appendix D, Dataset 1). (C) Hysteresis curve of cell
activity ζcell. (D) Distribution of thresholds on the Preisach plane (green); coloring as in Fig. 7.2B and C,
where additionally, the thresholds at baseline parameters (Table 7.1 are shown in yellow.
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reversible reactions
L+R
3k+−−⇀↽−
k−
C1, C1 +R
2k+−−⇀↽−
2k−
C2, C2 +R
k+−−⇀↽−
3k−
C3,
which describe the independent recruitment of Fas at each of three binding sites by FasL;
note that the reaction rates have been adjusted for combinatorial factors. The dynamics
are
dl
dt
= −v1, dr
dt
= −v1 − v2 − v3, dc1
dt
= v1 − v2, dc2
dt
= v2 − v3, dc3
dt
= v3,
where
v1 = 3k+lr − k−c1, v2 = 2k+c1r − 2k−c2, v3 = k+c2r − 3k−c3.
Nondimensionalize by setting
λ =
l
r0
, ρ =
r
r0
, γi =
ci
r0
, τ = k−t, κ =
k−
k+r0
,
where r0 is the total receptor concentration. In these variables, the system admits the
conservation relations
λ0 = λ+ γ1 + γ2 + γ3, 1 = ρ+ γ1 + 2γ2 + 3γ3,
interpreted as ligand and receptor conservation, respectively. At steady-state,
γ1,∞ = 3λ∞
(ρ∞
κ
)
, γ2,∞ = 3λ∞
(ρ∞
κ
)2
, γ3,∞ = λ∞
(ρ∞
κ
)3
,
where
λ∞ =
λ0
1 + 3 (ρ∞/κ) + 3 (ρ∞/κ)
2 + (ρ∞/κ)
3
and
ρ∞ =
1
2
[√
(3λ0 + κ− 1)2 + 4κ− (3λ0 + κ− 1)
]
.
In analogy with the hysteron model,
ζ ≡ γ1 + 2γ2 + 3γ3 = 1− ρ (7.20)
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
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Figure 7.4: Comparison with the crosslinking model. (A) Process diagram (comply with the SBGN Pro-
cess Description language Level 1 (Le Nove`re et al., 2009)) of the crosslinking model. (B) Variation of
the steady-state signaling Fas fraction ζ∞ with respect to the model parameter κ. (C) Minimization errors
, of the steady-state invariants ωH and ωC for the hysteron and crosslinking models, respectively (Ap-
pendix B.2), over data generated from each model (Datasets 3 and 4) using nonnegative least squares (see
Materials and methods for details).
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is used as a measure of the signaling Fas fraction (Fig. 7.4B). The crosslinking model
admits only one steady-state and cannot be bistable, in contrast to the hysteron model. In
principle, therefore, this provides a ready criterion for model discrimination, assuming
that the ligand-receptor dynamics can be isolated. Alternatively, if this level of exper-
imental control cannot be exercised, a discrimination test based on steady-state invari-
ants derived using tools from algebraic geometry can be provided, following Manrai and
Gunawardena, 2008. The basic idea is that dynamics resulting from mass action chem-
ical kinetics are polynomial equations in the species concentrations; consequently, their
steady-states describe algebraic curves, whose intersection—describing the steady-states
of the system—is an algebraic variety that can be studied using algebraic geometry.
The primary model selection tool is the Gro¨bner basis, which was used to compute
steady-state invariants of each model, i.e., polynomials in the species concentrations that
vanish at steady-state (Appendix B.2), with respect to the observables λ0, the total FasL
concentration, presumably a controlled experimental input; and ζ , the active Fas concen-
tration, which may be measured, for example, by using FADD binding as an indicator.
The identification of experimental observables is important as concentrations that can-
not be measured must, in principle, remain unknown and hence be eliminated from any
experimentally relevant invariant. Gro¨bner bases readily allow such elimination to be
performed. With each system expressed in terms of λ0 and ζ , and all other variables
eliminated, the resulting steady-state invariants ωH and ωC for the hysteron and crosslink-
ing models, respectively, are polynomials of the form∑i,j cijλi0ζj (Appendix B).
These invariants may be used for model discrimination by comparing the errors
.H = |ωH| and .C = |ωC| for the hysteron and crosslinking models, respectively, given
experimental data (λ0, ζ∞). If the model parameters are unknown, then .H and .C may
be minimized over the space of respective parameters and compared to their optimal
values. As a demonstration that such discrimination is feasible, sample steady-state con-
centrations from each model were generated (Datasets 3 and 4) and the data minimized
with respect to each invariant. The problem is highly nonlinear, so to improve the op-
timization, each term λi0ζj was considered as an independent variable, thus effectively
linearizing the problem with respect to the associated coefficients cij . The cij were fur-
ther constrained, and hence, by relabeling, the minimization was cast as a nonnegative
least squares (NNLS) problem, which can be solved exactly in that the error achieved is a
global minimum (Lawson and Hanson, 1995). The results show that the errors are small
if the models underlying the data generation and the invariant minimization are the same,
and large otherwise (Fig. 7.4C). This is precisely the condition necessary for effective
model discrimination.
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7.3.5 Feedforward caspase bistability
Bistability is often taken as a required property of apoptosis, under the intuitive reasoning
that a cell must possess both stable life and death states. One common way of achieving
bistability is by using positive feedback; in fact, positive feedback between caspases-8
and -3, e.g., through caspase-6 (Cowling and Downward, 2002; Slee et al., 1999), has
been shown to mediate bistability in the extrinsic pathway (Eissing et al., 2004). How-
ever, whether this feedback is relevant appears controversial, due, first, to its omission in
several recent models (Bentele et al., 2004; Hua et al., 2005; Okazaki et al., 2008); and
second, to the prediction that it does not contribute significantly to the qualitative dynam-
ics of the system (Albeck et al., 2008b). While numerous apoptotic processes generating
bistability have been identified in the intrinsic pathway (Bagci et al., 2006; Cui et al.,
2008; Legewie et al., 2006), such mechanisms operating independently of caspase feed-
back in the extrinsic pathway are scarce, including, so far, only direct inhibition of DISC
by cFLIP (Bentele et al., 2004). It is immediate, however, that the proposed hysteron
model offers another solution by moving the burden of bistability from the caspases to
the upstream death receptors; the model therefore provides a welcome resolution to the
problem of bistability in feedforward extrinsic caspase networks.
To demonstrate this, a rudimentary feedforward model of caspase activation was con-
structed capturing only the most basic interactions, particularly the activation of caspase-
3 by caspase-8, which itself is activated by DISC (Fig. 7.5A). Posit the inactive caspase
zymogens procaspase-8 (Casp8) and procaspase-3 (Casp3), and their corresponding ac-
tive forms caspase-8 (Casp8∗) and caspase-3 (Casp3∗). Caspase-3 represents all effector
caspases in the system, so its concentration will be considered a measure of the degree of
apoptotic activation. The model reactions are
Z + Casp8
k1−→ Z + Casp8∗, Casp8∗ + Casp3 k2−→ Casp8∗ + Casp3∗,
where the first reaction describes the activation of caspase-8; and the second, the acti-
vation of caspase-3. In general, Z denotes a death signal such as the DISC, but here it
will refer to active Fas, so as to provide a link to the hysteron and crosslinking mod-
els. For reasons of stability, we further supplement with the constitutive synthesis and
degradation reactions
k3−−⇀↽−
k−3
{
Casp8
Casp3
}
,
{
Casp8∗
Casp3∗
}
k4−→ ,
7.3 Results 148
 

 
 

Figure 7.5: Feedforward caspase bistability. All parameters were set at baseline values (Table 7.1) unless
otherwise stated. (A) Process diagram (comply with the SBGN Process Description language Level 1
(Le Nove`re et al., 2009)) of the feedforward caspase model. Caspases-8 and -3 represent all initiator and
effector caspases, respectively, and can each be active (orange) or inactive (green; procaspases-8 and -3,
respectively). The system input is a death signal (purple; e.g., DISC or active Fas) and its output, the degree
of apoptotic activation (red, taken as the caspase-3 concentration). (B) Variation of the steady-state caspase-
3 concentrationψ∗∞ with respect to the model parameters as a function of the scaled apoptotic signal ζ. (C)
Systems diagram of Fas-caspase coupling. The apoptotic signal generated by the Fas module (e.g., hysteron
or crosslinking) is used as input to the downstream caspase module. (D) Hysteresis curves of caspase-
coupled models using either the hysteron (left) or crosslinking (right) models for the Fas subsystem. Flow
of information as in C. In the absence of caspase feedback, only the hysteron model provides a mechanism
for bistability.
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which are taken to be symmetric for simplicity. Letting
x = [Casp8] , x∗ = [Casp8∗] , y = [Casp3] , y∗ = [Casp3∗] ,
the dynamics are
dx
dt
= −v1 + vx, dx
∗
dt
= v1 − vx∗ , dy
dt
= −v2 + vy, dy
∗
dt
= v2 − vy∗ ,
where
v1 = k1xz, v2 = k2x
∗y,
{
vx
vy
}
= k3 − k−3
{
x
y
}
,
{
vx∗
vy∗
}
= k4
{
x∗
y∗
}
.
Define Ω = k3/k−3 and σ = s/Ω, i.e., the equilibrium procaspase and relative receptor
concentrations, respectively, and let
φ =
x
Ω
, φ∗ =
x∗
Ω
, ψ =
y
Ω
, ψ∗ =
y∗
Ω
.
Then expressing the dynamics in terms of
piφ =
k1Ω
k−3
, piψ =
k2Ω
k−3
, piδ =
k4
k−3
, τ = k−3t,
obtained, at steady-state,
φ∞ =
1
1 + piφσζ
, φ∗∞ =
1− φ∞
piδ
, ψ∞ =
1
1 + piψφ∗∞
, ψ∗∞ =
1− ψ∞
piδ
.
Significantly, the model has only one steady-state; therefore, in the absence of bistabil-
ity at the DISC, hysteresis is clearly not possible (Fig. 7.5B). To probe this directly, the
model was coupled to the upstream hysteron and crosslinking models by using active
Fas as a functional surrogate for DISC (Fig. 7.5C). The results confirm that only the
hysteron-caspase model achieves hysteresis (Fig. 7.5D). The hysteron model thus pro-
vides a possible mechanism for extrinsic apoptosis to function as a bistable switch even
in cells with nonexistent or weak caspase feedback.
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7.4 Materials and methods
7.4.1 Model set-up
Receptor density estimate
Approximating the cell as a cube of linear dimension l ∼ 10 µm, the associated volume
v = l3 ∼ 1 pL implies the correspondence 1 nM∼ 600molecules∼ 10−6molecules/nm2
on restricting to the membrane, i.e., by averaging over the surface area s = 6l2 ∼ 600
µm2. Thus, for the typical cell, there are 40,000 Fas receptors (Bentele et al., 2004),
which with slight abuse of notation, is approximated as a concentration of ∼ 66.6 nM.
As the range varies between 10–100 nM, then for a receptor concentration of 100 nM,
the number of Fas molecules in the region about each receptor is only ∼ 1, assuming a
square patch of size 100 nm.
Parameter selection
The baseline value of n = 3was chosen for its biological relevance; the remaining param-
eters were set according to the following dimensional considerations. The characteristic
Fas concentration is s ∼ 10 nM, so the characteristic FasL concentration, estimated as
its threshold concentration, is l ∼ 0.1 nM (Bentele et al., 2004). Estimating k−1 ∼ 10−2
min−1 gives a reaction rate of v ∼ 0.1 nM/min for spontaneous receptor opening. Ref-
erencing the respective reactions against v hence gives k2 ∼ 10−3 nM−1 min−1 and
k(2)l ∼ 10−2 nM−2 min−1, so β ∼ 1 and λ ∼ 10l nM−1. Therefore, the nondimensional
threshold ligand concentration is λ+ ∼ 1; α, γ, and δ were set, where intuitively α 0 1
and δ . 1, to match this. Similarly, k4 ∼ 0.1 nM−1 min−1, i.e., θ = 1, but θ = 0 for
simplicity.
7.4.2 Model analysis
Steady-state solution
The steady-states of the hysteron model are given by solving dζ/dτ = 0, with each
steady-state classified as either stable if dζ/dτ |ζ=ζ∞ < 0 and unstable otherwise (Eqs. 7.6-
7.7); this was done analytically if θ = 0 and numerically otherwise.
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Dynamic characterization
Trajectory families were generated under two conditions: first, by fixing FasL at λ =
2.5 (within the bistable regime) and imposing the initial conditions (ξ0, η0, ζ0) = (1 −
ζ0, 0, ζ0) for 0 ≤ ζ0 ≤ 1; and second, by fixing (ξ0, η0, ζ0) = (1, 0, 0) and letting
0 ≤ λ ≤ 10. Integrations were performed at baseline parameter values (Table 7.1) over
0 ≤ τ ≤ 104 using ODEPACK (Hindmarsh, 1983).
Asymptotic analysis
Solving dζ/dτ = 0 for λ at n = 3 and θ = 0 gives
λ = fλ (ζ∞) ≡ pλ (ζ∞)
qλ (ζ∞)
,
where pλ and qλ are polynomials of degrees two and three, respectively, so
∂λ
∂ζ∞
= f∂λ/∂ζ (ζ∞) ≡ p∂λ/∂ζ (ζ∞)
q∂λ/∂ζ (ζ∞)
,
where p∂λ/∂ζ and q∂λ/∂ζ are of degrees four and six, respectively. The Fas activation and
deactivation thresholds ζ± are given by solving ∂λ/∂ζ∞ = 0, i.e., p∂λ/∂ζ = 0. Assuming
that ζ∞ = O(εν) with α = O(1/ε), β, γ = O(1), and δ = O(ε) for ε . 1, and
balancing the orders of each pair of terms in p∂λ/∂ζ , the admissible values ν = 0 and 1/2
were found (Appendix A Table A.1). Solving the asymptotic forms of p∂λ/∂ζ then gives
ζ+ = O(√ε) and ζ− = O(1) as the only nonnegative roots; the corresponding FasL
thresholds are λ± = fλ(ζ±).
Numerical computation of thresholds
Given α, β, γ, and δ, the bistability thresholds are computed by solving p∂λ/∂ζ numeri-
cally for ζ± and then computing λ± = fλ(ζ±). If the ζ± do not exist (i.e., all solutions
are negative or complex), then set ζ± = 1/2 and λ± accordingly.
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Log-normal distribution with scaled standard deviation
If X ∼ Log-N(µ, σ2), then the median and standard deviation ofX are
med (X) = eµ,
std (X) =
√
(eσ2 − 1) e2µ+σ2 ,
respectively. Hence rescaling the standard deviation by defining χ = std(X)/med(X),
i.e., the median analogue of the coefficient of variation,
σ =
√√√√log
(
1 +
√
1 + 4χ2
2
)
.
Parameter generation for threshold analysis
For the threshold variation analysis, N = 103 parameter sets (α, β, γ, δ) were drawn
from a log-normal distribution with baseline median values (Table 7.1) at χ = 0.25
(Appendix D, Dataset 1). For the robustness of bistability analysis, χwas taken at equally
spaced points over 0 ≤ χ ≤ 10, at each similarly drawing N parameter sets about
baseline values (Appendix D, Dataset 2).
Estimation of probability distributions
Probability distributions of parameters and thresholds were estimated using Gaussian ker-
nel density estimation, with automatic bandwidth selection using the Scott factor (Scott,
1992).
Cell-level analysis
The cell-level analysis was performed using the data computed at χ = 0.25 (Appendix D,
Dataset 1), i.e., the cell was partitioned into N = 103 relay hysterons. The hysteresis
curve was traced out by ranging FasL over 0 ≤ λ ≤ λmax+ , where λmax+ is the maximum
activation threshold over all parameters drawn, and then back, updating ζcell whenever a
threshold is crossed.
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7.4.3 Model discrimination
Steady-state invariants
Gro¨bner bases were computed overK = Z(a) using the lexicographic monomial order-
ing (Appendix B.2). For the hysteron invariant, λ = λ0 and ξ = 1−η−ζ , hence express-
ing the dynamics f = ∂τ (ξ, η, ζ) in terms of the variables x = (η,λ0, ζ); the variables
are a = (α, β, γ, δ). A Gro¨bner basis of 〈f〉 was computed, from which elimination of η
gives ωH. Similarly, for the crosslinking invariant was λ = λ0− γ1− γ2− γ3, ρ = 1− ζ ,
and γ1 = ζ−2γ2−3γ3, and a Gro¨bner basis was computed with f = ∂τ (λ, ρ, γ1, γ2, γ3),
x = (γ2, γ3,λ0, ζ), and a = κ; eliminating γ2 and γ3, to obtain ωC.
Nonnegative least squares for model discrimination
Considering each term ±λi0ζj (with sign chosen as appropriate) in ωH and ωC as an
independent variable, the associated constant cij was split into variable and constant
parts cvarij (a) and cconstij , respectively, so that cvarij ≥ 0, assuming the asymptotic order-
ing α = O(1/ε), β, γ = O(1), and δ = O(ε) for . . 1, with ∆ > 1. The required
optimization is then a nonnegative least squares problem (Lawson and Hanson, 1995)
minimizing . = ‖Ucvar + Ucconst‖2, suppressing model reference for generality, where
U = (u1, . . . , uN) is a matrix of experimental data, for each ui a row vector correspond-
ing to an experimental trial; cvar = (cvarij ) is a column vector of nonnegative coefficients
to be determined; and cconst = (cconstij ) is a column vector of constants.
Parameter generation for model discrimination
Parameters were randomly drawn for each model using the following procedure. The
initial FasL concentration λ0 was sampled from a log-normal distribution with median
med(λ0H) = 2.5 and med(λ0C) = 0.25 for the hysteron and crosslinking models, respec-
tively (FasL is nondimensionalized differently in the two models), and scaled standard
deviation χ(λ0) = 1. The concentrations of the remaining species, which are all con-
strained by nondimensionalization, were drawn uniformly in sequence over the appropri-
ate range, i.e., for the hysteron model, ξ0 ∈ [0, 1] was sampled, then η0 ∈ [0, 1− ξ0], then
ζ0 ∈ [0, 1− ξ0 − η0], while for the crosslinking model, ρ0 ∈ [0, 1] was taken, next γ01 ∈
[0, 1−ρ0], then γ02 ∈ [0, (1−ρ0−γ01)/2], and finally γ03 ∈ [0, (1−ρ0−γ01−2γ02)/3]. Steady-
state experimental data were obtained for each parameter set by solving the steady-state
equations governing each model and making the identifications λ0 = λ∞ for the hys-
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teron model, and λ0 = λ∞ + γ1,∞ + γ2,∞ + γ3,∞ and ζ∞ = γ1,∞ + 2γ2,∞ + 3γ3,∞ for
the crosslinking model. For each model, N = 100 parameter sets were drawn (Datasets
3 and 4).
7.4.4 SBML implementation
For standards compliance, the hysteron and hysteron-caspase models were implemented
in dimensional form using the Systems Biology Markup Language (SBML) Level 2 Ver-
sion 1 (Finney and Hucka, 2003; Hucka et al., 2003). The models and sample analyses
performed on them are given in the Appendix C.
7.5 Discussion
7.5.1 Summary and biological significance
In this work, a mathematical model of death ligand-receptor clustering was presented,
demonstrating bistability and hysteresis in apoptosis through biologically observed Fas
pair-stabilization (Scott et al., 2009). This work contributes to the signal processing ac-
tivities in which receptor clustering has been suggested to participate (Bray et al., 1998;
Endres et al., 2008; Sourjik, 2004). The Fas trimer hysteron model is a mathematical
formulation of the observation that Fas can aggregate and self-stabilize in their active
signaling forms; in this interpretation, FasL provides a clustering platform for Fas, pro-
moting receptor activation and hence apoptosis by enabling proximity-induced recep-
tor interactions. Although the precise mechanisms by which this may occur is unclear,
this bistability plays an important functional role by enabling robust threshold switch-
ing between life and death states. Significantly, the model predicts that bistability is a
consequence of receptor trimerization, furthermore, it provides an explanation for the
homotrimeric character of FasL.
The hysteron model implies an additional all-or-none switch in apoptosis, supple-
menting those that have been studied previously (Bagci et al., 2006; Bentele et al., 2004;
Cui et al., 2008; Eissing et al., 2004; Legewie et al., 2006). Critically, the proposed
mechanism is triggered upstream at the death receptors that initially detect the death sig-
nal encoded by FasL; therefore, this switch is apical in that it precedes and hence provides
context for all other switches in the system. Consequently, it thus operates independently
of all intracellular components and offers a general mechanism for bistability, even in
cell lines deficient in, for example, caspase feedback (see Albeck et al., 2008b). As the
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signal received by all downstream components is convolved with the signature of Fas
activation, the importance of understanding the mechanism and kinetics of death ligand-
receptor interaction was highlighted. More generally, this provides encouragment for
further research into the formation of the DISC, which, in this view, may be considered
the macromolecular aggregates of active Fas. It should be noted that the hysteron model
may also be applied to related death receptors such as those in the tumor necrosis fac-
tor receptor (TNFR) family, provided that they similarly possess an active form which is
capable of aggregate self-stabilization.
7.5.2 Model assumptions and analysis
In formulating the hysteronmodel, the emphasis was on simplicity and tractability, though
often at the expense of biological realism. For instance, it is more appropriate to use
Michaelis-Menten kinetics with generalized loads for all ligand-dependent reactions;
however, it is clear that this should not change the essential character of the model as
no new physical steady-state can be introduced. Although the emergence of a new phe-
notype in which apoptosis cannot occur due to saturation of reaction rates is possible,
this is not of practical novelty as, within the biological regime λ ∼ 1 is of interest, it is
essentially equivalent to a mass-action hysteron with activation threshold λ+ 0 1.
The model invokes the assumption that higher-order Fas interactions are not permit-
ted in the absence of FasL. This is a strong statement and should be replaced by the
requirement only that any such interaction, characterized by the analogous parameter γ˜,
is weak, i.e., γ˜ . 1. But clearly this relaxation poses no difficulty, since by rescaling it
can be seen that this modification has an effect only if γ˜ ∼ γλ+ = O(1). In particular,
this also shows that irreversible bistability cannot be achieved in this way.
Although monomeric Fas has been assumed, the model is not strictly incompatible
with pre-ligand receptor assembly, in which Fas dimerizes or trimerizes prior to ligand
exposure (Chan, 2007; Chan et al., 2000; Siegel et al., 2000). Indeed, it is necessary only
that pre-associated Fas be inactive with respect to signaling via FADD binding, and fur-
thermore be incapable of ligand-independent cluster-activation. We may then essentially
apply our model locally to the region about each pre-assembled receptor complex, with
the result that bistability is yet to be achieved. The interpretation now is that FasL acts on
pre-associated Fas to induce a structural shift from a metastable pre-assembled confor-
mation to a preferred state of aggregate activation. Notably, conformational change of the
pre-assembled complex upon ligand binding has been confirmed experimentally (Chan
et al., 2001); this is furthermore consistent with the finding that receptor pre-assembly
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promotes sensitivity to apoptosis, presumably by increasing the local receptor concentra-
tion (Muppidi and Siegel, 2004).
Presently only the asymptotic limit α 0 1 and δ . 1 has been considered. In
the event that this does not reflect reality, however, this analysis should be viewed only
as a representative application of asymptotics in general, which, in this particular case,
revealed the criticality of the derived parameter∆, whose importance would likely have
eluded standard numerical sensitivity tests operating on the explicit system parameters.
The value of such mathematical treatment is thus apparent. Moreover, it should be noted
that asymptotic analysis is an effective tool for biology in general, particularly for model
reduction, as biological systems often contain multiple timescales that separate naturally.
7.5.3 Tools for model selection
A primary goal of systems biology is to construct quantitative models of biochemical
processes that are mechanistically correct. However, for any given process, a number
of descriptions may exist—as due to, e.g., a lack of specificity from unresolved experi-
mental data—of which only one can in principle be correct. Model selection is therefore
essential; and a scalable unbiased algorithm for doing so is particularly desirable (see,
e.g., Apgar et al., 2008).
In discriminating the hysteron and crosslinking models, Gro¨bner basis methods were
used to compute steady-state invariants, whose satisfiability can assess model correct-
ness. This approach possesses three significant advantages: first, model parameters can
be absorbed into the coefficient field over which the dynamics are described, resulting in
invariants that are valid for all parameter choices and thus parameter-free selection crite-
ria; second, experimentally relevant invariants can be generated through the elimination
of variables that cannot be measured; and third, application of the method requires no
sophisticated experimental control, e.g., gene knockdowns or knockouts, revealing only
natural relations between the system variables. This last point deserves particular empha-
sis: steady-state invariants can be applied passively, tailored to the data at hand—which,
for example, may be existing data—and hence present a flexible, cost-effective basis for
model selection. Furthermore, note, that although this model was a mass-action systems,
the described approach can be generalized for other types of kinetics by using different
fields; in fact, the current choice of Z(a) is appropriate for Michaelis-Menten and Hill
reaction forms, as well as their integral polynomial generalizations.
Invariant assessment may be performed in a number of different ways. For example,
Manrai and Gunawardena, 2008 exploited the low effective dimensionality of invariants
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in multisite phosphorylation to derive a discrimination criterion based on the visual as-
sessment of planarity. In the current work, this was not feasible; therefore, numerical
optimization was used, specifically, nonnegative least squares (NNLS), for performance.
It is profitable to remember that an invariant is simply a polynomial that vanishes, so
a wide variety of methods may be well used for its analysis. For large systems, how-
ever, the method of choice will likely be optimization, and, in such cases, it is believed
that NNLS is a particularly strong tool: assuming effective linearization by introducing
additional degrees of freedom, NNLS provides an efficient scheme for minimizing the
resulting linear form exactly subject to physical constraints (Lawson and Hanson, 1995).
Thus, steady-state invariants and NNLS seem to form the basis for an effective procedure
for model selection and, more generally, model assessment. Scaling this up, however, is
difficult, owing primarily to the bottleneck of computing Gro¨bner bases for large systems,
though this may be overcome by embracing parallelism (Neun and Melenk, 1992) or by
implementingmore sophisticated algorithms such as Fauge`re’sF4 and F5 (Fauge`re, 1999,
2002). With such enhancements in place, a large-scale automated model assessment tool
may well be achievable.
Broadly, algebraic geometry is concerned with the solutions of systems of polyno-
mial equations; for an application of Gro¨bner basis methods in membrane biophysics,
see Fauge`re et al., 2003. Given its generality, we hence expect algebraic geometry to find
wide application across all of biology, not limited only to steady-state model characteri-
zation.
7.6 Concluding remarks
Amathematical model of death ligand-receptor interaction has been presented that strongly
implicates Fas aggregation, e.g., through trimerization, in generating bistability at the
level of the DISC. Naturally, this has profound consequences for apoptosis and therefore
deserves further investigation. The model assumptions of receptor clustering by FasL
and of cluster-stabilization of open Fas should hence be verified, either, ideally, exper-
imentally or by using atomistic simulations, e.g., molecular dynamics. Moreover, such
properties should also be tested for functional homologues like other death receptors, as
well as the PIDDosome, the apoptosome, and the inflammosome, as they may all share a
conserved mode of operation. Furthermore, the current work has highlighted the critical
role of receptor clustering, particularly in the context of pre-association, which enhances
sensitivity to extrinsic apoptosis and additionally is upregulated by localization to lipid
rafts (Muppidi et al., 2004). Therefore, future models of Fas signaling are likely to ben-
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efit from a spatial component modeling receptor distribution, which, in the continuum
limit, generates a system of partial differential equations rather than the simpler ordinary
differential equations presently considered. Finally, it is hoped that this study demon-
strates the tremendous insight that can provided by structural biology (see, e.g., Fesik,
2000), especially in collaboration with mathematical and computational modeling.
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Chapter 8
General conclusions
This thesis presented mathematical models of cellular decisions; specifically, those that
govern immune response and apoptosis. The development of models required an inter-
disciplinary approach whereby biology motivated the models and mathematics provided
a theoretical and quantitative framework. Often, constructing a model was an iterative
process requiring refinement as biological data was obtained. After developing a model,
mathematical analysis and numerical techniques were used to gain insights into the mech-
anisms governing the cellular response.
The two systems of interest, immune response in vascular plaque macrophages and
apoptosis, have different functions, yet share similarities. Both responses may be thought
of as an all-or-none switch, in the case of macrophage response, it is often characterized
by pro- or anti-inflammatory function; similarly, in the context of apoptosis, a cell is
either alive or dead. Systems exhibiting this type of qualitative behavior, i.e., changing
from one state to another over a given time, are perfect candidates to model and analyze.
As a consequence of the inherent complexity of these systems, due to the many protein
interactions during signal transduction such as feedback loops, mathematics of nonlin-
ear ODEs offered suitable methods of analysis to study these systems, and as seen in
Chapters 4 and 7, the biological system may exhibit bistable behavior. Furthermore, the
vascular and apoptosis systems investigated in this thesis presented a number theoretical
and biological contributions.
Mathematical models of vascular immune response were developed describing the
response of macrophage scavenger receptor CD163 and anti-inflammatory mediators to
different stimuli. Simple models were understood analytically and their behavior was
characterized, revealing a rich variety of bifurcations. Mechanisms were uncovered
within the macrophage scavenger receptor CD163 and its anti-inflammatory response
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to Hb:Hp complexes. We specifically predicted the existence of a positive feedback loop
between CD163 and IL-10. We also identified that the Hb:Hp responsible for the phe-
notypic switch occurs at a threshold H∗, which was supported experimentally. It would
be useful to extend the work presented here to include the behavior of groups of cells
and develop multi-scale models to capture the dynamics at the cell and population level
for the monocyte/macrophage lineage. Overall, constructing a number of models allowed
the investigation of specific system components and enabled a better understanding of the
benefits and limitations of each model and its assumptions. The model development pro-
cess may serve as an example and provide a theoretical framework for future modeling
of cellular mechanisms.
The simple models motivated the development of mechanistic models which included
CD163, IL-10 and HO-1 species. Data fitting and model selection was performed using
approximate Bayesian computation based on sequential Monte Carlo sampling which de-
termined parameter values and initial conditions; furthermore, ABC-SMC also served as
a model discrimination tool. The model selection identified a key mechanism necessary
for an anti-inflammatory response; specifically, the existence of a HO-1/IL-10 positive
feedback. While this model is rather simple, it provides a first step in understanding the
anti-inflammatory effects of hemoglobin and its intermediates and it may be beneficial to
include regulators of this response in future models. The parameter inference provided
a posterior distribution of estimated parameters which allowed us to identify parameters
that fit to the data and those that require additional refinement. Future work requires ad-
ditional experimentation; ideally, conducted under the same conditions to minimize the
prior parameter space. Additionally, the region of bistability of the CD163 system could
be enhanced by improving estimation of parameters. Our results also motivate further
study of the intracellular mechanisms in this system and others, consider the monocyte
differentiation into a M1/M2 lineage macrophage; and this work also serves as another
step to understanding the interactions of macrophage anti-inflammatory response.
The full system model of apoptosis, a conglomeration of many existing models, pro-
vided novel predictions. The modularized model was created by combining both the
extrinsic and intrinsic pathways through the implementation of functional modules and
subnetworks motivated by previous models and findings (Eissing et al., 2004; Fusseneg-
ger et al., 2000; Hua et al., 2005, 2006; Lai and Jackson, 2004; Legewie et al., 2006;
Nakabayashi and Sasaki, 2006; Okazaki et al., 2008). The subnetworks, responsible
for the activation of Casp3 and ultimately apoptosis, included descriptions of both the
extrinsic and intrinsic pathways as well as the coupling between them. The model iden-
tified key components of the apoptotic network under various cell conditions, despite
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the abstraction of activation complexes. This allowed the formulation of reduced mod-
els to capture only the essential dynamics of the system. Importantly, these reductions
allowed the extraction of biological insight and helped clarify the roles of specific molec-
ular components. The model identified the critical role of the inhibitor XIAP and the
shared-inhibitor motif, and characterized the transition from type I to type II apoptosis as
the induction of the extrinsic pathway is decreased. Finally, the analysis revealed the va-
riety of modes through which caspase activation can be achieved. In the cases considered,
caspase activation was observed to occur
1. solely through the extrinsic pathway;
2. solely through the intrinsic pathway;
3. through the extrinsic triggering the intrinsic pathway; and
4. through the intrinsic triggering the extrinsic pathway.
Whether cells employ all of these modes is an interesting experimental question, with
possibly profound biological significance.
The modularized model also presented a methodological construction of a straightfor-
ward and informative mathematical model of apoptosis. Modularization of the oligomer-
ization kinetics of the DISC, MAC, and apoptosome were achieved through the imple-
mentation of steady-state abstraction techniques. These techniques allowed the system
complexity to be reduced; however, the system was no longer bistable as a result of
removing the temporal dynamics of oligomerization. Future directions may include ex-
ploring model reduction in such a manner that the overall stability of the system is not
affected. Despite the instability, modularization enabled the full system to be analyzed
for a minimum number of variables and parameters. Sensitivity analysis was conducted
using linear regression, which motivated the formulation of reduced models and the study
of type I and type II cell mechanisms. As there are now many models describing the full
apoptosis signaling pathway, future work must focus on developing the steady-state ab-
straction in such a way that stability is maintained, that is, allowing a model of apoptosis
that is representative of the full system dynamics for different cell types, while maintain-
ing stability. It is hoped, in the future, that modularization through the use of steady-state
abstraction, becomes a common method for understanding larger systems and a tool for
model reduction.
The work by Scott et al., 2009 (crystallography data that Fas death receptors ex-
ist in two states: open and closed, and that Fas can stabilize each other) motivated the
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development of a new model to describe the receptor-ligand trimerization, responsible
for activating the extrinsic pathway of apoptosis. The pre-existing cross-linking model
(Lai and Jackson, 2004) exhibited monostable behavior (the model results of Lai and
Jackson, 2004 predicted an optimal ratio of receptor/ligand for activation); however, this
hysteron model strongly implicated Fas aggregation, e.g., through trimerization, in gen-
erating bistability at the level of the DISC and hypothesized a threshold amount of ligand.
The consequence of this result suggested that the switching mechanism in apoptosis may
occur as early as at the receptor, rather than during caspase positive feedback loops. This
model assumptions of receptor clustering by FasL and of cluster-stabilization of open Fas
should hence be verified, ideally by experimentation or by using atomistic simulations,
e.g., molecular dynamics. This theoretical and relatively simple model was thoroughly
analyzed, and the model bistability was found to be robust. The model was also extended
to the cell-level using relay hysterons; furthermore, comparison of this model with the
crosslinking model using steady-state invariants derived from Gro¨bner bases, provided a
heuristic for model selection, irrespective of confidence in parameter values. In addition
to the strong mathematical analysis, this model highlighted the critical role of receptor
clustering, particularly in the context of pre-association, which enhances sensitivity to
extrinsic apoptosis and additionally is upregulated by localization to lipid rafts (Muppidi
et al., 2004). The receptor clustering mechanism may also be tested for other death re-
ceptors with functional homologues, or intrinsic pathway activators. Future models of
Fas signaling are likely to benefit from a spatial component modeling receptor distribu-
tion, which, in the continuum limit, generates a system of partial differential equations
rather than the simpler ordinary differential equations presently considered.
This thesis attempted to gain a better insight into the mechanisms underlying the
biological behavior of macrophage response in the vascular system and the apoptotic
machinery responsible for cellular fate. The ability to quantitatively and theoretically
realize the behavior of vascular inflammation and apoptosis, as presented in this thesis,
may prove useful insight for the development of medical therapies for diseases associated
with their dysregulation.
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Appendix A
Bistability thresholds and robustness
A.1 Asymptotic analysis
The activation and deactivation thresholds λ± that define the bistable regime are given by
the values of λ at which ∂λ/∂ζ∞ = 0. As mentioned in Sec. 7.3.1, we restricted to the
biological context of n = 3 and further fixed θ = 0. Thus, solving dζ/dτ = 0 gives
λ = fλ (ζ∞) ≡ pλ (ζ∞)
qλ (ζ∞)
,
where pλ and qλ are polynomials of degrees two and three, respectively, hence
∂λ
∂ζ∞
= f∂λ/∂ζ (ζ∞) ≡ p∂λ/∂ζ (ζ∞)
q∂λ/∂ζ (ζ∞)
,
where p∂λ/∂ζ and q∂λ/∂ζ are polynomials of degrees four and six, respectively. Since we
are concerned with ∂λ/∂ζ∞ = 0, only p∂λ/∂ζ was considered in solving for λ±. The
strategy then is to solve p∂λ/∂ζ for the Fas thresholds ζ±, then to compute λ± = fλ(ζ±).
In the asymptotic limit
α = O
(
1
ε
)
, β, γ = O (1) , δ = O (ε) (A.1)
for ε. 1,
pλ (ζ) ∼ −α2βζ2 − α2 (αδ − β) ζ + 2αβ, qλ (ζ) ∼ α2γζ3 − α2 (γ − 1) ζ2 − α2ζ − 2α,
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c4 = O(ε4ν−4) c3 = O(ε3ν−4) c2 = O(ε2ν−4) c1 = O(εν−3) c0 = O(ε−3)
c4 — 0 0 1/3 1/4
c3 — 0 1/2 1/3
c2 — 1 1/2
c1 — 0
c0 —
1 0 −1 −2 −2 −3
(1/2) −2 −5/2 (−3) −5/2 (−3)
1/3 −8/3 −3 −10/3 −8/3 −3
1/4 −3 −13/4 −7/2 −11/4 −3
(0) (−4) (−4) (−4) −3 −3
Table A.1: Order balance of p∂λ/∂ζ =
∑4
i=0 ciζ
i
∞. Top, critical values of ν, where ζ∞ = O(εν) for
ε . 1, balancing each pair of terms in p∂λ/∂ζ ; bottom, corresponding ε-exponent of the order of each
term. Admissible balances are enclosed in parenthesis.
and
p∂λ/∂ζ (ζ) ∼ α4βγζ4 + 2α4 (αδ − β) γζ3 − α2 [(αδ − β) γ − αδ] ζ2 + 4α3βγζ + 2α4δ
on asympotically expanding each coefficient. Thus, suppose that ζ∞ = O(εν) and find
the critical values of ν that balance the orders of each pair of terms in p∂λ/∂ζ . Clearly,
the values of ν such that only one dominant term exists must be discounted, hence the
admissible values ν = 0 and 1/2 (Table A.1) have been obtained.
For ν = 1/2,
p∂λ/∂ζ (ζ) ∼ −α4γ (αδ − β) δζ2 + 2α4δ,
so
ζ+ ∼
√
2∆
α [γ (∆− 1)−∆] (A.2)
is the unique nonnegative root, provided that γ > 1 and ∆ > γ/(γ − 1), where, recall,
∆ =
αδ
β
= O (1) (A.3)
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is the relative intrinsic deactivation strength. Similarly, for ν = 0,
p∂λ/∂ζ (ζ) ∼ α4βγζ4 + 2α4 (αδ − β) γζ3 − α4 [(αδ − β) γ − αδ] ζ2,
so
ζ− ∼
√
∆Θ
γ
− (∆− 1) , (A.4)
where
Θ = γ (∆− 1)− 1 = O (1) , (A.5)
which exists if Θ ≥ 0, i.e., ∆ ≥ 1 + 1/γ; note that the trivial root ζ∞ ∼ 0 of multiplicity
two recovers the solutions of order O(√ε). As physical intuition demands, p∂λ/∂ζ has at
most two nonnegative roots, which both exist if
∆ > ∆∗ ≡ max
{
γ
γ − 1 ,
γ + 1
γ
}
> 1, (A.6)
given γ > 1.
Clearly, the ζ± give, under the map fλ, the activation and deactivation thresholds λ±,
respectively. Proceeding first with ζ+ = O(√ε),
pλ (ζ+) ∼ −α2 (αδ − β) ζ+, qλ (ζ+) ∼ −α2ζ+,
so
λ+ = fλ (ζ+) ∼ β (∆− 1) . (A.7)
Similarly, for ζ− = O(1),
pλ (ζ−) ∼ −α2βζ2− − α2 (αδ − β) ζ−, qλ (ζ−) ∼ α2γζ3− − α2 (γ − 1) ζ2− − α2ζ−,
so
λ− = fλ (ζ−) ∼ β
γ∆+Θ− 2√γ∆Θ , (A.8)
which, in particular, is positive ifΘ ≥ 0 as, in this case, the nontrivial positivity condition
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Figure A.1: Relative errors of approximation of the asymptotic forms. Relative errors of approximation of
the asymptotic forms of the Fas and FasL thresholds ζ± and λ±, respectively, with respect to the numeri-
cally computed thresholds.
is
√
γ∆
Θ
+
√
Θ
γ∆
> 2,
which is satisfied sinceΘ = γ∆−(γ+1) < γ∆, so γ∆/Θ (= 1. Therefore, all thresholds
ζ± and λ± are real and nonnegative if (A.6) holds.
The accuracy of the asymptotic forms of ζ± and λ± were verified by letting
α =
5
ε
, β = 1, γ = 5, δ = ε
(so that the baseline is achieved with ε = 10−2) and comparing with the numerically
computed thresholds over 10−6 ≤ ε ≤ 10−1. The results confirm the analysis and fur-
thermore reveal that ζ+ and λ+ have relative approximation errors ofO(√ε); and ζ− and
λ−, O(ε) (Fig. A.1).
A.2 Threshold variation data statistics
The statistics of the threshold variation data (Dataset 1;N = 103, χ = 0.25) are observed
to match well with expectations and furthermore reveal the effect of total parameter vari-
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Quantity Maximum Minimum Median Norm. std. dev.
parameters
α 1116.760 225.184 505.387 0.252
β 2.086 0.453 1.007 0.252
γ 10.859 1.887 4.989 0.254
δ 0.023 0.005 0.010 0.250
thresholds λ+ 11.020 0.636 3.258 0.504
λ− 8.297 0.579 2.482 0.480
Table A.2: Parameter and threshold statistics for threshold variation data (Dataset 1). The data comprise
N = 103 trials drawn by independently sampling each parameter from a log-normal distribution with
a scaled standard deviation of χ = 0.25 about its baseline median value. Bistability thresholds were
computed numerically for each parameter set, with statistics computed only over bistable sets.
Threshold Parameter Correlation
λ+
α +0.724982
β −0.148639
γ −0.168286
δ +0.638670
∆ +0.855905
λ−
α +0.663543
β −0.105978
γ −0.404652
δ +0.620883
∆ +0.783721
Table A.3: Parameter-threshold correlations for threshold variation data (Dataset 1). Correlations were
computed only over bistable parameter sets.
ation on the bistability thresholds λ± (Table A.2). Moreover, parameter-threshold cor-
relations suggest that both λ± are relatively insensitive to β, with λ+ being additionally
robust to γ (Table A.3).
A.3 Discrete variation analysis for robustness of bistability
In Sec. 7.3.2 Dataset 2 was described that suggested convergence of the bistable fraction
to 0.5 as the magnitude of parameter variation χ → ∞. This asymptotic value may be
explained using a very simple discrete analysis. Characterize the variation of each param-
eter as either greater or less than the baseline, and assume that all variation is identical in
proportion. Propagate changes in α, β, and δ to ∆ using (A.3), and further assume that
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Parameter Variation
α + + + + − − − −
β + + − − + + − −
δ + − + − + − + −
∆ + − + + − − + −
Table A.4: Discrete variation analysis for robustness of bistability. All variation is independent and as-
sumed binary (+/−, above/below baseline), identical in proportion, and large (∆ > ∆∗ if +; ∆ < ∆∗ if
−). Variations are propagated through ∆ = αδ/β, which predicts a 50% bistable fraction, assuming that
γ > 1.
variation is large so that ∆ > ∆∗ if the net result is an overall increase, and ∆ < ∆∗
if a decrease (Table A.4); recall that, given γ > 1, ∆ > ∆∗ is the asymptotic bistabil-
ity condition, which has been validated against the threshold variation data (Dataset 1).
Since the baseline values are also the median values of the parameter distributions, each
variation occurs independently with probability 1/2, so each outcome is equally likely.
Therefore, assuming that γ > 1, the bistable fraction (∆ with + variation) is also 1/2.
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Appendix B
Comparison with the crosslinking
model
B.1 Solution of crosslinking model
From Sec. 7.3.4, the steady-state FasL-Fas complex concentrations are
γ1,∞ = 3λ∞
(ρ∞
κ
)
, γ2,∞ = 3λ∞
(ρ∞
κ
)2
, γ3,∞ = λ∞
(ρ∞
κ
)3
, (B.1)
so apply ligand conservation, i.e., λ0 = λ+ γ1 + γ2 + γ3, at steady-state to obtain
λ∞ =
λ0
1 + 3 (ρ∞/κ) + 3 (ρ∞/κ)
2 + (ρ∞/κ)
3 , (B.2)
where ρ∞ is given by applying receptor conservation, i.e., 1 = ρ + γ1 + 2γ2 + 3γ3, and
solving
ρ4∞ + (3λ0 + 3κ− 1) ρ3∞ + 3κ (2λ0 + κ− 1) ρ2∞ + κ2 (3λ0 + κ− 3) ρ− κ3 = 0,
which has the unique nonnegative root
ρ∞ =
1
2
[√
(3λ0 + κ− 1)2 + 4κ− (3λ0 + κ− 1)
]
. (B.3)
B.2 Steady-state invariants
A brief overview of the relevant mathematics is given; for details, see, e.g., Cox et al.,
1997.
B.2 Steady-state invariants 170
Let f = (f1, . . . , fm) ∈ K[x] be a system of polynomials in x = (x1, . . . , xn) with
coefficients from a field K. For this context, f is a set of mass-action dynamics, where
x is a set of species concentrations, and K is, e.g., the real numbers R; or the field
R(a) of rational functions in the kinetic parameters a = (a1, . . . , ak) with coefficients
in R; or the field Z(a) of rational functions in a with coefficients in the integers Z.
Consider the variety V = {x ∈ Kn : f (x) = 0} on which f vanishes—this is simply
the set of steady-states of f—and let I = 〈f〉 be the ideal generated by f , containing
all polynomials of the form∑mi=1 fihi, where the hi ∈ K[x] are arbitrary polynomials.
Clearly, I consists of all polynomials in K[x] that vanish on V . Thus, I is invariant on
and hence characterizes V , in particular, through the requirement that for any x ∈ V ,
h(x) = 0 for all h ∈ I .
The elements f1, . . . , fm of f form a basis for I . This basis is not unique; notably,
may be expressed I = 〈g〉 in terms of a Gro¨bner basis g = (g1, . . . , gl), which has
particularly useful properties, chief among them, for this application, the elimination
property, which states that, relative to the lexicographic ordering x1 > · · · > xn, the
elimination ideal I˜ = I ∩K[x˜] of I containing only the variables x˜ = (xi+1, . . . , xn) is
simply I˜ = 〈g ∩K[x˜]〉. Gro¨bner bases thus give a straightforward method of computing
elimination ideals, which may be useful, for example, if the concentrations of certain
molecular species x1, . . . , xi cannot be measured experimentally and hence, in principle,
must remain unknown. The generators g˜ = g∩K[x˜] of I˜ then constitute experimentally
measurable steady-state invariants of the system, i.e., g˜(x˜) = 0 for all x˜ ∈ V˜ , where V˜
is the projection of V onto the coordinates x˜.
In the current context, since f comes from mass action, then K = Z(a), thus treat-
ing parameters symbolically and hence allowing the derivation of invariants valid for all
choices of a.
Gro¨bner bases are a standard tool in computational algebraic geometry and can be
computed by many software packages, including Maple (Waterloo Maple Inc., Waterloo,
Ontario, Canada), Mathematica (Wolfram Research, Inc., Champaign, IL, USA), and
Sage (http://www.sagemath.org/).
Steady-state invariants for the hysteron and crosslinking models were computed as
outlined in the Materials and methods using Sage (http://www.sagemath.org/), giving
ωH (λ0, ζ) = c13λ0ζ3 + c12λ0ζ2 + c11λ0ζ + c02ζ2 + c10λ0 + c01ζ + c00, (B.4)
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where
c13 = −α2γ − 2γ,
c12 = α
2 (γ − 1)− 2αγ + 6γ + 1,
c11 = α
2 + 2α (γ − 1)− (7γ + 3)
c02 = −α2β + β,
c10 = 2α + 3γ + 2,
c01 = −α2 (αδ − β)− α (3αδ + 2β)− 3 (αδ + β)− δ,
c00 = 2αβ + 2β,
and
ωC (λ0, ζ) = 3λ0ζ − ζ2 − 3λ0 + (κ+ 1) ζ , (B.5)
respectively. Correctness of ωH may be shown by observing that ωH/ζτ = (α + 1)3 is
constant under the identification λ = λ0; similarly, the correctness of ωC is demonstrated
by verifying that ωC = 0 for ζ = γ1,∞ + 2γ2,∞ + 3γ3,∞.
B.3 Nonnegative least squares for model discrimination
To cast the optimization of ωH and ωC into nonnegative least squares (NNLS) form, the
problem was linearized by considering ωH and ωC as functions of
xH =
(−λ0ζ3, λ0ζ2, λ0ζ , −ζ2, λ0, −ζ , 1) , xC = ζ ,
respectively. Then, given experimental data U = (λ0, ζ∞), we may write
ω (U ; c) = Uc (a)− b (U) , (B.6)
suppressing model reference for generality, where U is a row vector corresponding to
the data represented in terms of the variables x; c (a) is a column vector of nonnegative
coefficients in the model parameters a to be determined, constrained by the limit (A.1)
with∆ > 1; and b is a column vector of constants given the data. For the hysteron model,
cH ∈ R7+, bH = −λ0ζ2 + 3λ0ζ − 2λ0,
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where subscript notation has been used in the obvious manner and R+ denotes the non-
negative real numbers, while for the crosslinking model,
cC ∈ R+, bC = −3λ0ζ + ζ2 + 3λ0 − ζ .
For many experimental trials, U is considered instead as a matrix, with each row
denoting an individual sample, so that ω(U ; c) = 0 now gives an overdetermined system.
This leads to a natural least squares problem for . = ‖ω‖ = ‖Uc− b‖ as a function of c,
which in particular is in NNLS form given the nonnegativity of c. A significant advantage
of NNLS over direct nonlinear optimization is that . is minimized exactly, producing an
error that is indeed a global minimum (Lawson and Hanson, 1995).
B.4 Performance of model discrimination
As described in Sec. 7.3.4, the NNLS formulation for model discrimination was tested,
using N = 100 samples generated from each model (Datasets 3 and 4), chosen based on
the dimensions of cH and cC. The results show that errors are low if the models underlying
the data generation and the invariant minimization are the same, and large otherwise.
Note that NNLS provides a lower bound to the cross-model errors due to the introduction
of additional degrees of freedom for linearization. Furthermore, it is remarked that the
crosslinking-crosslinking optimization was able to recover the coefficient κ + 1 of ζ in
ωC.
To verify that these results should hold generally, the distributions of the data λ0 and
ζ∞ were analyzed (Fig. B.1). The data are clearly nondegenerate, thus it is believed that
the results are representative.
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Figure B.1: Distributions of the invariant measurablesλ0, the total FasL concentration, and ζ∞, the steady-
state active Fas concentration, for data generated from the hysteron and crosslinking models (Datasets 3
and 4).
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Appendix C
SBML implementation
C.1 Model definition
The hysteron and hysteron-caspase models with n = 3 were implemented in dimensional
form using the Systems Biology Markup Language (SBML) Level 2 Version 1 (Finney
and Hucka, 2003; Hucka et al., 2003) and are named hysteron.xml and
hysteron-caspase.xml, respectively.
Corresponding dimensional baseline parameters were used, though k4 = 0 (θ = 0)
was not restricted as in the nondimensional case (Table ??). Initial concentrations (Table
C.1) were estimated from the literature (Albeck et al., 2008a,b; Bagci et al., 2006; Bentele
et al., 2004; Eissing et al., 2004; Harrington et al., 2008; Hua et al., 2005; Legewie et al.,
2006; Okazaki et al., 2008; Rangamani and Sirovich, 2007), though it should be noted
that substantial variation exists (see Svingen et al., 2004). Time course simulation of the
models validates their definition (Fig. C.1).
The SBML models are demonstrated below by using standard SBML-compliant soft-
ware (see Bergmann and Sauro, 2006).
C.2 Sensitivity analysis
Sensitivity analysis of the hysteron model was performed with respect to the steady-state
by using openly available toolboxes such as SBML-SAT (Zi et al., 2008) and SBTOOL-
BOX2 (Schmidt and Jirstrand, 2006). Local sensitivity analysis was conducted using
SBML-SAT with a perturbation coefficient of 0.01 about baseline parameters (Tables ??
and C.1). The results highlight the importance of the parameters l, the FasL concentra-
tion; k±1, the rates of constitutive receptor closing and opening, respectively; k4, the rate
of ligand-induced receptor opening; and x0, the initial Fas concentration (Fig. C.2A).
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Model Species Initial condition (nM)
hysteron
X 10
Y 0
Z 0
L 0.2 (0.1)
caspase
Casp8 100
Casp8∗ 0
Casp3 100
Casp3∗ 0
Table C.1: Initial concentrations for the SBML implementations of the hysteron and hysteron-caspase
models. For sensitivity analyses, the FasL (L) concentration was set to l = 0.1 nM (within the bistable
regime). FasL is considered a species only nominally and is otherwise treated as a parameter.
Figure C.1: Time courses of SBML hysteron and hysteron-caspase models at baseline parameters and
initial conditions (Tables ?? and C.1).
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Figure C.2: Sensitivity and robustness analysis of the hysteron model with respect to the steady-state
using SBML-SAT. Baseline values as reference (Tables ?? and C.1). (A) Local sensitivity analysis using a
perturbation coefficient of 0.01. (B) Global sensitivity analysis using partial correlation coefficient analysis
(PRCC), Sobol’s method, and multi-parametric sensitivity analysis. Parameters were perturbed over five
orders of magnitude (N = 2× 103 simulations). (C) Robustness analysis usingN = 103 perturbations.
These corroborate, but do not completely reproduce, the nondimensional analysis.
Global sensitivity analyses were also performed. Methods employed include partial
rank correlation coefficient analysis (PRCC), Sobol’s method, multi-parametric sensitiv-
ity analysis (MPSA), weighted average of local sensitivities (WALS), and the Fourier
amplitude sensitivity test (FAST). Briefly, PRCC is based on multiple linear regression,
Sobol and FAST are variance-decomposition methods, MPSA uses a classifier-based dis-
crimination scheme, andWALS extends local sensitivity analysis; for details, see Bentele
et al. (2004); Chan et al. (1997);Marino et al. (2008); Saltelli et al. (2005); Sobol’ (2001);
Tura´nyi (1990); Zheng and Rundell (2006); Zi et al. (2005). Total effect sensitivities ac-
count for combinatorial parameter effects. Analyses performed using both SBML-SAT
and SBTOOLBOX2 exhibit general consistency in emphasizing the parameters l, k±1,
and k4 (Figs. C.2B and C.3).
C.3 Robustness analysis
Robustness analysis was also conducted using SBML-SAT. The robustness is defined as
R = − 1
N
N∑
i=1
∣∣∣∣∣log10
(
f˜i
f
)∣∣∣∣∣ , (C.1)
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Figure C.3: Global sensitivity analysis of the hysteron model with respect to the steady-state using
SBTOOLBOX2. Baseline values as reference (Tables ?? and C.1). Parameters were perturbed over five
orders of magnitude (N = 2× 103 simulations for PRCC, FAST, and Sobol;N = 103 for WALS).
where f is the reference model output, f˜i is the perturbed model output of parameter set
i, and N is the number of randomly generated parameter sets (see Kitano, 2007). Note
thatR ≤ 0; the closer thatR is to zero, the more robust the system. Parameter generation
was done using Latin hypercube sampling, with each parameter set characterized by the
total parameter variation
TPV =
M∑
i=1
∣∣∣∣∣log10
(
k˜i
ki
)∣∣∣∣∣ , (C.2)
where ki and k˜i are the reference and perturbed values of parameter i, and M is the
number of model parameters. For details, see Barkai and Leibler, 1997; Blu¨thgen and
Herzel, 2003; Zi and Sun, 2005. Results exhibit a double-banded structure for the steady-
state concentrations x∞ and z∞, demonstrating robustness in the context of bistability
(Fig. C.2C).
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Appendix D
Datasets
Threshold variation (Dataset 1), bistability robustness (Dataset 2), and hysteron and
crosslinking model discrimination (Datasets 3 and 4) data are consolidated in space-
delimited format (Table D.1), and are named threshold-variation.txt,
bistability-robustness.txt, hysteron-discrimination.txt, and
crosslinking-discrimination.txt, respectively.
Dataset Column
1 2 3 4 5 6 7
1 α β γ δ λ+ λ− 1b
2 χ 2b.f.
3 λ0 ξ0 η0 ζ0 λ0 ζ∞
4 λ0 ρ0 γ01 γ
0
2 γ
0
3 λ0 ζ∞
Table D.1: Space-delimited format for stored data. Dataset 1, threshold variation; dataset 2, bistability ro-
bustness; dataset 3, hysteron model discrimination; dataset 4, crosslinking model discrimination. Notation
as in main text; 1bistable (true/false), and 2bistable fraction.
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